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Introduction 
The nucleus is defined by the nuclear envelope (NE), which is composed of an 
outer and inner nuclear membrane (ONM, INM, respectively) interrupted by 
nuclear pore complexes (NPC)1 (Figure 1). The ONM, continuous with and 
functionally related to the endoplasmic reticulum (ER)2, is separated from the 
distinct INM by a luminal space. The INM and ONM converge at sites of 
incorporated NPCs, which are homogenously spread across the NE and regulate 
nuclear import and export of macromolecules. Furthermore, the nucleoplasmic 
side of the INM is coated by the nuclear lamina, a layer of intertwined 
intermediate filament A-type (Lamin A, C) and B-type lamins (Lamin B1, B2), 
membrane proteins anchoring the lamina to the NE (including Emerin, LAP2, 
LBR) and proteins that modulate and interact with peripherally localized 
chromatin (including BAF, HP1)3 (Figure 1). The discovery of a mutation in the 
LMNA gene, that encodes for lamin A and C, as the cause of the autosomal 
dominant Emery-Dreifuss muscular dystrophy4 merely a decade ago, launched 
numerous research studies investigating the role of A-type lamins in human 
disease. Since then, 11 distinct phenotypes have been associated with LMNA 
mutations , including several types of muscular dystrophyies lipodystrophies, 
cardiomyopathies, neurological disorders and premature aging syndromes.5 This 
broad range of LMNA related diseases, commonly referred to as laminopathies, 
suggests that A-type lamins play a pivotal role in diverse biological systems. 
 
The nuclear lamina are important for maintaining nuclear integrity. Lamin fibers 
are assembled by head-to-tail polymerization of lamin dimers, and loss or 
mutation of lamin A causes dramatic structural changes that make nuclei less 
capable to tolerate mechanical strain and result in increased cell death.6-7 
Furthermore, A-type lamins are involved in cell differentiation. Dominant 
negative lamin A mutants block myoblast differentiation8 and progerin, a lamin 
A mutant associated with the premature ageing disease HGPS (Hutchinson-
Gilford Progeria Syndrome), inhibits adipogenisis and favors osteogenic stem 
cell differentiation.9 In addition, lamins regulate the expression of gene 
pathways by interacting with numerous transcription factors.10-12 Finally, lamins 
are crucial for chromatin organization as loss of A-type lamins results in thinning 
or loss of peripheral heterochromatin13 and various LMNA mutations modify  
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Figure 1. Schematic cartoon of various proposed interactions of lamins with inner nuclear 
membrane (INM) proteins, the nuclear pore complex (NPC), chromatin and various other 
nucleoplasmic factors. Lamins are located both underneath the INM in a thick layer, as within the 
nucleoplasm. Lamin A is synthesized in the endoplasmic reticulum (ER) as a precursor (prelamin 
A), which is farnesylated and processed by Face1 to release mature lamin A. LAP2 β, Emerin and 
Man1 are localized in the INM and capable of interacting with barrier-to- autointegration factor 
(BAF) with their LEM domain. The lamin B receptor (LBR) interacts with lamins as well as with 
heterochromatic protein 1 (HP1). INM localized SUN proteins and outer nuclear membrane 
(ONM) localized nesprin proteins interconnect the nuclear lamina to the cytoskeletal 
intermediate filaments and actin fibers. Furthermore lamins interact with PCNA, and the 
transcription factors Rb and cFOS.
 
chromatin structure and localization as well.14-15 Although progress has been 
made in understanding molecular functions of A-type lamins, many aspects still 
remain elusive. 
 
The nuclear lamina are important for maintaining nuclear integrity. Lamin fibers 
are assembled by head-to-tail polymerization of lamin dimers, and loss or 
mutation of lamin A causes dramatic structural changes that make nuclei less 
capable to tolerate mechanical strain and result in increased cell death 6-7. 
Furthermore, A-type lamins are involved in cell differentiation. Dominant 
negative lamin A mutants block myoblast differentiation 8 and progerin, a lamin 
A mutant associated with the premature ageing disease HGPS (Hutchinson-
Gilford Progeria Syndrome), inhibits adipogenisis and favors osteogenic stem 
cell differentiation 9. In addition, lamins regulate the expression of gene 
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pathways by interacting with numerous transcription factors 10-12. Finally, lamins 
are crucial for chromatin organization as loss of A-type lamins results in thinning 
or loss of peripheral heterochromatin 13 and various LMNA mutations modify 
chromatin structure and localization as well 14-15. Although progress has been 
made in understanding molecular functions of A-type lamins, many aspects still 
remain elusive. 
 
First, it remains uncertain whether differentiation defects are common amongst 
tissues affected by laminopathies. LMNA mouse models have mainly been used 
to study tissue defects in the young adult mice, thereby potentially missing 
defects in tissue differentiation, which occurs especially during early post-natal 
development. A common role of lamin A in tissue differentiation is suggested by 
the observations that lamin A expression highly correlates with the level of 
differentiation. Lamin A expression is turned on during the embryonic 
developmental stage of tissue differentiation 16-17 and in stem cells lamin A is 
only expressed after differentiation induced loss of pluripotency 18. Furthermore 
loss of lamin A expression correlates with poor histological differentiation of 
primary gastric carcinomas 19.  
 
A second question to be answered is how A-type lamins regulate chromatin 
organziation. The findings that A-type lamins interact in vitro with DNA and 
histones 20-21  and B-type lamins bind chromatin in vivo 22,  led to the hypothesis 
that A-type lamins regulate chromatin organization by direct in vivo interaction 
with chromatin. Such chromatin organization could be important to regulate 
gene expression, as genes occupy preferred subnuclear positions in relation to 
their transcriptional status  23.  A peripheral localization of many loci is 
associated with a transcriptionally inactive state, and several repressed loci 
relocate towards the nucleus’ interior upon activation 24.       
 
Finally, the major enigma in laminopathies is how mutations in one gene can 
cause so many phenotypic diversity. It is hypothesized that lamin A mutations 
affect specific lamina protein- and chromatin-interactions, thereby giving rise to 
laminopathy specific defects. In line with this hypothesis, Dunnigan familial 
partial lipodystrophy (FPLD) associated lamin A mutations specifically disrupt 
interaction with the adipogenic transcription factor Srebp1 10. Moreover, 
expression of a premature ageing associated lamin A mutant, E145K, 
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mislocalizes telomeres due to erroneous lamina interaction 15. The low  amount 
of studies identifying protein or chromatin interactions specifically interrupted 
by LMNA mutations indicates how challenging this quest is. This is mainly due to 
technological restricions, as the number of applicable techniques is limited due 
to the insoluble nature of nuclear lamina, and those assays that can be used 
typically are biased or only identify a small subset of interactors. Furthermore, 
most assays identify general lamin interactors and do not enrich for those 
interactors specifically affected by LMNA mutations. These limitations prevent 
unbiased identification and comparison of wildtype and mutant lamin A protein 
and chromatin interactions in a proteome- and genome-wide fashion. Such 
complete mapping would help to clarify the exact function of lamin A in diverse 
biological processes and may provide disease mechanisms for specific 
laminopathies. 
Aim of thesis  
The overall aim of this thesis is to identify molecular mechanisms underlying 
laminopathies. Specifically the role of LMNA and the effect of LMNA mutations 
were studied in the context of disruption of protein- or chromatin interactions, 
chromatin organization and early postnatal tissue differentiation.  
  
Based on this aim we defined the following goals: 
• Map protein interactions of A-type lamins in a proteome-wide unbiased 
approach. 
• Map chromatin interactions of A-type lamins in a genome-wide unbiased 
approach. 
• Identify laminopathy-related changes in these chromatin- and protein-
interactomes. 
• Identify a molecular disease mechanism for a laminopathy based on these 
changes. 
• Determine the biological relevance of A-type lamin chromatin interactions 
on chromatin organization and gene expression 
• Determine the biological relevance of A-type lamins in tissue differentiation 
during early post-natal development. 
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A detailed review on technological approaches to identify lamina protein and 
chromatin interactions is presented in Chapter 2. The identification of protein 
interactors of lamin A and progerin, the HGPS associated lamin A mutant, is 
summarized in Chapter 3. The identification of lamin A and progerin chromatin 
interactions and the biological relevance of these interactions in chromatin 
organization and gene expression is revealed in Chapter 4. Chapter 5 describes a 
novel disease mechanism for HGPS. The biological relevance of A-type lamins in 
early postnatal tissue differentiation is described in Chapter 6. The results 
obtained in these studies and their implications are discussed in chapter 7. 
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Abstract 
The nuclear envelope and lamina define the nuclear periphery and are 
implicated in many nuclear processes, including chromatin organization, 
transcription and DNA replication. Mutations in lamin A proteins, major 
components of the lamina, interfere with these functions and cause a set of 
phenotypically diverse diseases referred to as laminopathies. The 
phenotypic diversity of laminopathies is thought to be the result of 
alterations in specific protein- and chromatin interactions due to lamin A 
mutations. Systematic identification of lamin A-protein and -chromatin 
interactions will be critical to uncover the molecular etiology of 
laminopathies. Here we summarize and critically discuss recent technology 
to analyze lamina protein- and chromatin interactions.   
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Introduction 
The nuclear periphery is marked by  the nuclear envelope (NE), which is 
composed of an outer and inner nuclear membrane (ONM, INM, 
respectively) interrupted by nuclear pore complexes (NPC).1 The nuclear 
lamina lines the NE and consists of a large collection of proteins, most 
prominently the intermediate filament A-type (Lamin A, C) and B-type 
lamins (Lamin B1, B2), INM proteins anchoring the lamina to the NE 
(including Emerin, MAN1, LAP2, Nesprin) and proteins that modulate and 
interact with chromatin such as BAF, HP1 and histone deacetylase 3 (Figure 
1).2  
 
Mutations in the lamina’s major constituent, particularly the A-type lamins, 
cause a diverse set of human diseases collectively referred to as 
laminopathies; these include several types of muscular dystrophies, 
lipodystrophies, cardiomyopathies, neurological disorders and premature 
aging syndromes.3 The phenotypic diversity of laminopathies is 
hypothesized to be caused by lamin A mutations affecting specific lamina 
protein- and chromatin-interactions, thereby compromising nuclear 
integrity, higher-order chromatin organization, gene expression and/or 
various other nuclear processes.4 In line with this notion are the 
observations that Dunnigan familial partial lipodystrophy (FPLD)-associated 
lamin A mutations specifically disrupt interaction with the adipogenic 
transcription factor Srebp15 and that failure of progerin, a lamin A mutant 
that causes premature aging, to interact with the NURD chromatin 
remodeling complex contributes to loss of peripheral heterochromatin, a 
hallmark of the premature aging disorder Hutchinson-Gilford Progeria 
Syndrome (HGPS).6 Another progeria-associated lamin A mutation, E145K, 
leads to aberrant interaction of the lamina with telomeres.7  
 
A key challenge in the field of lamin biology is to identify all protein and 
chromatin interactions at the nuclear periphery. Over the past years, several 
approaches have been developed and applied in order to systematically 
map the complete spectrum of lamina protein- and chromatin-interactions. 
Such approaches are crucial to elucidate the biological function of the 
lamina and pinpoint molecular defects for specific laminopathies. In this 
review we provide an overview of current technology aimed at identifying 
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protein- and chromatin-interactions at the lamina. We focus on proteome- 
and genome-wide unbiased approaches, with particular emphasis on 
technical advantages and potential pitfalls in the context of subsequent 
mass spectrometry8-9, high-throughput microscopy and mass sequencing 
analysis.10 The methods discussed each with its strengths and weaknesses 
are all complementary but they all contribute to increasing our knowledge 
of function of lamins and the nuclear periphery. 
Protein-interactions  
Visual Screens 
A basic approach to identify lamina proteins is by visual inspection of the 
localization of candidate proteins. In visual screens putative lamina proteins 
are expressed using specific tags and their localization, depending on the 
tag, is then detected either using live cell imaging or indirect 
immunofluorescence. The use of fluorescent or other epitope tags has 
made it possible to systematically visualize the localization of a large 
number of putative lamina proteins and lamin-interacting proteins by high-
throughput microscopy. The most commonly used tags are GFP and Myc. 
The foremost advantage of visual screens is the instant registration of 
dynamic or abnormal changes in subcellular protein-complex localization in 
the context of changed cell physiology or protein mutation, respectively 
(Table 1). Capture of such dynamic behavior has been successfully applied11 
to the study of the nuclear lamina; lamin A interactions with Rb, c-FOS and 
SMAD2 occur only under specified conditions, like proliferation, 
differentiation and TGFβ stimulation.12-13 Sensitivity, specificity and spatial 
resolution in cell-based imaging are somewhat confounded by the necessity 
to co-stain for relevant subcellular domains as well as low cellular 
abundance of NE proteins.14-17 Bioinformatic approaches can assist in visual 
screens by selecting for predicted membrane proteins18 localized at the 
NE.19   
 
A powerful and more sophisticated approach of a visual screen to identify 
novel lamin interaction partners is the use of GFP-fusion protein libraries. In 
this approach 
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collections of GFP-tagged fusion proteins are expressed, screened by high-
throughput microscopy for subcellular localization, and clones of interest 
are subsequently sequenced to determine the identity of the expressed 
protein. Rolls et al. successfully applied a heterologous promoter-driven 
GFP-fusion library to screen 40.000 clones and test in an unbiased fashion 
whether they localized to the nuclear periphery.20 In doing so they 
discovered the NE membrane protein Nurim, a six-transmembrane spanning 
INM protein with potential isoprenylcysteine carboxymethyltransferase 
enzymatic activity for Caax-motifs.20-21 A drawback of protein 
overexpression is possible mis-localization of the fusion protein; there is an 
obvious need for analysis of the effect of protein expression levels on its 
localization and the validation of each hit by analysis of the endogenous 
protein.15, 22 A key advantage of visual screens is that interactors which may 
associate with the small, but significant pool of lamin components present 
in the nucleoplasm, can be distinguished from those that interact with the 
peripheral pool of lamins.  In a more physiologically relevant approach, 
Bickmore and colleagues identified the NE associated protein Lyric/AEG-1, 
an apoptosis and cell growth implicated transcriptional regulator, by using 
gene trapping to insert 1350 reporters into active genes.11, 23 In this 
approach, endogenously expressed genes were spliced onto a  genomically 
integrated LacZ cassette, which allowed visualization of the resulting fusion 
proteins by X-gal staining and β-galactosidase immunohistochemistry.11 
Although such visual screens are becoming increasingly feasible, they are 
relatively labor intensive and slow.  
 Biochemical Fractionation 
NE proteins are highly lipophylic and lamina proteins are strongly resistant 
to high concentrations of salts and detergents. These biochemical 
characteristics are exploited in fractionation studies to separate NE and 
lamina proteins from other subnuclear domains. Such isolation drastically 
increases the frequency of detecting NE and lamina proteins by unbiased 
biochemical methods e.g. mass spectrometry (MS) (Table 1). Combined with 
recent MS advances in complex protein mixture analysis9, 24, such 
fractionation studies have the potential to contribute significantly to the 
identification of the full lamin proteome. As MS analysis itself cannot 
distinguish lamina proteins from contaminants, fraction purity is crucial. 
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Figure 1. A schematic view of lamina and lamina-interacting protein fractions purified by various 
techniques. The nuclear periphery consists of an inner nuclear membrane (INM), outer nuclear 
membrane (ONM), and is connected to the endoplasmic reticulum (ER). Salt solubilizes (left) weakly 
attached lamina proteins, but not the nuclear lamina. Detergents preferentially dissolve membrane 
proteins that are not anchored in the detergent resistant lamina.28, 66 Chaotropes and alkaline extraction 
generate an insoluble fraction mainly consisting of integral membrane proteins.66 Immunoprecipitations 
(right) with an antibody directed against lamin A/C, using mild lysis conditions (for example 01% NP-40, 
250 mM NaCl12), preferentially dissolve and precipitate nucleosoluble A-type lamins and protein 
interactors.35 For a lamin A OST pull-down assay46, cross-linking, indicated by crosses, captures protein-
protein and protein-chromatin interactions, and allows solubilization of the total lamin A/C pool while 
preserving interactions.   
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Various assays have been developed to fractionate NE and lamina proteome  
subsets, each with a specific trade-off between obtained purity and amount 
of background proteins.   
Protein Correlation Profiling (PCP) was developed to determine subcellular 
protein localization in crude extracts, separated by rate-zonal centrifugation 
into fractions which are subsequently analyzed by MS analysis (Table 1).25 In 
essence, the technology relies on co-detection of proteins known to reside 
in the organelle of interest and novel proteins.25 The main advantage of PCP 
is its ability to detect multiple co-segregating proteins in a complex mixture 
without the need to fully isolate and highly purify subcellular fractions. 
However, PCP comes at a price: as many subcellular domains are only 
partially separated by centrifugation, non-specific interactors co-purify and 
separation of true interactors relies strongly on computational analysis. 
Follow-up studies to characterize the properties of identified proteins are 
imperative. Although PCP analysis has not been applied yet to distinguish 
and define nuclear lamina/envelope proteins domains, the fact that 
differences in rate-zonal resolving properties have previously been used to 
purify NE fractions26, makes PCP a promising technique to identify NE and 
lamina proteins. 
 
In comparison to PCP, differential extraction assays use more highly purified 
fractions for MS analysis and consequently reduce non-specific co-
purification (Table 1). In general, biochemical fractionation of the NE starts 
with isolation of nuclei, removal of non-NE membrane fractions by 
centrifugation and digestion of chromatin to remove nucleoplasmic 
contents. Crude NE and lamina fractions are subsequently extracted in salt, 
detergent, and chaotrope or alkaline buffers to further remove different 
types of proteins. Salt preferentially dissolves chromatin-bound proteins 
and other non-membrane, weakly attached lamina proteins, but not lamina 
proteins (Figure 1). Detergents (Octyl glucoside, Trx-100, Empigen BB) mimic 
the lipid bilayer environment and particularly dissolve membrane-
associated proteins, except those that are anchored to the detergent 
resistant lamina (Figure 1). In this manner Cronshaw et al. successfully 
identified 6 novel NPC components, among which ALADIN, the gene 
mutated in the triple-A or Allgrove syndrome.27 Chaotropes (urea, thiourea) 
and alkalines (NaOH) are used to solubilize cytoskeletal, chromatin and 
lamina components, while leaving integral transmembrane proteins 
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embedded in the insoluble membrane fraction (Figure 1). As such lamina 
and lamina anchored INM/NE proteins are extracted by combined 
application of salt and detergent (Figure 1; 29-30), whereas integral INM- 
ONM- and ER-membrane proteins are purified by chaotrope or alkaline 
extraction (Figure 1).  
 
Despite increased sample purity by applying differential extractions, these 
fractionation studies are still hampered by co-purification of non-specific 
interactors, in particular from the peripheral ER, which is continuous with 
the ONM and therefore difficult to separate from the NE and lamina. To 
further reduce false positive hits, Dreger et al. compared salt, detergent and 
chaotrope/alkaline extractions, and were able to screen out ER 
contaminants in chaotrope/alkaline resistant fractions.28 This strategy 
identified 19 previously unknown and putative integral INM proteins, 
including Unc84a (Sun1), LUMA and two LAP2 isoforms.28 A disadvantage of 
this comparative approach is that selection is based on the assumption that 
all INM and lamina proteins have similar biochemical extraction 
characteristics. However, several lamina anchored INM proteins, like  
emerin, LBR and LAP1, behave biochemically very different in detergent or 
chaotrope-based extraction.28 
 
In an extenstion of purification methods, subtractive approaches can be 
used to filter out ER residing proteins. In these methods proteins identified 
in non-NE/lamina fractions, thus enriched for background, are subtracted 
from proteins detected in differential NE/lamina extracts. Schirmer and 
colleagues used microsomal membrane fractions as a source of background 
proteins, as these ER-rich fractions are easily obtained and can be prepared 
free of nuclear membranes.29 By combining differential fractionation and 
subtractive proteomics, they identified 67 previously unidentified NE 
transmembrane proteins. The disadvantage of using a reference background 
source is that proteins that reside in both the ER and NE, like AEG-1/Lyric, 
Sec13 and Torsin A, are inadvertently discarded.30-32 This is a serious 
concern, since it is now estimated that one third of cellular proteins have 
multiple organellar localizations.25 
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Affinity purification 
An alternative approach to identifying lamina interactions is affinity 
purification. In these approaches a protein of interest is epitope tagged and 
the bait protein is affinity purified using antibodies against the tag (Table 1). 
Affinity purification can identify and distinguish bound protein complexes 
from each other by co-elution and MS analysis. Such gradual elution was 
used for example to separate emerin-interacting RNA processing, signaling 
and chromatin remodeling complexes.33 In addition, it is possible to study 
interactions in the context of posttranslational modifications by using 
specific antibodies directed against them, for example phosphorylation-
dependent LBR-p32/p3434, lamin A-Rb and -Smad212 interactions. In 
contrast to biochemical fractionation, in which fractions are generated 
under denaturing conditions, the main challenge in affinity purification 
assays is to extract as many NE and lamina proteins while leaving protein 
interactions intact. Overly stringent solubilization dissolves many proteins at 
the cost of disrupting complexes, while excessively mild conditions do not 
dissolve all relevant interactors. Various strategies have been applied to find 
a good balance for this trade-off. 
 
In classic immunoprecipitations (IPs) solubilization conditions are optimized 
for the protein of interest (Table 1). Low amounts of detergents and salt 
preferentially solubilize nucleoplasmic pools of proteins (Figure 1), as 
described to exist for lamin A35 , and were mainly applied to study easy 
extractable, weakly bound NE interactors (Smad2, PP2A, Rb, Ubc9, hnRNP1, 
EGF1, SREBP1; See Table 2)5, 12, 36-38. Increasing amounts of detergents, salts 
and the solvent glycerol39 successfully solubilize protein complexes of well-
anchored NE and lamina components (LAP2β, Emerin, Nesprin2, Lamin B; 
Table 2), although sometimes at the cost of disrupting interactions 
(LaminA/B1/B2 - LAP2β)40 (Table 2). Highly stringent conditions were 
applied when studying NPC proteins as they were assumed to be highly 
stable structures (Table 2).41-43 Even though NPCs apparently better 
withstand stringent extraction, increased stringency of washing buffers 
disrupts interactions (Table 2).41 An additional disadvantage to be 
accounted for is that lysis buffers also can affect the antibody/epitope-
interaction. Various groups therefore prefer to dilute buffer compositions 
after initial lysis, which combines increased solubilization with the ability of 
protein complexes to reassemble and antibodies to bind under sequential 
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milder conditions. This strategy was used to identify unknown interactors 
for BAF and Emerin (Table 2).33, 44 Other limitations of antibody-based 
methods include the unavailability of IP-suited antibodies36, antibodies that 
recognize multiple epitopes (MAN1 antiserum)36, antibodies that cross-react 
undesirably with non-mature forms of a protein (prelamin A versus lamin 
A)38 or even disrupt protein interactions (laminA/B2 - LAP2β).40 
 
To avoid the use of antibodies, precipitations can be performed using 
bacterially expressed and purified baits, conjugated to beads prior to 
incubation with solubilized protein extracts. Fusing the bait to an epitope 
tag contributes to high quality purification of the bait, and efficient 
precipitation of interactors from protein extracts (Table 1). This approach 
was combined with mild lysis, for BAF and emerin interactors33, 44, or more 
stringent buffers for lamin-LAP2β and -nesprin 2 interactions (Table 2).40, 45  
In accordance with mild solubilization, identified BAF and emerin interactors 
represented many proteins that also reside outside the nuclear periphery 
(PARP, HP1gamma, RBBP4,7).40, 45 Another advantage of using a bait is the 
ability to pinpoint interactions to relevant protein domains, as the bait does 
not have to be incorporated in vivo and therefore cannot mislocalize, as 
described to occur for LAP2β constructs.40 The main disadvantages of IPs 
using a bait is that solubilization issues still remain and interactions formed 
in vitro do not necessarily occur in vivo.  
  
A major step forward in overcoming solubilization problems is the OneSTrEP 
(OST) pull-down assay6, 46, which combines the use of a biotin resembling 
OST-tag47-48 with mild cross-linking of cells prior to solubilization (Table 1). 
Cross-linking allows extraction of the total lamin A/C pool46 (Figure 1) while 
leaving protein interactions intact. The OST-tagged protein and its 
interactors can then be highly efficiently precipitated under denaturing 
conditions using a high-affinity, engineered streptavidin analogue (Table 2). 
Stringent washes reduce background, especially relevant for A-type lamins, 
known to be “sticky” proteins and reported to precipitate in negative pull-
down controls as well.44 The main advantages of the OST pull-down are that 
it can be used to identify a full in vivo interactome of a protein regardless of 
its subnuclear position, detect the effect mutations have on these 
interactions and identify weak interactors. OST pull-downs have been used 
to compare protein interactions for lamin A and progerin, an HGPS causing 
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lamin A mutant, and detected a decreased interaction for progerin with NPC 
components.44 The main disadvantages of this approach is that it is not 
possible to study endogenous proteins and that cross-linking does not allow 
gradual elution and thereby separation of interacting protein complexes 
(Table 1).   
Yeast Two-Hybrid 
An interesting alternative to affinity purifications is yeast two-hybrid (Y2H) 
(Table 1), in which a direct interaction between a DNA-binding domain 
fused bait and a co-expressed transcriptional activating domain fused prey 
allows growth under restrictive conditions. When the primary interest is to 
identify weak and direct interactors Y2H is useful as bait and prey are 
expressed by strong exogenous promoters, protein solubilization is not 
required and weak interactions are sufficient to allow restrictive growth. 
The focus on direct protein interactions, which might best reflect the core 
activities of the protein of interest, restricts the mapping of a complete 
interactome. Protein fragments can easily be used as bait since they don’t 
have to be incorporated in vivo, and have been applied to describe 
interactions between the specific domains of the nuclear envelope proteins 
Otefin, Lamin A, Nesprin2 and.45, 49-50The benefit of choosing the exact bait 
composition can further be exploited by choosing domains involved in 
disease mechanisms, like the 50 amino acid deleted region in progerin, 
shown in a Y2H screen to interact with the NURD chromatin remodeling 
complex component Rbbp4.6 Disadvantages of Y2H assays are the lack of 
information on protein complex composition, the inability to study 
posttranslational modifications and the large amount of false positives 
identified. The large amount of background can be caused by  endogenous 
transcriptional activity of bait or prey proteins, as reported for cFOS 
domains used to map lamin A interaction13, bait or prey proteins affecting 
yeast growth under restrictive conditions, and the fact that investigated 
interactions may never occur in vivo (Table 1). In addition, Y2H approaches 
for lamin proteins are particularly difficult since expression of lamin-fusion 
proteins in S. Cerevisiae has detrimental effects on the organism.  
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Chromatin-interactions 
In addition to protein-protein interactions, the importance of interactions 
between chromatin and the lamina is increasingly appreciated. In particular, 
many lamin proteins are now known to directly or indirectly interact with 
chromatin and chromatin defects are a hallmark of several laminopathies.51-
53 These observations have catalyzed the development of unbiased 
screening techniques for chromatin interactions at the NE. A broad 
distinction can be made between assays using affinity purification and those 
based on enzymatic activity (Figure 2, Table 3). 
Affinity based approaches: ChIP & OST pull-down 
Chromatin-protein interactions are most commonly interrogated using 
chromatin-immunoprecipitation (ChIP) methods. In this approach, a protein 
of interest is cross-linked to chromatin and immunoprecipitated using a 
specific antibody against the protein. The DNA is then identified either by 
targeted PCR methods or by genome-wide microarray or sequencing 
approaches. The major difference between conventional IPs and ChIP is the 
addition of a cross-linking step prior to solubilization of intact protein-
chromatin complexes. Cross-linking provides the advantage of combining 
ultra-sonication and stringent lysis, to shear DNA and dissolve NE proteins 
(Figure 2), with good preservation of protein-chromatin interactions (Table 
3). Just as for classic IPs, lysis buffers still need to be attuned to the strength 
of the epitope-antigen interaction. For this reason, initial ChIP studies were 
performed on Myc-tagged NPC proteins in S. Cerevisae54, as NPCs are easily 
dissolved in the absence of nuclear lamina and high quality ChIP-suited Myc 
antibodies are commercially available. For the INM protein Src1, a MAN1 
resembling protein, interactions with (sub)telomeric regions were identified 
in yeast using a high affinity protA-system.55-56 Silver et al. used endogenous 
Nup93 in HeLa cells by dialyzing the initial lysis buffer to a milder variant 
prior to incubation with antibodies.57 The foremost advantage of using 
antibodies is the ability to study endogenous proteins and chromatin 
interactions in the context of posttranslational modifications (Table 3).  
 
A modification of the classical ChIP approach is the use of the OneSTrEP tag 
(OST) pull-down which enables high affinity precipitation of OST-tagged 
proteins under denaturing conditions completely dissolving A-type lamins,  
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Figure 2. Schematic overview of techniques to identify chromatin interactions, which are 
categorized in enzymatic- and affinity-based approaches. For DamID59 a DNA adenine 
methyltransferase (Dam) tag (ball on stick) is fused to the protein of interest and adenylates 
(star) bound chromatin in vivo, enabling in vitro selective DpnI (scissor) restriction and 
subsequent amplification of restricted chromatin by ligation mediated PCR (LMPCR). For in 
vivo chromatin endogenous cleavage (ChEC)64 a protein of interest is fused to a micrococcal 
nuclease (MNase) tag , which introduces DNA double strand breaks (scissors) upon 
introduction of calcium chloride to weakly permeabilized cells. Due to the mild 
permeabilization of cells prior to addition of calcium chloride for activation, the MNase 
digestion step is indicated as being partially in vitro and in vivo. Restricted DNA is amplified 
by LMPCR. For chromatin immunocleavage (ChIC)64 cells are cross-linked (crosses). In vitro, 
MNase-conjugated antibody interacts with the epitope of interest and induces DNA breaks 
enabling LMPCR amplification of cleaved chromatin. For chromatin immunoprecipitation 
(ChIP) chromatin-protein interactions are cross-linked and chromatin is randomly sheared, 
typically by ultrasonication, ( lightning arrow and stripes). Antibodies are used to precipitate 
the endogenous protein of interest with the help of antibody binding beads (big ball). In a 
OneSTrEP (OST) pull-down a OST-tagged protein is expressed.58 Cells are cross-linked and 
ultrasonicated. The OST-protein is highly efficiently precipitated by a streptactin matrix (big 
square). 
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comparable to the use of OST tags used for pull-down of proteins (Table 3). 
46, 58 The OST pull-down for identification of chromatin interactions is highly 
similar to that for detecting protein interactions, and only includes slight 
changes in sonication and washing conditions.46, 58 Although OST pull-downs 
have the advantage of easy solubilization and high affinity pull-down 
without the use of antibodies, which in the case of lamin A have not been 
ideal in ChIP experiments, a limitation is the inability to directly study 
endogenous proteins and posttranslational modifications (Table 3). 
Enzymatic activity based approaches: DamID, In vivo ChEC, ChIC 
DamID is an enzyme-based method for the in vivo mapping of chromatin-
protein interactions. In DamID a protein of interest is fused to a DNA 
adenine methyltransferase (Dam) and expressed. Upon binding of the fusion 
protein to chromatin, the Dam activity marks in the vicinity bound 
chromatin by methylation, thereby enabling selective DpnI restriction in 
vitro. The marked sites can then be identified by targeted PCR or, more 
commonly, by genome-wide microarray analysis and deep-sequencing 59 
(Figure 2). The main advantage of using a tag that enzymatically marks DNA 
is that only isolation of DNA, not of intact protein/chromatin complexes, is 
required, thus eliminating any issues related to interaction stability. In 
addition, there is no need for cross-linking, thereby avoiding potential 
fixation artifacts. These characteristics made DamID the first technique to 
characterize and compare chromatin interactions for the relative insoluble 
lamin B and emerin proteins in a genome-wide fashion and resulted in the 
characterization of lamin associated domains (LADs) which define regions of 
the genome that preferentially interact with the lamina.59-60 Disadvantages 
of DamID include the inability to study posttranslational modifications, a 
slightly reduced resolution  
 
compared to alternative assays and potential interference of the tag with 
protein localization or functioning (Table 3).61 In addition, since DamID relies 
on the expression of an enzymatically active fusion protein, it monitors 
chromatin interactions over a relative long period of time (app. 24 hours) 
and therefore is less useful to detect rapid interaction changes and dynamic 
reorganization of chromatin. Due to the DNA binding activities and high 
enzymatic activity of Dam, tagged proteins can only be expressed in trace 
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amounts in order to prevent saturation of non-targeted DNA methylation.62 
This makes it not possible to study chromatin interactions in a dosage 
dependent manner, which could be relevant for diseases in which 
phenotypes are dependent on the amount of protein, such as HGPS.63     
 
An alternative method to measure protein-chromatin interactions is ChEC 
(chromatin endogenous cleavage). In this approach, micrococcal nuclease 
(MNase) is fused to a protein of interest and expressed. The fusion protein 
is recruited to its endogenous sites on chromatin where the MNase 
introduces double strand breaks at nuclease hypersensitive sites (HS).64-65 
The MNase tag remains inactive under physiological Ca2+ concentrations, 
which provides the ability to selectively turn its activity on in vivo by 
addition of calcium chloride to mildly permeabilized cells. Cleaved 
chromatin can either be directly used to map HS sites by indirect end-
labeling and Southern blotting, or is first selectively amplified by ligation-
mediated PCR prior to genome-wide microarray analysis and deep-
sequencing (Figure 2).64 Laemmli and colleagues used this approach to map 
chromatin interactions of the nuclear pore complex protein Nup2 and found 
that Nup2-gene promoter interactions typically are an early event of gene 
activation and are independent of transcription.64 Control over MNase 
activity and relative short times needed for  
 
digestion make this assay suitable for detection of rapid changes in 
interactions. The major strength of in vivo ChEC is that there is no need to 
dissolve intact protein/chromatin complexes and information on chromatin 
structure is obtained by mapping HS (Table 3). In comparison to DamID 
higher expression levels of MNase-tagged proteins can be used, although at 
very high expression levels background issues were reported.65 ChEC can 
also be modified to study posttranslational modifications as the MNase tag 
can also be conjugated to an antibody of interest. This in vitro method is 
referred to as chromatin immunocleavage (ChIC). In ChIC cross-linked cells 
are lysed and incubated with MNase-coupled antibodies that bind to the 
epitope of interest after induction of  DNA cleavage by Ca2+ (Figure 2). ChIC 
is a hybrid between affinity- and enzyme-based approaches in that it uses 
cross-linking and antibodies, but does not need to fully dissolve and 
precipitate intact protein-chromatin complexes due to the use of enzymatic 
activity, which specifically marks bound DNA (Table 3).  
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Concluding remarks 
The characterization of structural and other functional components in the 
nuclear lamina is vital for our understanding of higher-order chromatin 
organization, transcription, DNA replication and various other nuclear 
processes. Recent development of powerful techniques to map protein and 
chromatin interactions have begun to reveal these roles.  
 
Several approaches to identify the interaction network at the nuclear 
periphery are now available. These methods are all complementary and 
each has its own usefulness and limitations. Ideally, one would map the 
interactions of proteins and chromatin using multiple, complementary 
techniques. At present this is practically often not feasible, however, as 
interaction-detection methods are improved, it should become possible to 
interrogate interactions by multiple means.  For now, the choice of method 
often relies on the particular question to be addressed.  When it is 
important to identify multiple sub-cellular localizations of a protein, visual 
screens are the best option. Biochemical fractionation studies best assist in 
revealing a full proteome. A more detailed impression of an individual 
protein’s interactome can be obtained by classic IPs to study endogenous 
proteins, by OST pull-down to identify weak and relative insoluble proteins, 
and by IPs using a bait to distinguish individual protein complexes. Mapping 
interactions of direct and weak interactors to protein domains can best be 
done by Y2H. For DNA interactions a careful choice has to be made between 
the need for studying endogenous proteins and posttranslational 
modifications (ChIP, ChIC), obtaining extra information on chromatin 
structure (In vivo ChEC, ChIC), full protein solubilization and obtaining an 
instant snapshot of interactions (OST pull-down), or not dissolving 
protein/chromatin complexes and capturing interactions over a longer 
period of time (DamID).  
 
Even though the overlap between various chromatin techniques is slightly 
bigger then for protein techniques, in both fields a combinatorial or 
comparative use of techniques, as well as the target proteins they are 
applied on, will lead to more reliable results and provide a better 
understanding of the NE. These methods are becoming increasingly 
routinely used in many laboratories and is no doubt that proteome and 
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genome-wide mapping method and screening for mutation-induced 
interaction changes will play a key role in unraveling nuclear lamina function 
and  laminopathy disease mechanism. 
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Tables 
 
 
   Table 1: Techniques to identify protein interactions at the nuclear lamina 
 
Legend: No (-), endogenously expressed, but genetically modified (±), Yes (+). For ‘false positives’-column: low 
(-), moderate (±), high(+); AB=Antibody;*Data not analyzed for subnuclear structures yet.  
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Table 2: Solubilization conditions to identify protein interactions at the nuclear lamina 
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 Table 3: Techniques to identify chromatin interactions at the nuclear lamina 
Legend: No (-), Moderate time period (±), Yes (+) 
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Abstract 
The nuclear lamina is an interconnected meshwork of intermediate filament 
proteins underlying the nuclear envelope. The lamina is an important 
regulator of nuclear structural integrity as well as various nuclear processes, 
including transcription, DNA replication and chromatin remodeling. The 
major components of the lamina are A-type and B-type lamins. Mutations in 
lamins impair lamina functions and cause a set of highly tissue-specific 
diseases collectively referred to as laminopathies. The phenotypic diversity 
amongst laminopathies is hypothesized to be caused by mutations affecting 
specific protein interactions, possibly in a tissue-specific manner. Current 
technologies to identify interaction partners of lamin A and its mutants are 
hampered by the insoluble nature of lamin components. To overcome the 
limitations of current technologies, we developed and applied a novel, 
unbiased approach to identify lamin A-interacting proteins. This approach 
involves expression of the high-affinity OneSTrEP-tag, precipitation of lamin-
protein complexes after reversible protein cross-linking and subsequent 
protein identification by mass spectrometry. We used this approach to 
identify in mouse embryonic fibroblasts and cardiac myocyte NklTAg cell 
lines proteins that interact with lamin A and its mutant isoform progerin, 
which causes the premature aging disorder Hutchinson-Gilford Progeria 
Syndrome (HGPS). We identified a total of 313 lamina-interacting proteins, 
including several novel lamin A interactors, and we characterize  a set of 35 
proteins which preferentially interact with lamin A or progerin. 
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Introduction 
The nuclear lamina lines the nuclear envelope (NE), which is composed of an 
outer and inner nuclear membrane (ONM, INM,) interrupted by nuclear 
pore complexes (NPC).1 The lamina is a proteinaceous structure consisting 
of the intermediate filament A-type (somatic: lamin A, AΔ10, C; germ cell 
specific: C2) and B-type lamins (somatic: lamin B1, B2; germ cell specific: 
B3), integral membrane proteins anchoring the lamina to the NE including 
LAP2, Emerin, Lamin B receptor, MAN1, and proteins involved in a variety of 
nuclear processes including DNA replication, chromatin remodeling, cell 
cycle progression and signal transduction.2 Mutations in lamins or other 
lamina proteins can impair specific functions or interfere with the structural 
integrity of the nucleus.3 Mutations in lamin components cause various 
human diseases referred to as laminopathies and include several types of 
muscular dystrophies, lipodystrophies, cardiomyopathies, neurological 
disorders and premature aging syndromes.2  
 
One model for the tissue-specificity and phenotypic diversity among 
laminopathies is the notion that mutations which cause laminopathies lead 
to differential interactions of mutant lamins with their associated proteins.2 
In support, several mutations in the carboxy-terminus of lamin A that lead 
to Emery-Dreifuss muscular dystrophy (EDMD) or dilated cardiomyopathy 
1A (CMD1A) impair a direct binding of lamin A to emerin.4 In addition, 
progerin, the lamin A isoform that causes the premature aging disease 
Hutchinson-Gilford Progeria Syndrome (HGPS), is unable to interact with 
several members of the NURD chromatin remodeling complex, thereby 
contributing to HGPS characteristic chromatin defects.5 Although these 
observations suggest a role for differential protein interactions in the tissue-
specificity of laminopathies, they are circumstantial. Systematic mapping of 
the complete spectrum of wild-type and mutant lamin A interacting proteins 
is required to test this disease model. Such  approaches will also clarify the 
function of lamin A in biological processes and may contribute to the 
identification of targetable pathways relevant to specific laminopathies. 
 
Experimental approaches to identify lamin interacting proteins are severely 
hampered by the unique biochemical  properties of the nuclear lamina, 
which is classically defined as a non-ionic detergent, salt and nuclease 
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insoluble peripheral nuclear structure.1 Solubilization of the lamina by ultra-
sonication and high concentrations of ionic- or chaotropic detergents 
inevitably results in disruption of intact lamin-protein complexes, impeding 
analysis by precipitation methods. Various alternative strategies have been 
applied to circumvent these technical problems, including 
immunoprecipitation (IP) with partial solubilization under mild conditions, IP 
using harsh solubilization conditions followed by in vitro protein complex re-
assembly under mild conditions, mass spectrometry (MS) analysis of 
differential extractions from isolated whole nuclear membrane fractions, 
and yeast two-hybrid, GST-pull-downs and other techniques which do not 
need protein complex solubilization.6-12 Each technology has its specific 
drawbacks including low recovery, high false positive rates and non-
physiological conditions. 
 
Here we have developed and applied a novel method to identify wild-type 
and mutant lamin A interacting proteins. This approach is unbiased and 
overcomes many of the limitations of current methods to identify lamin A-
interacting proteins. Our approach consists of expression of lamin A tagged 
with a OneSTrEP biotin analogue tag followed by isolation of intact lamin-
protein complexes after protein cross-linking for 5 minutes using 1% 
formaldehyde. Direct and indirect interaction partners are identified by 
sensitive MS after a highly specific streptactin matrix precipitation. Using 
this approach we identify 313 lamina-interacting proteins including 
numerous novel candidates, and proteins that appear to associate 
preferentially with either wildtype lamin A (8 candidates, including Nup153, 
Nup98 and Translocated promoter region) or progerin (27 candidates, 
including Paired related homeobox 1, Proliferating cell nuclear antigen and 
Pinin). 
Materials & Methods 
Cell lines and culture 
A lentiviral expression plasmid for N-terminal OneSTrEP tagged progerin 
(OST-P) was created by PCR amplification of lamin A, omitting amino acids 
609-658 using the previously described pCDH MCSNard OST-A plasmid as 
template.5 Forward and reverse primers, containing a BamHI and EcoRI 
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restriction site, were used for subsequent ligation of the PCR product in 
BamHI/EcoRI digested pCDH MCSNard OST-A plasmid. For the cloning of 
pCDH MCSNard OST-Lamin C (OST-C), lamin C was PCR amplified from the 
previously described pBabe purox HA-Lamin C plasmid, adding an in frame 
5’ SalI and a 3’ EcoRI  site, which were used for ligation into equally digested 
pCDH MCSNard OST-A plasmid.13 Lentivirus was produced in 293 FT cells 
(Invitrogen, Carlsbad, USA) co-transfected with pCDHblast MCSNard OST-A, 
OST-P or OST-C in combination with pSPAX and pMD2.G vectors (Trono Lab). 
The mouse cardiac myocyte cell line NklTAg, human osteosarcoma cell 
(U2OS), as well as mouse embryonic fibroblasts (MEFs) of wildtype 
(LMNA+/+) and LMNA knock-out (LMNA-/-) embryos were infected with 
various concentrations of lentivirus and 48 hours post infection selected 
with blasticidin.14-15 Infected cells with OST-tagged lamin protein amounts 
comparable to endogenous lamin protein levels were further cultured and 
grown in Dulbecco’s modified Eagle’s/F-12 media  (for NklTAg cells) or 
Dulbecco’s modified eagle medium (for U2OS and MEFs) both 
supplemented with 2mM L-glutamine, 10mM non-essential amino acids, 
110 mg/l pyruvate, 10% fetal bovine serum and antibiotics in a humidified 
atmosphere at 37⁰C and 5% CO2. NklTAg cells were plated on 12.5 μg/ml 
fibronectin and 0.1% gelatin coated plates.  
Immunofluorescence 
For immunofluorescence microscopy LMNA-/- MEFs infected with control, 
OST-A or OST-P lentivirus were grown on 0.1% gelatin/PBS solution coated 
multi-wells glass slides (MP Biomedicals). After fixation (4% 
paraformaldehyde/PBS; 15 min), cells were permeabilized (0.5% Triton X-
100/PBS; 5 min), blocked (1%  BSA, 1% sucrose in milliQ; 1 hour) and 
incubated for one hour with appropriate primary antibodies (α-LMNA/C, Sc-
7292, Mouse, Santa Cruz, detects OST-tagged and endogenous human, but 
not mouse, lamin A, Lamin C and Progerin; α-emerin, Cl.4G5, mouse, Leica; 
α-HP1γ, mab3450, Chemicon, Temecula, USA ; α-LAP2, kind gift from K.  
Wilson, raised against residues 1-187 of human LAP2, and suitable for 
detection of all LAP2 isoforms). Primary antibodies were detected with an 
Alexa Fluor 488 chromophore labeled secondary antibody (Invitrogen). Cells 
were mounted in Vectashield containing 10g/ml DAPI and observed on a 
Nikon E800 microscope. Quantitative microscopy measurements were 
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performed as previously described.16-17 Exposure times and acquisition 
settings were established at the beginning of the experiment and kept 
constant for all samples. The average nuclear intensity of total LAP2 (all 
isoforms included) and HP1γ  minus average background signal was 
measured for at least 200 cells per sample in duplicate using Metamorph 
software (Molecular Devices). The criteria to define cells with reduced levels 
of chromatin proteins were previously described.16-17 
OneSTrEP-lamin A farnesylation and proliferative effects 
To determine whether OST-A was correctly farnesylated U2OS cells 
expressing OST-A and C at endogenous levels were treated with indicated 
concentrations of Atorvastatin (10 mM stock dissolved in DMSO was further 
diluted in cell culture medium) for 48 hours. Samples were harvested in 
Laemmle Sample Buffer and further analyzed by western blotting. 
Proliferative effects of OST-tagged lamin A/C were determined with the MTS 
assay, as described elsewhere.13 LMNA-/- MEFs infected with empty control 
or OST-A and C were seeded at 1000 cells per well in 96 wells plates.15 62 
hours post attachment 20 ml 2 mg/ml 3-(4,5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (Promega 
CellTiter 96w AQueous MTS) and 1 ml 0.92 mg/ml phenazine methosulfate 
(Merck) was added for 3 hours. The tetrazolium is reduced by the living cells 
into a colored formazan product, which absorbance was measured at 490 
nm and is directional proportional to the cell number. Statistical analysis 
was performed by Student’s t-test. 
OneSTrEP pull-down assay and mass spectrometry 
U2OS, NklTAg and MEF cell lines were grown until confluency in 150 mm 
dishes. Plates were left for several minutes at  ambient temperature before 
protein complexes were mildly cross-linked by direct addition of 
formaldehyde to the culturing medium to a final concentration of 1% (10 
minutes, ambient temperature). The cross-linking reaction was stopped by 
addition of glycine (125 μM final conc.) and gentle shaking for 5 minutes at 
ambient temperature. Fixed cells were scraped in PBS, pelleted, dissolved in 
ice-cold SDS lysis buffer (1% SDS, 10 mM EDTA, 50 mM Tris pH 8.1), snap 
frozen in dry ice once, thawed, left for 30 minutes on ice and finally 
sonicated for 2 times 30 seconds at 10μm amplitude using a tip sonicator. 
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Endogenous biotinylated proteins were blocked by addition of avidin (10 
µg/ml). As the affinity of avidin for biotin is much higher then for the 
OneSTrEP epitope, OST-tagged lamin pull-downs will not be impaired by the 
addition of avidin.18 A small sample aliquot was taken, de-cross-linked for 6 
hours at 65⁰C in the presence of 200mM NaCl and 30 μg/ml RNAase A, after 
which the genomic DNA concentration was determined with a Qiagen PCR 
clean-up kit (Qiagen). Next, protein samples were diluted in SDS lysis buffer 
to contain equal amounts of genomic DNA (typically 200μg genomic 
DNA/pull-down for MS purposes) and subsequently diluted in ChIP dilution 
buffer (0. 1% SDS, 1.1% Triton X-100, 1.2 mM EDTA, 17 mM Tris pH 8.1, 170 
mM NaCl) to reach a final concentration of 0.2% SDS, 0.1% Triton X-100, 
2mM EDTA, 20 mM Tris.HCl pH 8.1, 150 mM NaCl. Both SDS lysis buffer and 
ChIP dilution buffer were supplemented with 2 mM sodiumortohovanadate 
and protease inhibitors (Boehringer MannHeim). Undissolved fractions were 
discarded after a 10 minute centrifugation step (16,000 g) at 4 degrees and 
a small sample of the supernatant (i.e. input fraction) was stored for further 
analysis. ChIP dilution buffer pre-washed Strep-Tactin Matrix (IBATagnology) 
was added and OST-lamin/protein complexes were bound by overnight end-
over-end rotation. Strep-Tactin matrix was pelleted by centrifugation and 
the supernatant (i.e. depleted fraction) was stored, while the pellet was 
washed four times with OST stringent wash buffer (2M NaCl, 2% Trx-100, 
500 mM LiCl, 0.1% SDS, 1% Sodium Deoxycholate, 20 mM Tris pH 8.1, 2mM 
EDTA) and twice with ChIP dilution buffer. LiCl was included to  improve the 
effective removal of non-specific interactors by the presence of different 
types of salts. Pelleted protein-chromatin complexes (pull-down fraction), 
input and depleted fractions were de-cross-linked by boiling for 20 minutes 
at 95⁰C in Laemmli Sample Buffer.  
 
For pull-down verification purposes samples were analyzed by western blot 
(see below). For mass spectrometry (MS) pull-down fractions were 
separated on NuPage Novex Bis-Tris 4-20% gradient gels (Invitrogen) and 
stained with Coomassie Brilliant Blue (CBB). For CBB staining gels were first 
fixed for minimally 2 hours in solution 1 (50% v/v ethanol, 2% v/v 
phosphoric acid), washed 3x30 minutes in distilled water, incubated for 1 
hour in solution 2 (34% v/v methanol, 17% w/v ammonium sulphate, 2% v/v 
phosphoric acid) and finally stained with CBB-G (0.66% w/v in distilled 
water) until desired staining intensity was reached (1-3 days). Gels were 
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stored in distilled water and transported for subsequent MS analysis at the 
Erasmus MC Proteomics Center (Rotterdam, The Netherlands). Gel lanes 
were cut and subjected to in-gel digestion with trypsin (Promega), 
essentially as described previously.19 Polypeptides were identified on  an 
LQT Orbitrap hybrid mass spectrometer (ThermoFischer), coupled to an 
1100 series capillary liquid chromatography system (Agilent Technologies) 
as described elsewhere.20 Data analysis was performed using a Mascot 
based search algorithm (version 2.2; MatrixScience).20 
Mass spectrometry data analysis 
In order to compare MS results of various samples, all retrieved GI and IPI 
protein identifiers were converted to Mus Musculus and Homo Sapiens 
Entrez identifiers, using the Database for Annotation, Visualization, and 
Integrated Discovery (DAVID), BioDBNet 
(http://biodbnet.abcc.ncifcrf.gov/db/db2db.php), Clone/Gene ID 
converter and g:profiler databases.21-24 For identifiers that could not be 
converted to Entrez identifier with these databases, the top hit with 
matching Entrez ID of a protein blast search 
(http://blast.ncbi.nlm.nih.gov) using a PSI-Blast algorithm was used. This 
created one list of all MS identified proteins in our study, which was used for 
alignment of individual MS sample results using excel software with a DigDB 
plugin (http://www.digdb.com/). To select true lamin interactors, several 
selection criteria were sequentially applied. First, proteins needed to be 
detected at high levels, i.e. average OST-A mascot score above 100, with the 
average calculated only in OST-A samples in which the protein was 
detected. Second, proteins were required to be detected at levels minimally 
3-fold less in background pull-downs (based on average mascot scores, 
calculated as described for previous criterion). Third, keratin proteins and 
proteins with gene ontology (GO) codes for mitochondria and ribosome, 
which are all considered non-lamin A interacting proteins, were excluded. In 
order to compare OST-A and OST-P pull-down results in LMNA-/- and 
LMNA+/+ MEFs these selection criteria were first applied to identify lamina 
interactors, independent of cell line and OST-A or OST-P construct. Amongst 
this protein set of lamina interacting proteins, differential interactors were 
selected by several additional criteria. Proteins were only included if in 
either cell line the overall average mascot score (including samples in which 
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no protein fragment was detected for calculation of the average) of OST-A 
or OST-P was above 100 and more than 3-fold larger than background pull-
down overall average mascot scores. Next, proteins were required to have a 
ratio of OST-P over OST-A overall average mascot scores above 3.0 or below 
0.33 in either LMNA-/- or LMNA+/+ MEFs;. The final inclusion criterion was 
that this ratio was similar directed (both above or below 1.0) in both cell 
lines. Mascot scores were considered semi-quantitative only, and were used 
to distinguish proteins that might either have higher affinity for lamin A or 
progerin (or associated proteins) or were expressed more abundantly in 
OST-A versus OST-P cells. Whether these candidates bound lamins directly 
or indirectly was not revealed by this method. 
 
GO analysis for indicated proteins subsets were performed separately for 
GO categories “cellular components level 5” (CC), “biological process all” 
(BP) and “molecular function all” (MF) using Mus Musculus Entrez Identifiers 
as input values and standard DAVID settings for functional annotation 
clustering, listing significant clusters by most significant GO term.22-23 GO 
analysis was performed against a random protein background consisting of 
all known Mus Musculus Entrez identifiers, or a set of previously identified 
nuclear envelope proteins.6, 10 To identify enrichment of protein complexes 
a clustering analysis was performed with DAVID against the reactome 
database, using Homo Sapiens Entrez gene identifiers.  
Plasmid transfection 
For verification of differential interactors U2OS Ctrl, OST-A and OST-P 
expressing cells were plated at 80% confluency in 10mm-dishes and FuGENE 
transfected with previously described expression plasmids for Myc-Nup98, 
Myc-Nup153, GFP-Nup107, GFP-Tpr and Myc-Prx1 (Kindly provided by 
respectively Günter Blobel, Brian Burke, Thomas Schwartz, Larry Gerace and 
Peter Lloyd Jones).25-29 32 hours after transfection cells were harvested for a 
OST pull-down assay. 
Western blot 
Western blots were performed essentially as described elsewhere.5 SDS-
PAGE Laemmli sample buffer was added to protein samples from various 
stages of the OST-pull-down (input, depleted, pull-down) and heated for 20 
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minutes at 95⁰C to de-cross-link and denature proteins. Equal amounts of 
protein extract were loaded and run on NuPage Novex Bis-Tris 4-20% 
gradient gels  (Invitrogen, Carlsbad, USA), blotted on immobilon-PVDF 
membrane (Millipore, Billerica, USA), blocked 1 hour in 5%  bovine serum 
albumin /TBS-T (20 mM Tris-HCl pH 7.5, 150 mM NaCl and 0.1% Tween 20). 
The blocked membrane was incubated at 4⁰C overnight in block buffer 
diluted primary antibodies. The following antibodies were used: α-LaminA/C 
(Sc6215, Goat, Santa Cruz; detects endogenous Lamin A and C, OST-A, OST-C 
and OST-P), α-LaminA/C (Sc7293, mouse, Santa Cruz; detects only 
endogenous Lamin A and C, and not OST-A, OST-C or OST-P), α-LAP2 (Y-20, 
Sc19783, Goat, Santa Cruz; detects all LAP2 isoforms), α-GFP (Ab6673, Goat, 
Abcam), α-Onestrep (2-1507-001, mouse, IBATagnology), α-c-Myc (MS-139-
P, mouse, Labvision), α-Emerin (Cl.4G5, mouse, Leica), α-Beta-Actin 
(Cl.AC15, A-5441, mouse, Sigma), α-Trim28 (A300-767A, rabbit, Bethyl 
Laboratories), α-Ku70 (Ab10878, rabbit, Abcam). After incubation with 
appropriate secondary HRP-labeled secondary antibodies 
immunoluminescence was detected with an ECL Western Blotting detection 
system from Amersham. Intensity of signals were quantified using ImageJ 
software and statistically analyzed with a Student’s t-test. 
Results 
Characterization of OneSTrEP tagged A-type lamins 
To ensure protein purification with high affinity and specificity, we made use 
of a modified version of the well-characterized streptavidin/biotin system.30-
31 A-type lamins were tagged with the OneSTrEP (OST) tag (Figure S1), and 
expressed at endogenous levels in human osteosarcoma (U2OS), mouse 
myocyte NklTAg or mouse embryonic fibroblasts (MEFs) from LMNA+/+ or 
LMNA-/- cells (Figure 1A).14 The OST-tag is a biotin analogue, but offers the 
advantage of binding with high specificity and affinity (Kd=1μM) to the 
streptavidin analogue Strep-Tactin matrix.18 In addition, the OST-tag is 
relatively small (3kDa) compared to other epitope tags typically used for MS 
purposes, thus reducing the likelihood of interference with protein function. 
To test for physiological functionality of OST-tagged A-type lamins, we first  
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Figure 1. Characterization of OneSTrEP tagged A-type lamins. (A) Western blot of endogenous and 
tagged A-type lamin in OneSTrEP-tagged lamin A (OST-A), lamin C (OST-C), progerin (OST-P) or control 
virus-infected mouse cardiac NklTAg myocytes, human osteosarcoma U2OS cells, and mouse 
embryonic fibroblasts (MEFs) from wildtype (LMNA+/+) or LMNA knock-out (LMNA-/-) embryos. The 
following antibodies were used: α-LaminA/C (Sc6215, Goat, Santa Cruz; detects endogenous Lamin A 
and C, OST-A, OST-C and OST-P) and α-Beta-Actin (Cl.AC15, A-5441, mouse, Sigma). (B) Western blot 
of endogenous and OST-tagged  lamin A, lamin C and prelamin A in U2OS cells infected with OST-A or 
OST-C and treated for 48 hours with indicated concentrations of atorvastatin, an inhibitor of lamin A 
farnesylation. The following antibodies were used: α-LaminA/C (Sc7293, mouse, Santa Cruz; detects 
only endogenous Lamin A and C, and not OST-A, OST-C or OST-P) and α-Onestrep (2-1507-001, 
mouse, IBATagnology). (C) Immunofluorescence staining of OST-A, OST-P and control infected LMNA-
/- MEFs for A-type lamins (LMNA) and emerin. DNA was stained with DAPI. The following antibodies 
were used: α-LMNA/C (Sc-7292, Mouse, Santa Cruz, detects OST-tagged human Lamin A and Progerin, 
but no endogenous murine lamins), α-emerin (Cl.4G5, mouse, Leica). (D)  MTS ((3-(4,5-
dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium)) assay to 
quantify relative cell number 62 hours after attachment of equal cell numbers of control or OST-A/C 
infected LMNA-/- MEFs. An asterisk indicates a significant difference (p<0.05) between control and 
OST-A/C infected cells.  
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determined whether OST-tagged lamin A (OST-A) was farnesylated correctly 
in U2OS cells. Normally mature lamin A is formed after cleavage of the 
farnesylated C-terminal Caax motif in prelamin by Zmpste24.32 Atorvastatin 
inhibits the synthesis of farnesyl pyrophosphate and thereby impairs 
farnesylation and processing of prelamin A to mature lamin A.33 The 
farnesylation of both OST-A and endogenous lamin A in U2OS cells was 
inhibited similarly by increasing concentrations of atorvastatin (Figure 1B). 
OST-tagged and wildtype lamin C do not contain a Caax motif and remained 
unaffected by atorvastatin (Figure 1B). 
 
Next, we visualized the localization of OST-A and OST-tagged progerin (OST-
P) in A-type lamin knock-out (LMNA-/-) MEFs (Figure 1C).15 As expected, both 
OST-A and OST-P were detected at the nuclear rim. In contrast to OST-A, 
OST-P generated distortions in of the nuclear lamina identical to those seen 
in HGPS patient cells (Figure 1C).16 Furthermore, expression of OST-P leads  
to a  decrease of total LAP2 (all isoforms included) and HP1γ protein levels in 
the nucleus (Figure S2) as observed as well in HGPS and progerin-expressing 
fibroblast.17 OST-A expression further restores correct localization of 
endogenous emerin in LMNA-/- MEFs to the NE (Figure 1C).34 This capacity 
was reduced after 3 days in culture for OST-P (Figure 1C). Finally, combined 
expression of OST-A and OST-C inhibited cell proliferation, in line with 
previously reported endogenous lamin knock-down and HA-tagged lamin A 
and C overexpression studies (Figure 1D).13 Taken together, these data 
demonstrate that OST-tagged A-type lamins recapitulate endogenous lamin 
farnesylation, subcellular localization and dominant functions.  
OneSTrEP pull-down assay 
To isolate lamin A-associated proteins we used mild reversible cross-linking 
(5 minutes, 1% formaldehyde) to capture protein/protein and protein/DNA 
complexes (Figure 2A). Cross-linking enabled us to extensively solubilize A-
type lamins by using vigorous sonication in combination with high 
percentage ionic detergent (1% SDS; Figure 2B). Solubilized protein 
complexes were diluted to comparable amounts of starting material, by 
correcting sample volumes to reach equal genomic DNA concentrations, 
(Figure 2A) and OST-tagged lamins were precipitated using Strep-Tactin 
matrix, a high-affinity streptavidin analogue.30-31 Precipitated lamin-protein  
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Figure 2. OneSTrEP pull-down assay. (A) Schematic overview of the OST pull-down protocol for cells 
infected with control and OST-tagged lamin, with the input, depleted and pull-down fraction indicated 
in bold. Depending on the purpose of the experiment proteins separated on SDS-Page gels were 
stained with Coomassie Brilliant Blue (CBB) (for mass spectrometry), or immunoblotted for verification 
of individual candidates. (B) U2OS cells were fixed in 1% formaldehyde, sonicated in SDS lysis buffer 
and further diluted in ChIP dilution buffer as described in Materials and Methods. Total protein 
extracts were spun down, separating the solubilized fraction (i.e. supernatant) and the insoluble 
fraction (i.e. pellet, twice washed with PBS). Total, unsolubilized and solubilized fractions were 
compared for endogenous lamin A/C protein levels by western blot. The following antibody was used: 
α-LaminA/C (Sc6215, Goat, Santa Cruz; detects endogenous Lamin A and C). (C) Western blot of U2OS 
OST-A/C cell extracts (1% formaldehyde vs. no fixation) dissolved in Laemmli sample buffer (no heating 
vs. 20 minutes at 95⁰C) before loading on SDS-PAGE gels. The following antibodies were used: α-LAP2 
(Y-20, Sc19783, Goat, Santa Cruz; LAP2β isoform depicted) and α-Onestrep (2-1507-001, mouse, 
IBATagnology). (D) Western blot of endogenous lamin A/C and Lap2β after cross-linking with 1% 
formaldehyde in U2OS cells infected with control or OST-A/C virus. The following antibodies were 
used: α-LAP2 (Y-20, Sc19783, Goat, Santa Cruz; LAP2β isoform depicted), α-LaminA/C (Sc7293, mouse, 
Santa Cruz; detects only endogenous Lamin A and C, and not OST-A or OST-C) and α-Onestrep (2-1507-
001, mouse, IBATagnology). (E) Western blot of OST-pull-down for lamin-A/protein complexes 
solubilized in SDS lysis buffer with increasing sonication strength (from 12x1 sec at 5μm amplitude, +; 
to 6x5sec at 10μm amplitude, +++). The following antibodies were used: α-LAP2 (Y-20, Sc19783, Goat, 
Santa Cruz; LAP2β isoform depicted) and α-Onestrep (2-1507-001, mouse, IBATagnology).   
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epitope masking on western blot without detectable protein degradation 
(Figure 2C). Cross-linking was crucial for co-precipitation of lamin complexes 
were eluted and de-crosslinked under conditions (20 minutes at 95⁰C in 
Laemmli Sample Buffer) that fully reversed crosslink-induced interactors, as 
omitting this step resulted in loss of the known OST-A/C interaction partners 
wildtype lamin A/C and LAP2β in purified protein complexes (Figure 2D).35-36 
Increasing sonication strength drastically improved retrieval of the lamin A 
interacting partner LAP2β (Figure 2E). These findings demonstrate that the 
OST-tag/Strep-Tactin pull-down approach is able to recover lamin A protein 
complexes after temporal cross-linking and solubilization. 
Identification of lamin A interacting proteins  
To identify and characterize lamin A-interacting proteins OST pull-downs 
were performed on murine cardiac myocyte NklTAg cells expressing OST-A 
at endogenous levels or a control virus lacking the lamin A transgene. Co-
purified proteins were size-separated and retrieved from SDS-PAGE gels and 
analyzed by MS (Figure 3A). In total 5,162 unique peptide fragments 
corresponding to 649 individual proteins were detected in two independent 
experiments (Figure 3A). We reduced the list of potential interactors by 
stringent restrictive analysis (i.e. mascot score cut-off, minimum fold over 
background and filtering out non-essential peptides;  see Materials and 
Methods; Figure 3A) to 60 proteins. The set of identified proteins contains 
several known lamin A interactors including Lamin B, Lap2β ,Emerin, MAN1, 
Sun1 and 2, as well as the muscle specific interactor Syne-2 (Figure 3A, Table 
S1).37 About half of our candidate lamin A interactors were identified in two 
previous NE proteome studies which had identified proteins in an 
INM/lumen/ONM6 fraction or an INM/lamina/nucleoplasmic fraction10, 
respectively, in other cell types.6, 10  
 
We identified 29 novel lamin A interactors (Table S1). These include proteins 
implicated in muscle differentiation (Luc1-like, Serpine1 mRNA binding 
protein), transcription factors (Strap, Similar to calponin 3) , DNA repair 
(Ku70) and heterochromatin maintenance (Trim28).38-43 Several known 
(Emerin, Lap2β) as well as previously unidentified lamin A interactors 
(Trim28, Ku70) were chosen for validation of the MS data by targeted co-
precipitation. Trim28 and Ku70 were specifically chosen as they represented  
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Figure 3. Identification of lamin A interacting proteins. (A) Overview of the selection criteria for 
identification of lamin A interacting proteins from raw mass spectrometry data. Control and OST-A pull-
down average mascot scores for several lamin A interactors identified in NklTAg cells are depicted 
(Underlined proteins are verified in figure 3B). (B) Western blot indicating protein levels of mass 
spectrometry identified lamin A-interactors (endogenous lamin A/C, Lap2β, Emerin, Trim28 and Ku70) 
precipitated in NklTAg cells infected with control or OST-A virus. The following antibodies were used: α-
Onestrep (2-1507-001, mouse, IBATagnology), α-LaminA/C (Sc7293, mouse, Santa Cruz; detects only 
endogenous Lamin A and C, and not OST-A), α-LAP2 (Y-20, Sc19783, Goat, Santa Cruz; LAP2β isoform 
depicted), α-Emerin (Cl.4G5, mouse, Leica), α-Trim28 (A300-767A, rabbit, Bethyl Laboratories) and α-Ku70 
(Ab10878, rabbit, Abcam). (C) GO analysis of identified lamin A interactors. GO analysis was performed 
separately for the GO categories “cellular components” (CC), “biological process” (BP), “molecular function” 
(MF) and compared against a random protein set.22-23 The number of lamin A interacting proteins identified 
within a specific GO category versus the total amount of annotated lamin A interacting proteins is indicated 
next to the significantly enriched GO categories (p<1x10-3 indicated by asterisk; statistical tests include 
using a kappa statistic measurement and is further described elsewhere).71 
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the two proteins that were closest to the selection cut-off and therefore 
were most likely to represent false positives. OST-A co-precipitated 
considerable amounts of endogenous Lamin A/C, Lap2β, Emerin, as well as 
Trim28 and Ku70 (Figure 3B). In contrast no interactions were observed in 
control pull-downs from cells only expressing OST (Figure 3B). In comparison 
to Lap2β and Emerin, Ku70 and Trim28 appear to be weaker interactors of 
OST-A (Figure 3B). In addition to Lap2β we identified interactions of lamin A 
with Lap2α, γ, δ and ε isoforms in U2OS cells by OST pull-down and 
immunoblotting (Figure S3). Taken together these data demonstrate that 
the OST pull-down/MS assay and bioinformatical selection criteria can be 
used for identification of lamin A interacting proteins. 
Functional annotation of lamin A interacting proteins 
To globally characterize the identified lamin A interactors, we performed a 
GO analysis to describe the subcellular localization (CC, cellular component), 
biological processes (BP) and molecular functions (MF) of identified  
interactors (Figure 3C). As expected, compared to random proteins lamin A 
interactors were 22-fold enriched for ‘nuclear envelope’ components 
(p=5.0x10-12; Figure 3C, TableS2), and to a lesser extent for other subcellular 
compartments. The interactors are enriched in the functional groups of NE 
organization’ (p=2.5x10-4), actomyosin structure organization (p=9.9 x10-3), 
and protein transport (p=5.6x10-6), with a preferential molecular function of 
‘nucleotide binding’ (p=5.5x10-4). The GO analysis had high similarity to the 
previously identified proteins in the NE proteome (Table S2).6, 10 
Identification of preferential lamin A or progerin interactors  
We next applied the OST pull-down method to identify proteins that bind 
exclusively to lamin A or progerin as well as interactors that bind to both 
proteins with different affinity. To this end, we expressed control virus, OST-
A or OST-P in LMNA-/- or LMNA+/+ MEFs at endogenous levels (Figure 1A). 
OST pull-downs were performed in duplicate in all cell lines. In total we 
detected 54,939 unique peptide fragments in all OST and control pull-
downs, corresponding to 2804 different proteins (Figure 4A). Using similar 
selection criteria as validated for the NklTAg OST-A pull-down (mascot score  
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Figure 4. Identification of preferential lamin A/progerin interacting proteins. (A) Overview of the selection 
criteria applied to identify preferential laminA/progerin interacting proteins (See also Material and 
Methods). (B) Verification of lamin A and progerin preferential interactors in U2OS cells transfected with 
GFP-Nup107, GFP-Tpr, Myc-Nup98, Myc-Nup153 or Myc-Prx1. OST pull-down was performed in U2OS cells 
infected with control, OST-A or OST-P virus. The following antibodies were used: α-LaminA/C (Sc6215, Goat, 
Santa Cruz; detects endogenous Lamin A and C, OST-A, and OST-P), α-Emerin (Cl.4G5, mouse, Leica), α-c-
Myc (MS-139-P, mouse, Labvision) and α-GFP (Ab6673, Goat, Abcam). (C) Quantification of western blot 
protein levels in OST-A and OST-P pull-down fractions (average ± standard deviation) corrected for input 
signal intensity. Relative protein levels for OST-A pull-down fractions were set arbitrarily at 1. Protein levels 
identified by western blot in OST-P pull-down fractions (Figure 4B) are indicated. Asterisks indicate a 
significant (p<0.05; Student’s T test) difference between OST-A and OST-P pull-down fraction. 
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cut-off, minimum fold over background and filtering out non-essential 
peptides; see Materials and Methods) we defined 274 lamina-interacting 
proteins, 209 in LMNA-/- MEFs and 111 in LMNA+/+ MEFs, of which 46 
proteins were identified as interactors in both cell lines. Of these 274 
interactors 150 proteins interacted with lamin A and 170 with progerin 
(Table S5). The relatively low number of interactors identified in both 
LMNA+/+ and -/- cells may be due to the very high stringency used in 
identifying interactors or may be due to differential effects of lamin A 
expression in a wild-type or null background. As many of the identified 
lamin A interactors were also detected by MS at levels just below inclusion 
criteria in progerin pull-down samples and vice versa, we used additional 
criteria to identify preferential interactors (minimal fold difference between 
OST-A and OST-P mascot scores and similarity of results in MEFs-/- and 
MEFs+/+; see Materials and Methods; Figure 4A). 110 proteins interacted 
with both lamin A and progerin and applying these criteria resulted in a final 
selection of 35 proteins candidates that preferentially interact with either 
wildtype lamin A (8 candidates, including Nup153, Nup98 and Translocated 
promoter region) or progerin (27 candidates, including Paired related 
homeobox 1 (Prx1), Proliferating cell nuclear antigen (Pcna) and Pinin). 
 
To validate preferential interactors we performed OST pull-downs in U2OS 
cells expressing control virus, OST-A or OST-P at endogenous levels (Figure 
4B) and transiently expressed several potential differential interactors (Myc-
tagged Nup98, Nup153, Prx1 and GFP-tagged Tpr). In support of the pull-
down results, we found weaker interaction of OST-P with Nup98, Nup153 
and Tpr (all p<0.05, Figure 4B and C). The NPC protein Nup107 also showed 
reduced, albeit statistically not significant, binding to OST-P. Prx1 was 
confirmed to have increased, but not unique, affinity for OST-P (p<0.05, 
Figure 4B and C). Finally, immunoblot detection confirmed the predicted 
interaction of endogenous emerin with OST-tagged lamin A and progerin 
(p>0.05, Figure 4B and C). These data show that lamin A and progerin have 
distinct protein-interactions that can be identified by OST pull-down assays.  
Functional analysis of preferential lamin A or progerin interactors  
A GO-signature comparison of 150 identified lamin A-associated proteins 
and 170 progerin-associated proteins, shows that both protein sets were  
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Table 1. Overview of preferential lamin A/progerin interactors. 
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21825 Thbs1 Thrombospondin 1# 133 0 627 0 0 21 No 
22004 Tpm2 Tropomyosin 2, beta 0 0 219 249 199 290 No 
634386 FTL2 Ferritin light chain 2# 0 0 158 0 0 35 No 
14156 Fen1 
Flap structure specific 
endonuclease 1 
0 0 156 57 118 172 No 
19072 Prep Prolyl endopeptidase 32 0 130 99 58 140 No 
665766 PSME1 Proteasome 28 subunit, alpha 0 0 123 20 0 92 No 
17524 Mpp1 Membrane protein, palmitoylated 0 0 111 0 0 29 No 
241490 Rbm45 RNA binding motif protein 45 55 0 62 0 0 122 No 
67543 Pabpc3 
Poly(A) binding protein, 
cytoplasmic 3 
0 0 51 0 0 276 No 
18949 Pnn Pinin 299 0 49 0 0 105 Yes10 
18933 Prx1 Paired related homeobox 1 0 0 28 0 0 135 No 
108123 Napg 
N-ethylmaleimide sensitive fusion 
protein attachment protein 
gamma 
0 15 145 0 0 23 No 
18950 Pnp 
Similar to purine nucleoside 
phosphorylase; purine-nucleoside 
phosphorylase 1 
18 20 168 0 0 57 No 
433862 Ppid Peptidylprolyl isomerase D 61 26 189 0 96 153 Yes10 
74122 Tmem43 Transmembrane protein 43 0 27 181 0 165 172 Yes6 
110960 Tars Threonyl-tRNA synthetase 18 61 295 16 0 99 No 
15525 Hspa4 Heat shock protein 4 100 92 334 16 49 60 No 
 14300 Frg1 FSHD region gene 1 46 41 138 0 62 64 No 
 18538 Pcna Proliferating cell nuclear antigen 0 58 189 0 54 101 No 
 28114 Nsun2 Sun domain family member 2 56 57 182 99 77 174 No 
 
13722 Scye1 
Aminoacyl tRNA synthetase 
complex-interacting 
multifunctional protein 1 
0 105 199 24 29 152 No 
 
70804 Pgrmc2 
Progesterone receptor membrane 
component 2 
0 320 603 0 0 125 Yes6 
 
12903 Crabp1 
Cellular retinoic acid binding 
protein I 
128 198 361 68 35 279 No 
 
14683 Gnas 
Guanine nucleotide binding 
protein, alpha stimulating 
19 106 182 0 0 100 No 
 19344 Rab5b RAB5B 0 289 350 0 0 133 Yes10 
 620016 LOC620016 Glutaredoxin 3 19 41 44 19 28 130 No 
 65114 Vps35 Vacuolar protein sorting 35 239 432 457 142 131 447 No 
Pr
ef
er
nt
ia
lly
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ds
 A
 
56758 Mbnl1 Muscleblind-like 1 0 38 17 0 104 0 No 
218210 Nup153 Nucleoporin 153 0 302 101 0 218 141 Yes6,10 
109168 5730596K20Rik Atlastin GTPase 3 104 360 89 0 75 50 No 
226747 Ahctf1 
AT hook containing transcription 
factor 1 
0 143 32 0 47 26 No 
108989 Tpr Translocated promoter Region 0 234 42 0 268 133 Yes10 
270192 Rab6b RAB6B 0 101 0 0 180 0 No 
269966 Nup98 Nucleoporin 98 0 178 0 0 227 125 Yes6,10 
14681 Gnao1 
Guanine nucleotide binding 
protein, alpha O 
0 192 0 0 43 0 No 
Preferential lamin A/progerin interacting proteins were identified amongst all lamin A and progerin interactors in LMNA-/- and LMNA+/+ MEFs 
according to standard selection criteria (see Materials and Methods). Overall average mascot scores for individual pull-downs are indicated, as 
well as whether proteins were identified in  two previous NE proteome studies (see grey shaded column) which had identified proteins in an 
INM/lumen/ONM6 fraction or an INM/lamina/nucleoplasmic fraction10. Hashes indicate proteins GO-annotated as ‘Extracellular region’. 
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over 50-fold enriched for INM and nuclear lamina proteins, are 
preferentially involved in NE organization, mRNA and protein transport and 
enriched for proteins with GTP binding capacity (Figure S4, Table S3). Lamin 
A interactors were preferentially enriched (p<1x10-4) in NPC-related 
nucleocytoplasmic and protein transport proteins and to a lesser extent 
(1x10-2<p>1x10-3) in proteins of the NE, the cytoskeleton and ECM 
(‘sarcomere’ and ‘PDGF binding’ GO-terms). Progerin interactors showed 
enrichment for endoplasmatic reticulum (ER) membrane proteins involved 
in protein folding and processing (‘cell redox homeostasis’, ‘intramolecular 
oxidoreductase’ and ‘signal peptidase processing’ GO-terms) as well as 
proteins involved in chromatin organization (mainly histone 1 and 2A 
variants). ER-localized A-type lamin interacting proteins were preferentially 
membrane-associated (43 out of 46) and not lumenal localized (3 out of 46). 
To further assess the functional context of lamin A and progerin interactors 
we used the Reactome protein interaction database, which contains maps 
of known protein complexes, as a reference.44 This analysis showed that 10 
proteins of the 26S proteasome complex were identified as progerin 
interactors (Figure S4, Table S3). These GO and Reactome profiles for lamin 
A and progerin interactors resemble those found in the previously identified 
NE proteome (Table S3).  
 
GO-analysis of the 35 preferential lamin A/progerin interactors showed 
enrichment of NE proteins, proteins involved in RNA metabolism (‘ncRNA 
metabolic transport’ and ‘RNA metabolic process’ GO terms), general 
protein transport components, including members of the NPC ( ‘Ran binding 
protein 2’ Reactome term) and proteins with GTPase activity (All p<1x10-2; 
Figure 5A, 5B, Table S2).44 NPC lamin-interacting proteins were 
preferentially located at the nucleoplasmic site of the NPC (Figure 5C), of 
which a vast majority showed an overall diminished interaction with 
progerin in both LMNA-/- and LMNA+/+ MEFs, including 3 proteins identified 
in our assay as preferential lamin A interactors (Tpr, Nup98, Nup153; Figure 
5C, Table 1). 
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Figure 5. Functional annotation of preferential lamin A/progerin interactors. (A) GO profile 
of preferential interactors specified for “cellular components” (CC), “biological process” (BP), 
“molecular function” (MF) GO categories. Representation of protein complexes was analyzed 
using the Reactome database (R) 44. Significant  categories based on comparision are indicated 
by asterisks (p<1x10-3; random proteins used as background; statistical tests include a kappa 
statistic measurement as described elsewhere 71), as well as the number of proteins within the 
specific category out of the total number of annotated preferential interactors. (B) Overview 
of GO annotated lamin A/progerin preferential interactors in significant categories. Individual 
categories are marked A-F and correspond to figure 5A. (C) Schematic illustration of the 
nuclear pore complex (NPC) indicating the location of lamin A-interacting NPC proteins 
identified by mass spectrometry analysis (underlined).72 Identified interactors preferentially 
localize in the nuclear basket (Nup153, Tpr), nuclear ring (Nup50, Nup98) or scaffold (Nup-93, -
107, -133, -155, -160 and -205). Nup98 has been described to localize in both the nuclear 
basket as well as the NPC central channel. Asterisks indicate proteins identified to 
preferentially interact with lamin A. Hashes indicate proteins with MS data indicative of 
diminished interaction with progerin as well (similar direction change for ratio OST-P/OST-A 
overall average mascot ratio’s in both MEF LMNA-/- and MEF LMNA+/+).  
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Discussion 
The systematic mapping of lamin A interaction partners is currently 
hampered by the insoluble nature of lamina proteins. We have developed 
and applied a novel pull-down approach based on the One-STrEP tag to 
identify in vivo A-type lamin interactors, of which a subset interacts 
preferentially with lamin A compared to its mutant isoform progerin. To 
isolate lamin-associated protein complexes we took advantage of the 
OneSTrEP-tag/Strep-Tactin matrix system, an engineered version of the 
strongest non-covalent biological interaction known (biotin/streptavidin).18, 
45 We first verified that the addition of a 3 kDa small OST-tag to lamin A 
recapitulated endogenous lamin A as judged by farnesylation, subnuclear 
localization, emerin NE localization and cell proliferative effects. Lamin 
interactors were identified, by subsequent solubilization of the majority of 
A-type lamins, high affinity precipitation of OST-tagged lamins, high 
stringency washes of precipitated protein complexes, important as lamins 
have a propensity to non-specifically interact with other proteins, and a 
highly restrictive selection based on MS results.46 We identify a large 
number of known direct A-type lamin interactors (including Emerin, Ubc9, 
LAP2α, LAP1β, LMNB1, Rbbp7), as well as known indirect interactors 
(including Nesprin/Syne-1, Nesprin/Syne-2; HP1γ/CBX3, HP1α/CBX5, MAN1), 
therefore directly validating our approach.5, 12, 47-52 Our approach is able to 
identify physical associations which occur via multiple hierarchical 
interactions as indicated by the identification TorsinA, which is indirectly 
connected to the lamina via Nesprins and Sun proteins.52 The identification 
and verification of two previously unidentified lamin A interactors (Trim28 
and Ku70) that met the inclusion criteria justifies the applied selection 
threshold. Comparative analysis with two published NE proteomes further 
validates the OST approach.6, 10 Although these studies differ in their starting 
materials with one using isolated nuclear envelopes and the other isolated 
lamina preparations, they identify a significant part of the NE proteome, 
including laminar proteins, and therefore are considered of value for a 
cross-comparison. About half of the OST pull-down identified lamin A 
interactors in NklTAg cells were identified in these previous studies and the 
GO signature of our hits highly resembles that of NE proteins identified in 
these analyses.6, 10  
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Our OST pull-down method differs from previously published approaches. 
First, in comparison to approaches that biochemically fractionate nuclear 
membranes or the lamina, we specifically precipitate lamin A interactors, 
regardless of their subcellular localization. Secondly, the inclusion of a cross-
linking step preserves short-lived lamin-protein interactions and thereby 
contributes to detection of identified transient and indirect interactors. 
Thirdly, we use a highly sensitive and stringent MS analysis approach. Our 
validation indicates a low level of false positives. However, we cannot 
formally rule out that a small percentage of identified hits reflect non-
specific interactions. Especially various extracellular matrix (ECM) identified 
interactors and proteins involved in Golgi related vesicle trafficking might 
reflect non-specific interactions. ER proteins form a group of identified 
interactors that have been considered background in previous NE proteomic 
studies.10 Although this exclusion is correct for lumenal ER proteins, which 
are not directly accessible to lamins, membrane-associated ER proteins 
could reflect bona fide interactors of OST-tagged lamins involved in protein 
folding and processing during their synthesis and post-translational 
modification or diffuse from the ER to the continuous INM and anchor to 
the lamina.53 In accordance with this, our data indicate that almost all 
identified A-type lamin interactors residing in the ER are membrane-
associated and not lumenal. 
 
Our method combines beneficial aspects of several methods used to identify 
protein-content of and interactions at the nuclear lamina. IP studies have 
the advantage of enriching for the interactome of a protein of interest and 
the ability to analyze the impact of mutations on protein interactions, but 
are hampered by the need to solubilize intact NE protein complexes.54 In 
contrast, differential extraction from isolated whole nuclear membrane 
fractions permits disruption of protein complexes prior to MS analysis, but 
identifies general protein composition at a subnuclear level based on 
similarity of proteins in biochemical characteristics.6, 8, 10 Yeast two-hybrid 
screens allow comparison of protein interactions for wild-type and mutated 
protein fragments without solubilization, but have the drawback of high 
false positive-rates and non-physiological conditions.55-57 The OST pull-down 
approach combines advantages of identifying and comparing the 
interactome for a wild-type and mutated protein of interest with a low false 
positive rate under physiological conditions, with complete extraction of 
66 | Chapter 3 
intact lamina protein complexes. These unique characteristics complement 
current technology to identify lamin A interactors. 
 
We identified both interactors of lamin A and of progerin and compared 
their GO profiles. Differences in profiles indicate a loss of interactions of 
progerin with the cytoskeleton in comparison to lamin A, in agreement with 
reported disruption of nuclear-cytoskeletal coupling by progerin.58 
Furthermore, GO analysis suggests a preferential interaction of progerin 
with protein folding and processing enzymes as well as proteasome complex 
members. This observation is intriguing in the light of the reported 
degradation in HGPS patient cells of a large set of nuclear proteins, 
particularly chromatin-associated proteins.5, 16 To further  investigate 
differences between lamin A- and progerin-interacting proteins we 
identified preferential interactors  by comparing OST pull-downs in both 
LMNA-/- MEFs, in the absence of endogenous lamin A/C which could mask 
distinct interactions due to dimerization with progerin, as well as biological 
more relevant LMNA+/+ MEFs.36 Several identified distinct lamin A/progerin 
interactors preferentially possessed GTPase activity and others were 
involved in RNA metabolism or nucleocytoplasmic transport.  
 
We found reduced interaction of Nup153 with progerin compared to wild-
type lamin A. Nup153 anchors NPCs to the nuclear lamina and directly 
interacts with Tpr, which is involved in formation of NPC-associated 
heterochromatin exclusion zones.59-61 Interestingly, HGPS is associated with 
peripheral loss of heterochromatin and clustering of Nup153 and other NPC 
proteins.62-63 A diminished interaction between OST-P and Nup153 could 
explain a loss of NPC anchoring to the nuclear lamina, as well as clustering 
and defective NPC-mediated nuclear import which have all been implicated 
in HGPS.62-63  
 
We found an increased interaction of progerin with paired related 
homeobox 1 (Prx1 or Prrx1), a transcriptional co-activator involved in 
skeletogenesis and vasculogenesis.28, 64 Loss of Prx1 results in lethal 
vertebrae and craniofacial skeletal defects, while overexpression induces 
vascular smooth muscle cell (VSMC) proliferation and ECM remodeling by 
direct upregulation of tenascin C expression.28, 64 These phenotypes highly 
resemble HGPS etiology as Zmpste24 knock-out mice, which serve as a 
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model system for HGPS, suffer from osteogenesis imperfecta, manifested in 
vertebrae and craniofacial bone fractures.65 Furthermore progerin 
drastically downregulates tenascin C expression  and progerin transgenic 
mice suffer from a progressive loss of VSMCs and changes in ECM 
composition.66-67 An increased interaction of progerin with Prx1 could impair 
transcriptional activation of tenascin C and cause consecutive HGPS 
characteristic ECM, VSCM and bone related disorders. 
 
A number of differential interactors link lamin A and progerin to previously 
reported abnormal cell biology in the context of LMNA mutations. We find 
an increased interaction of Proliferating cellular nuclear antigen (Pcna) with 
progerin. Pcna, as a replication fork processivity factor, regulates genomic 
replication and has been reported to redistribute upon introduction of 
progerin.68. Several studies report abnormal proliferation in LMNA mutant 
cells.69 Pcna is thought to become trapped in intranuclear mutant lamin 
aggregates, thereby ultimately blocking DNA replication and causing HGPS-
associated DNA damage.63, 68 Of relevance in this context is also the 
identification of Trim28 and Ku70 as interaction partners of lamin A. Both 
are associated with DNA damage response and/or repair and Trim28 is a 
reported interaction partner of heterochromatin protein 1.70 While the 
contribution of these preferential interactions will need to be elucidated in 
targeted studies,  the global identification of novel lamin A and progerin 
interactors  using a novel pull-down method has generated several leads for 
studies of specific interaction partners of lamin A and its mutants with the 
goal of  uncovering the molecular mechanisms of tissue-specific 
laminopathies. 
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 Supplemental Figures and Tables 
 
 
Figure S1. Schematic overview of OneSTrEP-tagged lamin constructs. Lamin A, C and 
progerin were tagged at their N-terminus by a OneSTrEP-tag, consisting of two Strep-tag II 
epitopes (underlined), which interact with high affinity to Streptactin matrix, separated by a 
serine and alanine linker region. The chemical structure of a Strep-tag II epitope is furher 
depicted. Mature OneSTrEP-tagged lamin A (OST-A) is released after farnesylation of the C-
terminal Caax-motif, cleavage of the -aax amino acids and subsequent carboxymethyation 
of the C-terminus, followed by an upstream cleavage by Zmpste24 in mice cells (indicated 
by scissor; Face-1 for human cell lines). Due to a loss of 50 amino acids (indicated as Δ50 
aa.), including the Zmpste24 restriction site, OneSTrEP-tagged progerin (OST-P) is only 
processed by  farnesylation of the C-terminal Caax-motif, subsequent cleavage of the –aax 
amino acids and carboxymethyation of the C-terminus, and cannot be further cleaved by 
Zmpste24. OneSTrEP-tagged lamin C (OST-C), contains a Lamin C-specific terminus, as well 
as the A-type lamins common coiled-coil rod domain and nuclear localization signal (NLS). 
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Figure S2. Progerin dependent loss of HP1γ and LAP2 protein. Fluorescent detection of 
HP1γ, LAP2 and DNA (DAPI) in human dermal fibroblasts (HDF) expressing an empty vector, 
OST-A or OST-P at endogenous lamin A levels. The nuclear intensity of total LAP2 (all 
isoforms included) and HP1γ was determined as described in the Material and Methods, and 
average expression values are depicted in numbers. Distribution curves were tested to be 
different or comparable using a Kolmogorov-Smirnov statistical test. An asterisk indicates a 
significant (p<0.01) difference between HDFs expressing OST-A or OST-P in comparison to 
empty vector (Ctrl) infected HDFs. The following antibodies were used: α-HP1γ, mab3450, 
Chemicon, Temecula, USA ; α-LAP2, kind gift from K.  Wilson, raised against residues 1-187 of 
human LAP2, and suitable for detection of all LAP2 isoforms). 
 
 
Figure S3. Interactions between Lamin A and LAP2 isoforms. Western blot of a OneSTrEP 
pull-down performed on U2OS cells infected with OST-A and control virus.  Input and pull-
down fractions were immunoblotted with  α-LaminA/C (Sc6215, Goat, Santa Cruz; detects
endogenous Lamin A and C as well as OST-A) and α-LAP2 (Y-20, Sc19783, Goat, Santa Cruz; 
suitable for LAP2α,β,γ,δ,ε and ζ detection). With the exception of LAP2ζ, which could not be
detected, all other isoforms were immuoblotted at their respective molecular weights. 
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Figure S4. GO analysis of lamin A and progerin interacting proteins identified in MEFs. Identified lamin A 
and progerin interacting proteins were analyzed separately for the GO categories “cellular components” 
(CC), “biological process” (BP), “molecular function” (MF), as well as the reactome (R) database. Significant 
categories were determined by standard statistical algorithms incorporated into the DAVID database (see 
Material & Methods)  and are indicated by asterisks (p<1x10-3; random proteins used as background). 
Categories enriched for by either OST-A or OST-P are indicated by arrows. 
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Table S1. Mass spectrometry data for identified lamin A interacting proteins in NklTAg cells.  
GI code 
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74219697 16905 Lmna 75 3534 3230 Yes6,10 
52869 16906 Lmnb1  2272 2122 Yes6,10 
27503473 16907 Lmnb2  1230 1296 Yes6,10 
74202572 21917 Tmpo  1154 1152 Yes6,10 
9845253 56258 Hnrph2  379 370 Yes10 
9790069 53817 Bat1a  350  Yes10 
28192672 98386 Lbr  342 378 Yes6,10 
103484305 208263 Tor1aip1  327 118 Yes10 
114612484 628648 HP1g  302 185 Yes10 
50953786 223697 Unc84b  302 166 Yes10 
12852531 77053 Unc84a  241 104 Yes6,10 
20379977 232989 Hnrpul1 63 234  Yes10 
74180977 17886 Myh9  220 39 Yes6,10 
3065929 22628 Ywhag  198 204 Yes10 
12832758 100046125 RAB5A  179  Yes10 
6679641 13726 Emd  174 211 Yes6,10 
554262 26900 Ddx3y  172 119 Yes10 
21704124 433739 RBM10  168  Yes10 
7106546 383901 Mme1  163  Yes10 
1389682 16480 Jup  147  Yes10 
77812697 22138 Ttn  136  Yes10 
6919955 24010 Ik  136 68 Yes10 
4507785 100043681 UBC9  132  Yes10 
21312784 100047806 PPIL1 32 127  Yes10 
267150 21973 Top2a  123  Yes10 
10946940 59021 Rab2  117 172 Yes10 
6755863 22027 Hsp90b1  113  Yes10 
145864461 380664 Lemd3  113 89 Yes6,10 
26325884 624311 IPO2  111  Yes10 
145699091 319565 Syne2  95 106 Yes10 
148670589 19345 Rab5c   313 Yes10 
4501887 667260 actG  677  No 
34147513 19349 Rab7 93 387 297 No 
13430890 50709 Hist1h1e  244 226 No 
5902786 100045085 ANX3  242 81 No 
9055370 54709 Eif3i  232 44 No 
109735018 239673 4732456N10Rik  226  No 
7710086 19325 Rab10  220 219 No 
51092301 406223 EG406223  196  No 
12857003 66978 Luc7l  192  No 
6671694 12419 Cbx5 47 179 129 No 
12229677 11867 Arpc1b  178  No 
30424655 270192 Rab6b  178  No 
21703344 20224 Sar1a  172 179 No 
109081395 22003 Tpm1  162  No 
9790159 56305 Pitpnb  158  No 
1621617 21849 Trim28 75 153 298 No 
12845035 675981 eif2a  148  No 
6755448 20333 Sec22b  143 62 No 
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12836024 66870 Serbp1  129  No 
4063383 20901 Strap 33 118  No 
45544618 66902 Mtap  117  No 
27369836 217980 Larp5  115  No 
21312564 218501 cnn3  106  No 
149272300 100039086 Gm15032  105  No 
6755204 19173 Psmb5  105 101 No 
21595163 234407 Glt25d1  104  No 
12846304 13885 Esd  104  No 
198637 14375 Ku70 33 100  No 
124486993 433923 EG433923 
 
  131 No 
Mascot scores for identified lamin A interacting proteins in NklTAg cells are listed. Furthermore it is indicated 
whether identified lamin A interactors were identified in two previous NE proteome studies (see grey shaded 
column) which had identified proteins in an INM/lumen/ONM6 fraction or an INM/lamina/nucleoplasmic 
fraction10. Hashes indicate proteins GO-annotated as ‘Extracellular region’. 
 
 
 
 
 
Table S2. GO analysis for identified lamin A (NklTAg) and preferential lamin A/progerin (MEF) interactors.  
Protein Set Database Database Category 
Protein in 
category/ 
Total 
annotated 
Proteins 
Enrichment  
Factor vs. 
Random 
Protein 
Background P-Value 
Enrichment  
Factor vs. 
NE Protein 
Background P-value 
NKLTAG all GO-CC GO:0005635~nuclear envelope 12|52 21.5 5.0E-12 6.3 1.0E-07 
NKLTAG all GO-CC GO:0048770~pigment granule 6|52 19.3 1.3E-05 6.2 2.2E-02 
NKLTAG all GO-CC GO:0015629~actin cytoskeleton 6|52 8.0 8.1E-04 2.8 2.8E-01 
NKLTAG all GO-CC GO:0005694~chromosome 6|52 4.3 9.7E-03 2.0 2.3E-01 
NKLTAG all GO-BP GO:0006998~nuclear envelope 
organization 
3|39 121.5 2.5E-04 27.5 2.1E-04 
NKLTAG all GO-BP GO:0031032~actomyosin structure 
organization 
3|39 43.8 2.0E-03 4.8 1.0E+00 
NKLTAG all GO-BP GO:0006333~chromatin assembly or 
disassembly 
3|39 10.0 9.9E-03 1.2 1.0E+00 
NKLTAG all GO-BP GO:0015031~protein transport 11|39 6.2 5.6E-06 2.8 4.5E-02 
NKLTAG all GO-MF GO:0000166~nucleotide binding 18|53 2.4 5.5E-04 1.5 1.2E-01 
MEF diff GO-CC GO:0005635~nuclear envelope 4|30 12.4 3.6E-03   
MEF diff GO-BP GO:0034660~ncRNA metabolic 
process 
4|29 9.7 7.1E-03   
MEF diff GO-BP GO:0015031~protein transport 7|29 5.3 1.4E-03   
MEF diff GO-BP GO:0016070~RNA metabolic process 6|29 4.4 8.7E-03   
MEF diff GO-MF GO:0003924~GTPase activity 4|29 16.6 1.6E-03   
MEF diff Reactome 823753:RAN binding protein 2 4|12 8.8 6.9E-03   
Identified lamin A interacting proteins in NklTAg cells and preferential lamin A/progerin interactors in MEFs,  were analyzed separately for the GO 
categories “cellular components” (GO-CC), “biological process” (GO-BP), “molecular function” (GO-MF), as well as the Reactome (R) database. 
Categories are listed, together with the amount of proteins represented in the category compared to the total amount of annotated proteins. 
Enrichment factors are determined in comparison to random protein sets 21-22 as well as NE proteins 6, 10, and p-values are indicated (p<1x10-3 
indicated in bold) based on statistical algorithms incorporated into the DAVID database.66 
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 Table S3. GO analysis for identified lamin A- and progerin-interacting proteins in MEFs.  
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GO-CC 
GO:0005639~integral to nuclear inner 
membrane 
3|141 101.1 2.9E-04 3|173 82.4 4.3E-04 3|959 14.9 1.3E-02 
GO-CC GO:0005652~nuclear lamina 6|141 75.8 4.7E-09 7|173 72.1 7.8E-11 6|959 11.1 6.4E-05 
GO-CC GO:0005637~nuclear inner membrane 9|141 60.6 4.3E-13 10|173 54.9 2.1E-14 9|959 8.9 1.7E-06 
GO-CC GO:0031080~Nup107-160 complex 4|141 50.5 5.0E-05 3|173 30.9 3.9E-03 7|959 13.0 2.3E-06 
GO-CC GO:0005635~nuclear envelope 23|141 15.2 8.5E-20 22|173 11.8 1.3E-16 63|959 6.1 3.8E-33 
GO-CC GO:0048770~pigment granule 6|141 7.1 1.5E-03 7|173 6.8 5.6E-04 18|959 3.1 4.2E-05 
GO-CC GO:0030017~sarcomere 5|141 6.3 7.9E-03 4|173 4.1 7.2E-02 16|959 3.0 2.5E-04 
GO-CC 
GO:0005789~endoplasmic reticulum 
membrane 
9|141 6.0 1.3E-04 8|173 4.3 2.5E-03 18|959 1.8 2.7E-02 
GO-CC GO:0044427~chromosomal part 13|141 4.1 7.0E-05 21|173 5.4 1.6E-09 58|959 2.7 7.0E-12 
GO-CC 
GO:0043232~intracellular non-membrane-
bounded organelle 
40|141 2.1 5.0E-06 53|173 2.3 7.2E-09 279|959 2.2 1.3E-39 
GO-CC GO:0044446~intracellular organelle part 60|141 1.9 1.3E-07 78|173 2.0 5.4E-11 495|959 2.3 1.4E-93 
GO-BP 
GO:0006998~nuclear envelope 
organization 
4|120 52.7 4.6E-05 3|157 30.2 4.1E-03 6|876 10.8 8.9E-05 
GO-BP 
GO:0043242~negative regulation of 
protein complex disassembly 
6|120 20.3 1.0E-05 4|157 10.4 6.6E-03 7|876 3.3 9.1E-03 
GO-BP GO:0006465~signal peptide processing 1|120 19.7 1.0E+00 3|157 45.3 1.7E-03 3|876 8.1 4.8E-02 
GO-BP GO:0051028~mRNA transport 7|120 13.4 1.3E-05 6|157 8.8 5.8E-04 43|876 11.3 1.5E-36 
GO-BP GO:0006913~nucleocytoplasmic transport 8|120 9.9 1.6E-05 5|157 4.7 2.1E-02 31|876 5.2 4.0E-14 
GO-BP GO:0015031~protein transport 34|120 6.2 1.6E-17 30|157 4.2 9.0E-11 87|876 2.2 9.1E-12 
GO-BP 
GO:0007264~small GTPase mediated signal 
transduction 
13|120 6.0 1.7E-06 13|157 4.6 2.7E-05 13|876 0.8 8.8E-01 
GO-BP 
GO:0006333~chromatin assembly or 
disassembly 
5|120 5.4 1.3E-02 14|157 11.6 1.9E-10 27|876 4.0 1.5E-09 
GO-BP GO:0016192~vesicle-mediated transport 14|120 3.6 1.4E-04 16|157 3.1 1.9E-04 31|876 1.1 4.3E-01 
GO-BP 
GO:0016043~cellular component 
organization 
33|120 2.1 5.7E-05 43|157 2.1 4.1E-06 192|876 1.6 5.2E-13 
GO-BP GO:0045454~cell redox homeostasis 1|120 1.9 1.0E+00 5|157 7.3 4.7E-03 0|876 0.0  
GO-MF 
GO:0048407~platelet-derived growth 
factor binding 
3|135 38.0 2.6E-03 0|167 0.0  3|926 5.5 9.8E-02 
GO-MF 
GO:0016864~intramolecular oxido-
reductase activity, transposing S-S bonds 
1|135 14.3 1.0E+00 3|167 34.6 3.1E-03 0|926 0.0  
GO-MF GO:0008565~protein transporter activity 7|135 12.1 2.3E-05 3|167 4.2 1.6E-01 14|926 3.5 1.3E-04 
GO-MF GO:0005525~GTP binding 18|135 5.8 1.2E-08 19|167 5.0 5.2E-08 32|926 1.5 2.3E-02 
GO-MF GO:0003924~GTPase activity 6|135 5.3 5.2E-03 5|167 3.6 5.0E-02 22|926 2.9 2.4E-05 
Reactome 810245:nucleoporin like 2 10|56 14.8 7.2E-09 10|62 13.3 1.9E-08 28|240 9.6 2.1E-24 
Reactome 783524:SEC11 homolog A (S. cerevisiae) 4|56 9.0 8.7E-03 4|62 8.1 9.8E-03 4|240 2.1 2.9E-01 
Reactome 
799755:proteasome (prosome, macropain) 
26S subunit, ATPase, 2 
0|56 0.0 
 
10|62 10.7 1.6E-07 0|240 0.0  
Identified lamin A and progerin  interacting proteins in MEFs, as well as previously identified NE proteins were analyzed separately for the 
GO categories “cellular components” (GO-CC), “biological process” (GO-BP), “molecular function” (GO-MF), as well as the reactome (R) 
database.6, 10 Categories are listed together with the amount of proteins represented in the category versus to the total amount of 
annotated proteins, the enrichment factor compared to random protein sets 21-22 and significance level. Significance p-values (p<1x10-3; 
statistic testing includes kappa statistic measurement and is further described elsewhere 66) are indicated; non-significant values are 
underlined or blank in case no  proteins were found within the respective GO-term.
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Abstract 
Mutations in the A-type lamins A and C, both major components of the 
nuclear lamina, cause phenotypically diverse diseases collectively referred 
to as laminopathies. These diseases often involve defects in chromatin 
organization, however, it is unclear whether aberrant chromatin-lamin 
interactions contributes to disease. Here we have used an unbiased 
approach to comparatively map genome-wide interactions of gene 
promoters with lamin A and progerin, the mutated lamin A isoform in the 
premature aging disorder Hutchinson-Gilford Progeria Syndrome (HGPS). 
We find that lamin A-associated genes are predominantly silent or 
expressed at low levels. We identify multiple classes of common or uniquely 
lamin A- or progerin-associated genes. Loss of lamin-association is not 
sufficient for gene activation and does not determine peripheral gene 
localization. Progerin induces global changes in chromatin organization and 
leads to relocation of peripherally localized genes, but not necessarily to 
their activation. These observations provide insight into the role of lamin A 
in chromatin organization and demonstrate that progerin affect specific 
chromatin-lamina interactions.  
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Introduction 
The nuclear envelope (NE) defines the boundary between the nucleus and 
the cytoplasm and is composed of an outer and inner nuclear membrane 
(ONM, INM, respectively), interrupted by nuclear pore complexes (NPC) 1. 
The NE is lined by a proteinaceous network made up of lamin proteins. The 
nuclear lamins are intermediate filament proteins and are categorized in A-
type lamins (lamin A, AΔ10, C and C2), encoded by the LMNA gene, and B-
type lamins (lamin B1, B2 and B3), encoded by the LMNB1 and LMNB2 
genes, respectively 2.  
 
Mutations in A-type lamins cause a group of phenotypically diverse 
diseases, collectively referred to as laminopathies 3. They include several 
types of muscular dystrophies, lipodystrophies, cardiomyopathies, 
neurological disorders and premature ageing syndromes. A-type lamins are 
crucial in maintaining higher-order chromatin organization as loss of lamin 
A/C results in reduction or loss of heterochromatin at discrete regions close 
to the INM 4. Laminopathy-associated point mutations in lamin A/C often 
deregulate chromatin structure and organization, most dramatically in the 
premature aging disease Hutchinson-Gilford Progeria Syndrome (HGPS). 
TheHGPS-associated mutant lamin A isoform progerin causes loss of 
heterochromatin and reduced mono- and tri-methylation of lysines 9 and 20 
on histone 3 5-6. Another progeria-related lamin A mutation, E145K, leads to 
alterations in pericentric chromatin, abnormal clustering of centromeres 
and mislocalization of  telomeres 7. Loss of heterochromatin and 
mislocalization of HP1β also occurs in mandibuloacral dysplasia (MAD) 8-9.  
 
Several lines of evidence suggest that A-type lamins interact directly with 
chromatin in vivo and that these interactions are affected by LMNA 
mutations. First, structurally related B-type lamins directly bind histones 
H2A and H2B in vitro 10 and lamin B interacts with chromatin in vivo at 
discrete lamin-associated domains (LADs) which are characterized by low 
gene activity and demarcated by insulators 11-13. Second, amino acids 396-
430 of the human lamin A/C tail bind core histones in vitro 14. Third, the 
immunoglobulin domain of lamin A/C covalently binds 30 bp dimerized DNA 
fragments in vitro and the familial partial lipodystrophy (FPLD)-associated 
R483Q and –W mutations lower this affinity 15. Based on these findings it 
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was hypothesized that direct interaction of A-type lamins with chromatin is 
important for chromatin organization and gene regulation 16. However to 
date it is unknown which chromatin regions directly interact with A-type 
lamins in vivo, and how loss or mutation of lamin A/C affects chromatin 
organization and gene expression. 
 
To probe the role of the lamina in genome organization and gene expression 
we have conducted an unbiased and genome-wide mapping of gene 
promoters that interact with lamin A and/or progerin. We find that lamin A 
preferentially binds silent or lowly expressed genes. This association 
facilitates, but does not determine, peripheral localization and loss of the 
interaction is not sufficient for gene activation. Progerin differentially 
interacts with many of the lamin A-associated genes and the basal 
expression level of those and common interactors correlates with their 
relative subnuclear position. These data demonstrate a direct and distinct 
effect of lamin A and progerin on chromatin interaction and organization at 
the lamina.  
Materials & Methods 
Cell lines and culture 
The lentiviral expression plasmid for N-terminal One-STrEP tagged lamin A 
(OST-A) is described 17. An N-terminal One-STrEP tagged progerin (OST-P) 
lentiviral expression plasmid was created by lamin A PCR amplification 
omitting amino acids 609-658 using the pCDH MCSNard OST-A plasmid as a 
template and consequent ligation of the PCR product back into BamHI and 
EcoRI restriction sites. A lentiviral vector expressing shRNA directed against 
mouse lamin A/C  (pSIHpuro-shRNA-mouseLMNA) was created by annealing 
5’gatccGAGCTTGACTTCCAGAAGAACATttcaagagaATGTTCTTCTGGAAGTCAAG
CTCtttttg3’ and  
5’aattcaaaaaGAGCTTGACTTCCAGAAGAACATtctcttgaaATGTTCTTCTGGAAGTC
AAGCTCg 3’ oligos and consequent ligation into BamHI and EcoRI restricted 
pSIH H1 plasmid (System Biosciences, Mountain View, USA). Lentivirus was 
produced by co-transfecting 293 FT cells (Invitrogen, Carlsbad, USA) with 
pSIHpuro-shRNA-mouseLMNA, pCDHblast MCSNard OST-A or OST-P in 
combination with pSPAX and pMD2.G vectors (a gift from D. Trono, 
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Lausanne, Switzerland). The mouse cardiac myocyte cell line NklTAg 18, as 
well as mouse embryonic fibroblasts of wild-type (WT) MEFs and LMNA 
knock-out (LMNAKO-/-) embryos 4 were infected with various concentrations 
of lentivirus and 48 hours post infection selected with blasticidin. Infected 
cells with OST-A or OST-P protein expression levels comparable to 
endogenous lamin A were further cultured and grown in Dulbecco’s 
modified Eagle’s/F-12 media  (for NklTAg cells) or Dulbecco’s modified eagle 
medium (for MEFs) both supplemented with 2mM L-glutamine, 10mM non-
essential amino acids (NEAA), 110 mg/l pyruvate, 10% fetal bovine serum 
and antibiotics in a humidified atmosphere at 37⁰C at 5% CO2. NklTAg cells 
were plated on 12.5 μg/ml fibronectin and 0.1% gelatin coated plates.  
Western blot 
Western blots were performed essentially as described elsewhere 17. Cells 
were lysed in SDS-PAGE Laemmli loading buffer and further denatured by 
heating for 5 min at 95⁰C. Equal amounts of cell lysates were loaded and run 
on NuPage Novex Bis-Tris 4-20% gradient gels  (Invitrogen, Carlsbad, USA), 
blotted on immobilon-PVDF membrane (Millipore, Billerica, USA), blocked 1 
hour in 5%  bovine serum albumin /TBS-T (20 mM Tris-HCl pH 7.5, 150 mM 
NaCl and 0.1% Tween 20). The blocked membrane was incubated at 4⁰C 
overnight with primary antibodies (α-Lamin A/C, Sc6215, StCruz, Santa Cruz, 
USA; α-Beta Actin, A-5441, Sigma, St Louis, USA) in blocking buffer diluted. 
After incubation with appropriate secondary HRP-labeled secondary 
antibodies, immunoluminescence was detected with an ECL Western 
Blotting detection system (Amersham, Roosendaal, Netherlands). The 
intensity of signals was quantified using ImageJ software.  
Immunofluorescence 
For immunofluorescence microscopy, cells were grown on 0.1% gelatin/PBS 
solution coated  multi-wells glass slides (MP Biomedicals, Solon, USA), fixed  
for 15 min in 4% paraformaldehyde/PBS,  permeabilized with 0.5% Triton X-
100 in PBS for 5 min, blocked for 30 minutes in block buffer (1%  BSA, 1% 
sucrose in milliQ) and incubated for one hour at room temperature in 
appropriate primary antibodies (α-LMNA/C, Sc-7292, StCruz, Santa Cruz, 
USA) and for one hour with secondary antibodies labeled with the Alexa 
Fluor 488 or 568 chromophores (Invitrogen, Carlsbad, USA). Cells were 
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mounted using Vectashield containing 10g/ml DAPI and observed on a 
Nikon E800 microscope. 
Chromatin Immunoprecipitation (ChIP) 
NklTAg and MEF cell lines were grown in 150 mm dishes, formaldehyde 
fixed and lysed in SDS lysis buffer (1% SDS, 10 mM EDTA, 50 mM Tris pH 
8.1). After sonication the SDS concentration was lowered 10-fold by adding 
ChIP dilution buffer (0.01% SDS, 1.1% Triton X-100, 1.2 mM EDTA, 17 mM 
Tris pH 8.1, 170 mM NaCl). Both SDS lysis buffer and ChIP dilution buffer 
were supplemented with 2 mM ortohovanadate and protease inhibitors 
(Boehringer MannHeim, Indianapolis, USA). Undissolved fractions were 
discarded after a 10 minute 16,000 g centrifugation step at 4 degrees. ChIP 
dilution buffer pre-washed and herring sperm DNA coated Strep-Tactin 
Matrix (IBA BioTagnology, Göttingen, Germany) was added and samples 
were end-over-end rotated overnight at 4 degrees. The next day pelleted 
Strep-Tactin matrix was washed consequently with low salt buffer (0.1% 
SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris pH 8.1, 150 mM NaCl), high 
salt buffer (0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris pH 8,1, 500 
mM NaCl), LiCl buffer (0.25 M LiCl, 1% Igepal-CA630, 1% deoxycholic acid, 1 
mM EDTA, 10 mM Tris pH 8.1), OST stringent wash buffer (2M NaCl, 2% Trx-
100, 500 mM LiCl, 0.1% SDS, 1% Sodium Deoxycholate, 20 mM Tris pH 8.1, 
2mM EDTA) and TE buffer (10 mM Tris, 1mM EDTA pH 8.0). Precipitated 
protein-chromatin complexes were eluted at room temperature in fresh 
elution buffer (1% SDS and 0.1 M NaHCO3). After de-cross-linking for 6 
hours at 65⁰C in the presence of 200mM NaCl and 30 μg/ml RNAase A, DNA 
was purified using a Qiagen PCR clean-up kit (Qiagen, Hilden, Germany) and 
amplified according to Whole Genome Amplification kit instructions (Sigma, 
St. Louis, USA) for further analysis on promoter arrays.  
ChIP-on-chip analysis 
Amplified DNA fragments were hybridized to NimbleGen MM8 385K Refseq 
promoter arrays, tiling a region of 2000 bp downstream to 500 bp upstream 
for transcription start sites of ~19,000 Refseq genes, excluding 
chromosomes 20 to 22. NklTAg OST-A targets were identified based the 
combined data from 4 independent experiments. Two arrays were 
hybridized with Cy-3 labeled input DNA and Cy-5 labeled ChIPed DNA from 
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NklTAg cells. To correct for non-specific enrichment of DNA fragments ChIPs 
on cells transfected with an empty vector (Cy-3 labeled) served as a 
reference for ChIPs on OST-A expressing NklTAg cells (Cy-5 labeled) on two 
additional arrays. To identify differences in lamin A and progerin promoter 
association, data of 4 independent experiments were combined. Lamin A 
and progerin targets were identified independently in WT and LMNAKO-/- 
MEFs 4 by hybridization of OST-A ChIPed DNA (Cy-5 labeled) against ChIPed 
DNA from empty vector infected cells (Cy-3 labeled), and hybridization of 
OST-P ChIPed DNA (Cy-5 labeled) against OST-A ChIPed DNA (Cy-3 labeled). 
Hybridization and data acquisition were performed in-house by NimbleGen 
according to standard procedures (Roche NimbleGen, Madison, USA).  
 
To identify binding targets in the microarray data, we applied a between-
array analysis approach in the statistical programming language R. This 
method compares all replicates and any negative controls directly at probe 
level, which is thereby expected to produce a statistically more robust set of 
potential targets compared to NimbleGen’s standard within-array analysis 
method. Our approach is fully described elsewhere 19. In short, a log-ratio 
between experimental and control samples are calculated separately for 
each array. Next, all probes are ordered according to genomic location and 
dichotomized using a threshold around twice the estimated standard 
deviation of the log-ratio. Probes with a log-ratio above this threshold are 
considered positive, those below negative. Next, for each array a sliding 
window of a variable number of base pairs is moved over all probes, 
calculating a detection p-value for the probes in each probe-window using a 
Yates corrected Chi-square test, to assess whether there are significantly 
more positive probes present than expected by chance. A promoter is 
significantly enriched when at least one probe-window shows significant 
enrichment in all experimental arrays for a particular condition and in none 
of any available arrays suitable as negative controls for that condition. To 
minimize false positives a detection p-value of 0.05 was used as the cut-off 
per array. OSTA- and OST-P associated gene promoters needed to be 
recognized as such independently in both WT and LMNAKO-/- MEFs, and are 
collectively referred to as MEF OST-A and OST-P ChIP targets.  
 
Cluster analysis of identified lamin targets was essentially performed as 
described previously 13. To test whether lamin targets were clustered, we 
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defined clusters as two or more adjacent lamin-associated genes not 
interrupted by non-target genes. Next, unclustered (cluster size=1 gene) and 
clustered (cluster size>1 gene) lamin targets for all chromosomes were 
compared by Fisher’s exact test to randomly expected occurrences of gene 
clusters, determined in 10,000 simulations.  
 
Gene ontology (GO) analysis was performed with the Database for 
Annotation, Visualization, and Integrated Discovery (DAVID) using standard 
settings for functional annotation clustering, listing significant clusters by 
most significant GO Biological Processes class 20-21. Average conservation 
plots were generated with Cis-regulatory Element Annotation System (CEAS) 
(http://ceas.cbi.pku.edu.cn/submit.htm) 22, showing the level of 
conservation of the ChIP regions compared to the genomic background. 
MatInspector software and the Genomatix transcription factor motif 
database (www.genomatix.de) were used to identify enriched 
Transcription Factor Motifs (TFM) in target sites and target promoters 23.  
Fluorescent In Situ Immunohybridization (FISH) 
To produce probes for DNA FISH, bacterial artificial chromosomes (BACs, 
BACPAC Resources Center, Oakland, USA) were labeled by nick translations 
with dUTP conjugated with biotin or dioxygenin (Roche, Madison, USA) 
using the mouse BAC clones (Acpp, RP24-383K20; Sp100, RP24-235A6; 
OLFR681, RP24-324M2; OLFR1471, RP24-346K11; Eif2b, RP24-285P5; Fanca, 
RP24-157M4; Eef1a2, RP24-163K20; Kcnip2, RP24-337I2; Scn5a, RP23-
103G4; Sdro, RP24-244F19; Cyp3a25, rp-23-332c3; Olfr804, rp24-167G2; 
Abpd, rp24-238I13; Defcr5, rp24-243l16; Daf2, RP24-154P21; Tcf21, RP23-
93MI0; Trim30, RP23-312K22; Abcb10, RP24-361K8) as described 24-25. 
Probes consisted of 150-300 ng of digoxigenin- and/or biotin-labeled probe 
DNA, 3 μg mouse COT1 DNA (Roche, Madison, USA) and 20 μg tRNA (Sigma, 
St Louis, USA) resuspended in 7 μl of hybridization mix (10% dextran sulfate, 
50% formamide/2xSSC, and 1% Tween 20). Cells grown on glass slides were 
fixed in 4% PFA/PBS for 10 min, permeabilized for 20 min in 0.5% 
saponin/0.5% Triton X-100/PBS and incubated in 0.1 N HCl for 15 min with 
PBS washes between each step. After a 2x SSC wash, cells were equilibrated 
in 50% formamide/2xSSC. Nuclei and probes were denatured together at 
85°C for 5 min and left to hybridize at 37°C overnight in a humidified 
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chamber. The next day, slides were washed three times with 50% 
formamide/2xSSC at 45°C for 5 min each and thrice with 1x SSC at 60°C for 5 
min each. Next, the cells were placed in 0.05% Tween-20/4xSSC at room 
temperature to cool and blocked for 20 min in 3% BSA/0.05% Tween-
20/4xSSC. For immunofluorescence of LMNB1 slides were incubated at 
room temperature for 45 minutes with 1:50 in block buffer diluted LMNB 
antibody (Sc-6217, Santa Cruz Biotechnology, Santa Cruz, USA). Next, 
detection antibodies (anti-dioxigenin-rhodamine; Roche, Madison, USA), 
fluorescein avidin DN (Vector Laboratories, Burlingame, USA) and Alexa 
Fluor 647 Donkey-anti-goat  IgG (Invitrogen, Carlsbad, USA)) diluted 1:200 in 
blocking solution were incubated with cells for one hour at 37°C. Slides were 
mounted in DAPI-containing Vectashield mounting medium after three 5-
min washes in 0.05% Tween-20/4xSSC at 42°C. 
FISH image acquisition and analysis 
Cells were imaged with an IX70 microscope (Olympus) controlled by a 
Deltavision System (Applied Precision) with SoftWoRx 3.7.0 Release 13EL 
(Applied Precision) and fitted with a charge-coupled device camera 
(CoolSnap; Photometrics) using a 60x 1.4 oil objective lens (Olympus) and an 
auxiliary magnification of 1.5 using an optical step size of 0.2 μm. Typically, 
25 focal sections were imaged covering the entire nucleus. Using SoftWoRx 
3.7.0 Release 13EL (Applied Precision) FISH signals were detected and 
analyzed in the z section with the brightest signal intensity. The two 
brightest FISH signals were used for quantification and frequency of cells 
with minimally one FISH signal within 500 nm distance of (NklTAg 
experiments) or overlapping (MEF experiments) with LMNB staining were 
quantified. Minimally 150 nuclei were analyzed in duplicate per probe per 
cell line. Per probe quantification results were statistically tested between 
different cell lines using the chi-square test. To test whether the distribution 
of observed frequencies of cells with FISH signals at the NE for OST-Auniqe, 
common OST-A&P and OST-Punique targets differ for different cell lines a 
Kruskal-Wallis One way analysis of variance by ranks  was applied, using 
Dunn’s method for pair-wise multiple comparisons. SigmaStat 3.1 software 
was used for statistical analysis. For all tests P-values <0.05 were considered 
significant.  
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RNA isolation and expression microarray 
RNA was isolated using the RNAeasy minikit (Qiagen, Hilden, Germany) from 
MEF, cardiac myocyte NklTAg cells and cardiac left ventricles of a gene trap 
LMNA null mouse model (LMNAGT-/-) (Kubben et al., in preparation). For 
whole transcriptome analyses RNA from 5 days old WT and LMNAGT-/- mice 
(N=2 each) and from WT MEFs infected with a OST-A, OST-P or empty vector 
lentivirus (N=2 each) were isolated and hybridized to Nugo Mouse 
Affymetrix expression arrays and Affymetrix Mouse Gene 1.0 ST arrays, 
respectively. Intensity values after hybridization were normalized to the 
median signal intensity of the array. For individual genes differences in 
expression levels were statistically tested by a one way ANOVA. Expression 
heatmaps were generated with DNA Arraystar 3.0 Software (DNAStar, 
Madison, USA). Expression profiles between different cell lines were 
statistically analyzed by first testing for normality of distribution by a 
Kolmogorov-Smirnov test. P-values tested were all significant (p<0.05) 
hence expression values were not considered to be normally distributed. 
Consequently differences in expression values were tested with the non-
parametric Mann-Whitney Rank Sum test between 2 groups, and the 
Kruskall-Wallis one-way analysis of variance for more than 2 groups. P-
values below 0.05 were considered significant. Verification of microarray 
expression data by PCR cDNA was synthesized with the iScriptTM cDNA 
synthesis kit (BioRad, Hercules, USA). SYBR Green real-time quantitative PCR 
analysis was performed in experimental duplos with primers for Beta-Actin 
(FW 5’TGGAGCCTGTGTTCTATCCA3’, Rev 5’TGGAGCCTGTGTTCTATCCA3’), PCNA 
(FW 5’AGGGTTGGTAGTTGTCGCTGTAG3’, Rev 5’GGTCCCCCGATTCACGAT3’), Sp100 
(FW 5’AACGACGCAGAAAAAGAGGT3’, Rev 5’GTGAATAACCGCCCTGTCTT3’), Cdkl4 
(FW 5’ACCAGGGCACCTCTAATCAC3’, Rev 5’CTCTGGTGAAACTGGAAGCA3’), 
OLFR686 (FW 5’TGGATATCCCTTCCCTTCTG3’, Rev 5’TGGAGCCTGTGTTCTATCCA3’), 
OLFR826 (FW 5’ACTCGGGCTTAGGAAGATGA3’,  Rev 
5’GGATCATGGCATACACAAGC3’), OLFR1098 (FW 
5’TGTCCTACATCGTTGGAGCTAT3’, Rev 5’TGCAGAAATCCAGTGTGCTT3’), Defb28 
(FW 5’TAGCTGTCCTTGTGGTCCTG3’, Rev 5’CCAAGCCATAAAAGCAGGTT3’), Acpp  
(FW 5’CTGGGTCTTTTTCCCTGTGT3’, Rev 5’ACTCGGGCTTAGGAAGATGA3’) and 
HPRT (FW 5’GCGTCGTGATTAGCGATGATGAAC3’, Rev 5’ 
CCTCCCATCTCCTTCATGACATCT3’). Differences in real-time PCR quantification 
were determined applying a student T-test with 0.05 significance level. 
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Figure 1. Genomic localization and characteristics of lamin-associated genes. (A) Identified 
ChIP-chip targets of OST-LMNA in NklTAg myocytes are plotted according to their genomic
location. Chromosomes are depicted in a relative scale, which corrects for size differences
between individual chromosomes. (B) Summary of a gene ontology (GO) analysis on
identified lamin A-targets. Per GO category the amount of lamin A-associated genes, out of a 
total of 292 targets, enriched for is indicated, as well as the minimal amount of genes needed
to reach a significance level of 0.05, based on statistical algorithms of the DAVID database
described elsewhere 39. 
Results 
Identification of lamin A-associated genes 
To map lamin A interacting chromatin regions genome-wide we stably 
expressed One-STrEP-tagged lamin A (OST-A) at endogenous levels in a 
murine myocyte NklTAg 18 cell line 26. The One-STrEP (OST) tag is a modified 
version of the biotin-related 8 amino acid StrepII epitope, which binds with 
high affinity (Kd = 1μM) to Strep-Tactin Matrix, an engineered streptavidin 
analogue 27. OST-A has previously been characterized in detail  and the OST-
tag does not interfere with correct localization or function of lamin A at the 
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nuclear lamina (26 also Figure S1A). To identify lamin A-associated genome 
regions, we performed chromatin immunoprecipitation (ChIP) using the 
Strep-Tactin matrix for highly selective binding to the OST tag 28-29 (Materials 
and methods; Figure S2A). Recovered chromatin was hybridized to 
NimbleGen promoter tiling arrays covering 2,500 bp promoter regions 
flanking the transcriptional start site of ~ 19,000 annotated Refseq genes. 
Samples were run in duplicates and ChIPed DNA from empty vector infected 
cells, as well as input DNA from OST-A expressing cells, were used as  
 
 
Figure 2. Subnuclear localization of lamin A-associated genes. (A) FISH on 4 lamin A targets 
(Acpp, Sp100, Olfr681, Olfr1471) and 2 non-targets (Eif2b, Fanca). The percentage of cells 
with at least one FISH signals near the nuclear lamina (overlapping or within 500 nm of lamin 
B) was measured. Typical examples of each scoring category are depicted for the lamin A 
target Sp100 (green), and the non-target Fanca (red). (B) Quantification of FISH staining for 
lamin A targets and non-targets in NklTAg cells infected with control shRNA, lamin A/C 
shRNA, OST-A or a control vector. Asterisks indicate a significant (p<0.05; χ2 test) change in 
peripheral positioning in comparison to control infected cells. 
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controls (Figure S2A). 292 lamin A-associated genes were identified, based 
on enrichment in four independent experiments and stringent statistical 
criteria 19(Material and methods). 
 
The 292 OST-A target genes localize to all chromosomes with the exception 
of the Y chromosome, which is absent in the female NklTAg cell line (Figure 
1A and S3). 27% of the 292 lamin A targets localize in gene clusters (defined 
 
 
  
 
Figure 3. Expression profiles of lamin A-associated genes. (A) A genome-wide heatmap of 
RNA expression levels in cardiac left ventricle of wild-type (WT) and LMNAGT-/- mice, which 
are functional knock-out for A-type lamins 40. (B) Average fold changes (±sd) of absolute 
linear RNA expression levels for lamin A targets and random gene sets upon loss of lamin A/C 
(WT vs. LMNAGT-/- mice). Observed fold changes did not differ significantly from 1.0 (p>0.05; 
Mann-Whitney U test). (C) Real-time quantitative PCR on 7 lamin A targets (Sp100, Cdkl4, 
Olfr826, olfr686, olfr1098, Defb28 and Acpp) and 2 non-targets (B-Actin and Pcna) in the 
presence and absence of lamin A/C shRNA in NklTAg myocytes. Ct values (±sd) are indicated, 
and reversely correlate to RNA expression levels (approximately a 2-fold decrease in 
expression levels per increased Ct value of 1). Ct values were all corrected for the 
housekeeping gene GAPDH expression levels and determined in hexaplo, using equal 
amounts of starting material (100ng cDNA) for each reaction. The detection limit 41 of 
quantitative PCR (Ct value of ~35) is indicated with a dotted line. Ct values did not differ 
significantly (p>0.05; Students T-test) for all targets between NklTAg cells infected with 
control and LMNA shRNA respectively.  
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as two or more adjacent genes), which is 5-fold higher (p<1.0x10-4; Fisher’s  
exact test) than expected for random gene association (Figure S4A and B). 
Gene ontology (GO) analysis identified 74 of the 292 target genes as 
involved in ‘G protein coupled receptor signaling’ pathways (Figure 1B), with 
the vast majority (N=55) belonging to the GO subcategory ‘perception of 
smell’ including 52 olfactory receptors (OLFR) and 3 vomeronasal receptors 
(VMNR). This frequency is significantly higher (p<1.0x10-5) than would be 
expected based on random association, which would predict less than 30 of 
the 292 lamin A-associated genes to be involved in this GO category. Other 
significantly enriched GO categories included ‘locomotion’ (N=11/292, 
p=1.3x10-2) and ‘regulation of blood coagulation’ (N=3/292, p=3.5x10-2; 
Figure 1B). 
 
Conservation plots using the Cis-regulatory Element Annotation System 
(CEAS) database 22 did not reveal significant sequence conservation of 
precipitated DNA fragments (Figure S5), arguing against the existence of a 
specific lamin A-binding sequence. Analysis of known transcription factor 
binding motifs (TFM) by MatInspector software 23 revealed 42 of the 170 
known TFM to be significantly enriched in OST-A-associated gene promoters 
in comparison torandom promoter sequences (p<0.05). The most highly 
enriched TFMs include those for the bromodomain and plant homeo 
domain transcription factor (BPTF, p<1.0x10-4) family, the three-amino acid-
loop extension (TALE, p<1.0x10-4) and auto-immune regulator (AIRE, 
p<1.0x10-4) TF families. These data demonstrate that A-type lamin 
interacting gene promoters preferentially localize in genomic clusters, lack 
unique consensus lamin A binding sequences but are enriched for several 
transcription factor binding motifs. 
Nuclear localization of lamin A-associated genes 
To assess the subnuclear localization of lamin A-associated genes and to 
validate the ChIP technique, the location of 4 lamin A targets and 2 non-
targets in NklTAg cells were probed by DNA FISH. We measured the 
percentage of cells with at least one FISH signal within 500 nm of the 
nuclear periphery identified by lamin B (material and methods; Figure 2A) 30.  
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For the randomly selected lamin A targets Acpp, Sp100, Olfr681 and 
Olfr1471 located on chromosomes 9, 1, 7 , and 19, respectively, at least one 
allele localized to the periphery in 55, 45, 55 and 30%, respectively, of cells 
compared to 17 and 9% for the non-targets Eif2b and Fanca (Figure 2B). The 
difference between peripheral localization of lamin A targets and non-
targets is statistically significant at p<0.001 in a χ2 test.Next we set out to 
probe the effects of loss of A-type lamins on the subnuclear localization of 
lamin A associated-genes by knocking-down lamin A/C using shRNA in 
NklTAg cells. Expression of lamin A/C shRNA resulted in over 90% knock-
down for both lamin A and C proteins (Figure S1B). The peripheral 
localization of the lamin A target loci Acpp, Sp100 and OLFR681  decreased 
significantly to  35 , 31 and 25% (p<0.01, χ2 test; Figure 2B). In contrast, the 
lamin-associated OLFR1471 locus and the non-targets Eif2b and Fanca 
retained their subnuclear position (p>0.05, χ2 test; Figure 2B). In contrast, 
overexpression of OST-A at endogenous levels did not affect localization of 
lamin A-associated genes, with the exception of the lamin A target OLFR681, 
which showed increased localization to the nuclear lamina upon 
introduction of OST-A (from 46% to 63%, p<0.05,  χ2 test). These findings 
support a role for lamin A in recruiting gene promoters to the nuclear 
periphery. 
Expression profile of lamin A-associated genes 
To obtain insights into the effect of lamin A/C and its loss on lamin A target 
genes in NklTAg cardiac myocytes, we analyzed the expression profiles of 
lamin A interacting genes using microarray expression profiles of neonatal 
cardiac tissues of WT and LMNAGT-/- mice, a LMNA null model based on gene 
trap technology (Kubben et al., in preparation). Basal expression levels of 
lamin A-interacting genes are significantly lower compared to random gene 
sets (Δlog2 -1.28, p<0.001, Mann-Whitney U test; Figure 3A). Amongst the 
292 lamin A-associated target genes, 238 genes were not expressed or 
expressed at very low levels (absolute linear expression value <25, which is 
650-fold lower than the housekeeping gene GAPDH), 18 were expressed at 
low levels (linear expression value 25-100) and 36 had roughly average 
expression levels (linear expression value >100).  
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Loss of A-type lamins in LMNAGT-/- cardiac tissue significantly changed the 
transcriptional profile of 1136 genes (Kubben et al., in preparation). The 
average expression fold change (FC) of the 292 lamin Aassociated genes was 
similar to the FC observed in the total genome, and indicated no 
preferential effect of lamin A loss on the lamin A-associated genes (OST-A 
targets FC 1.03±0.12, p=0.604; Random genes FC 1.01±0.16, P=0.478, Mann-
Whitney U test; Figure 3B). As these genes lose their association with the 
lamina (Figure 2B), absence of any effect on gene transcription argues that 
re-activation/expression isprobably not dependent on interaction with 
lamin A or the lamina.  
 
Microarray data were confirmed by quantitative real-time PCR on seven 
lamin A targets (Sp100, Cdkl4, Olfr826, Olfr686, Olfr1098, Defb28 and Acpp) 
and two non-targets (B-actin, Pcna) in NklTAg cardiac myocytes. All lamin A 
targets were expressed at low levels near the detection limit of the RT-PCR 
(Ct values in the range of 33-38), with the exception of Sp100 (Ct values of 
29), in contrast to the non-targets B-actin and Pcna (Ct values of 18-21; 
Figure 3C). Knock-down of lamin A/C did not result in significant changes in 
expression levels for the tested genes (p>0.05, Student’s T-test) in 
accordance with the expression microarrays results. Combined, these 
findings support a role for lamin A in nuclear organization of chromatin 
through association with transcriptionally silent genes. Our data also 
suggest that loss of association of genes with A-type lamins is not sufficient 
for gene activation. 
Identification of lamin-A and progerin associated genome regions 
We next sought to identify genome regions which interact uniquely with 
lamin A, uniquely with progerin or with both. To this end OST tagged lamin 
A (OST-A) or progerin (OST-P) were expressed at endogenous levels in wild-
type (WT) or LMNA knock-out (LMNAKO-/-) MEFs. As previously shown, and in 
contrast to OST-A, OST-P expression leads to distortions of the nuclear 
lamina (Figure S1A) and global loss of LAP2 and HP1γ nuclear levels 26 as 
observed in HGPS patient cells 5. Lamin A-associated gene promoters were 
first identified by hybridizing ChIPed chromatin of WT or LMNAKO-/- MEFs 
expressing OST-A against that of empty vector infected cells (Figure S2B).  
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Figure 4. Genomic localization and characteristics of common and differential lamin A- and progerin-
associated genes. (A) Venn-diagram of lamin A- and progerin-interacting genes determined by ChIP-chip 
in MEF cells (See Material & Methods). Overlapping targets are referred to as common OST-A&P targets, 
while genes only interacting with lamin A or progerin, are named OST-A unique and OST-P unique targets 
respectively. (B) A genomic plot of OST-A unique, OST-P unique and common OST-A&P subsets of targets 
on chromosome 2 and 16. Boxes highlight examples of genomic areas containing gene targets from all 3 
subsets (on chromosome 2), and regions that preferentially represent gene targets from one subclass (on 
chromosome 16). (C) Summary of gene ontology (GO) analysis on gene targets of all 3 subsets, indicating 
the GO class, the amount of genes (N) per total ChIP target genes in that GO class, the minimal amount of 
targets needed for a significance level of 0.05 and the p-value, based on statistical testing fully described 
previously 39. (D) ChIPed DNA fragments of all 3 subclasses were analyzed for the occurrence of 170 
transcription factor motifs (TFM) (See Material & Methods). Common OST-A&P targets were shown to be 
enriched for 58 TFM, while all 170 TFM were normally represented in OST-Aunique and OST-P unique 
targets subsets. 
 
 
 
 
96 | Chapter 4 
Progerin-interacting gene promoters, as well as differences in lamin A and 
progerin-gene promoter interaction profiles, were then determined by 
comparing OST-P ChIPed chromatin with OST-A ChIPed chromatin as a 
control (Material and methods; Figure S2B). We identified 595 lamin A-
associated gene promoters (defined as promoters interacting with OST-A in 
both WT and LMNAKO-/- MEFs) and 552 progerin-associated gene promoters 
(defined as promoters interacting with OST-P in both WT and LMNAKO-/- 
MEFs) (Figure 4A, S2B). A significant  overlap was present for lamin A-
interacting genes (n=595) between WT (N=1686) and LMNAKO-/- MEFs 
(N=840) (p<1x10-3, χ2 test), as well as for progerin-interacting genes (n=552) 
in WT (N=1214) and LMNAKO-/- MEFs (N=1642) (p<1x10-3, χ2 test) . Lamin-
associated genes identified in MEFs and NklTAG cells significantly 
overlapped  as 23% of the 595 lamin A target genes, and 23% of the 552 
progerin target genes identified in MEFs were also identified at the nuclear 
lamina in at least one ChIP-on-chip experiment in NklTAg cells as well 
(p<1x10-3, χ2 test).  
 
Over two-thirds (N=402) of the identified lamin-associated genes in MEFs 
interacted with both lamin A and progerin, and will further be referred to as 
common OST-A&P targets (Figure 4A). 193 lamin A target genes interacted 
uniquely with lamin A (OST-A unique targets) and 150 target genes 
interacted specifically with progerin only and were not enriched in OST-A 
ChIP experiments in the absence of progerin (OST-P unique targets). Closer 
examination of the genomic localization reveals that 38% of the lamin A- as 
well as the progerin-associated genes occurs in clusters (varying in size from 
2 to 11 adjacent genes), which is 5-fold more frequent than expected for 
random gene sets (p<1x10-4; Fisher’s exact test), and both sets of interactors 
overlap significantly (p<1x10-10; Figure S4 C-F). Despite this genomic co-
localization of lamin A- and progerin-associated genes, occasional genomic 
regions that preferentially bind to progerin or lamin A could be found, for 
instance on chromosome 16 (Figure 4B).  
 
GO analysis identified 157 of the 402 common lamin A and progerin targets 
involved in ‘G protein coupled receptor signaling’ pathways (Figure 4C). This 
frequency is significantly higher (p<1.0x10-5) than would be expected based 
on random association of genes, which predicts less than 42 of 402 
associated genes to be involved in this GO category. Other GO categories 
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that were significantly enriched, include ‘Defense response to bacteria’ 
(12/402, p=7.2x10-5) and ‘Response to pheromone’ (11/402, p=2.6x10-5). 
The former category mainly consists of defensin and defensin-related 
cryptdin proteins, and the latter of vomeronasal receptors, which are also 
represented in the ‘G protein coupled receptor signaling’ GO class. In 
comparison to common OSTA&P targets, lamin A uniquely associated genes 
were significantly less enriched in the ‘G protein coupled receptor signaling’ 
category (27/193, p=1.7x10-2; Figure 4C), but instead were enriched in 
‘cation transport’ (16/193, p=7.4x10-5), ‘response to cytokine stimulus’ 
(5/193, p=1.8x10-4) and ‘regulation of hormone levels’ (7/193, p=1.2x10-3). 
OST-P unique targets were enriched for ‘G protein coupled receptor 
signaling’ (27/150, p=9.7x10-4) and ‘regulation of translation’ (4/150, 
p=3.9x10-2). The enrichment of different GO families amongst OST-A, OST-P 
and OSTA&P targets suggests distinct preferential association of various 
gene groups with lamin A or progerin. 
 
As for lamin A- and progerin-interacting genes, no consensus lamin binding 
sequence could be identified in any subclass of target genes (Figure S5). 
TFM analysis indicated enrichment of common lamin A/progerin-associated 
gene promoters for 58 TFMs (p<0.05, Figure 4D, Table S2). Over half of 
these TFMs were also found enriched in lamin A targets within the NklTAg 
cardiac myocytes, including the 5 most significantly enriched TFs brain-5 
(BRN5), serum responsive factor (SRF), octamer transcription factor 1 (Oct-
1), bromodomain and plant homeo domain transcription factor (BPTF) and 
HOXC (all p<1x10-5, Table S2). Lamin A unique and progerin unique targets 
contained TFM (170 analyzed) at similar frequencies as random promoter 
sequences (p>0.05). Overall these data show that lamin A and progerin 
interact differently with chromatin, and that common and uniquely lamin A- 
or progerin-associated genes possess distinct features including their 
biological function and TFMs.  
Subnuclear localization of common versus unique lamin A- and 
progerin-associated genes 
To assess the subnuclear localization of common and unique lamin A- and 
progerin-associated genes, four randomly selected target genes for each 
subset (OST-A unique: Eef1a2, Kcnip2, Scn5a, Sdro; common OST-A&P: 
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Cyp3a25, Olfr804, ABPD, Defcr5; OST-P unique: Daf2, Tcf21, Trim30, 
Abcb10) were analyzed by FISH. Peripheral localization was assigned to FISH 
signals when at least one allele per cell overlapped with the nuclear 
periphery, defined by lamin B staining (Figure 5A). In WT MEFs cells infected 
with an empty vector, the non-target E1f2b only sporadically localized 
peripherally (1%), while for unique lamin A target genes the frequency of 
lamin B signal overlap varied from 4% (Eef1a2) to 29% (Scn5a), for progerin 
unique interacting genes from 2% (Daf2) to 23% (Abcb10) and for common 
targets frequencies were between 53% (Cyp3a25) and 65% (ABPD) (Figure 
5B). Overall, these data indicate that common lamin A/progerin targets 
showed an overall significantly higher frequency of lamin B signal overlap 
(58% on average) than OST-A unique (17% average) and OST-P unique 
targets (16% average) (Figure 5B, Table S4; Pvalue<0.001, χ2 test). This 
preferred peripheral localization of common lamin A/progerin-associated-
genes was independent of the presence of endogenous A-type lamins as 
common interactors in empty vector infected LMNAKO-/- MEFs also more 
frequently overlapped with lamin B (47% average, range 43-54%), in 
comparison to lamin A (19% average, range 8-39%) and progerin (11% 
average, range 5-15%) uniquely associated genes (Table S4; Pvalue<0.001, χ2 
test).  
 
Expressing OST-A at endogenous levels in LMNAKO-/- MEFs affected 
subnuclear positioning of unique lamin A targets, as Eef1a2, Kcnip2 and 
Scn5a, but not Sdro showed increased peripheral localization (OST-A unique 
targets; p<0.05, χ2 test; Figure 5B). In contrast all common lamin A/progerin 
interactors (Cyp3a25, Olfr804, Abpd, Defcr5) as well as progerin unique 
interactors (Daf2, Tcf21, Trim30, Abcb10) examined, were insensitive to 
higher levels of OST-A and did not change subnuclear positioning (all p>0.05, 
χ2 test). In WT MEFs, introduction of OST-A significantly increased peripheral 
localization of the lamin A uniquely associated gene Kcnip2, but not of the 
other probed loci. These results suggest that the subnuclear positioning of 
uniquely lamin A-interacting genes is sensitive to the levels of lamin A, in 
contrast to genes which interact both with progerin or both lamin A and 
progerin.  
 
Expression of OST-P at endogenous levels in LMNAKO-/- MEFs specifically 
influenced the peripheral positioning of the progerin uniquely-associated  
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Figure 5. Subnuclear positioning of common and differential lamin A- and progerin-
associated genes. (A) FISH was performed on 4 loci per subset of ChIP targets (OST-Aunique: 
Eef1a2, Kcnip2, Scn5a, Sdro; common OST-A&P: Cyp3a25, OLFR804, ABPD, Defcr5; OST-
Punique: Daf2, Tcf21, Trim30, Abcb10) as well as one non-target (E1f2b). An example is 
shown of the Tcf21 gene in wild-type (WT) MEFs expressing OST-A, OST-P or an empty 
control vector. Signals (red) were scored to overlap with lamin B (blue) at the nuclear rim or 
not. (B) FISH quantification of the frequency of cells with minimally one FISH signal 
overlapping with lamin B, indicated for all ChIP targets in A-type lamin knock-out (LMNAKO-/-
) MEFs and WT MEFs, expressing OST-A, OST-P or an empty control vector. Significant 
differences in localization with the corresponding empty vector control cells are indicated by 
an asterisk (p<0.05; χ2 test). 
 
 
genes, as Daf2 and Tcf21 became more frequently peripherally localized 
(OST-P unique targets; P<0.05, χ2 test; Figure 5B). In addition, an opposite 
effect was observed for the lamin A unique interactor Sdro, which 
significantly lowered its peripheral localization in the presence of progerin 
(p<0.01, χ2 test; Figure 5B). All other investigated unique lamin A- and 
common lamin A/progerin-associated loci maintained their subuclear 
position. Interestingly, the introduction of OST-P in a WT MEF background,  
similar to the situation found in heterozygous HGPS patients, increased 
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peripheral localization of the Tcf21 progerin uniquely interacting gene, but 
none of the other loci tested, suggesting that the presence of progerin in a 
wild-type background may have gene-specific effects, but does not 
dramatically alter the location of genes globally. 
 
For the lamin A unique interactors expression of OSTA in LMNAKO-/- MEFs 
increased the relative frequency of lamin B signal overlap by 54% on 
average, which is significantly (p<0.05, Student’s T-test; Table S3) different 
from the 17% decrease observed upon the introduction of progerin. In WT 
MEFs these differences were less pronounced, +38% upon lamin A and -13% 
upon progerin expression (p=0.08, Student;s T-test; Table S3). These results 
suggest that lamin A contributes significantly to the peripheral localization 
of lamin A-unique interactor sequences. 
 
For uniquely progerin-associated genes, the increased peripheral 
localization upon the introduction of OST-A in LMNAKO-/- MEFs (+18% on 
average), was significantly less pronounced than upon the expression of 
OST-P (+83%; Table S4; p<0.05, Student’s T-test). In WT MEFs these 
differences, +10% and +106% upon lamin A or progerin expression, 
respectively, were borderline significant (p=0.09, Student’s T-test; Table S3). 
 
Common targets on average did not change (p>0.05) their peripheral 
positioning upon the addition of either OST-A or OST-P in either LMNAKO-/- 
MEFs (+11% OST-A; +11% OST-P) or WT MEFs (-1% OST-A; -3% OST-P). 
Overall, these data demonstrate that common lamin A/progerin interacting 
genes differ from unique interactors by an increased peripheral positioning, 
which is relatively insensible to nuclear  lamin A or progerin protein levels. 
In contrast, unique lamin A and progerin targets can further be 
distinguished from each other in that they specifically increase their 
peripheral localization upon the expression of OST-A and OST-P respectively.  
Global gene expression profiles of common versus unique lamin A- 
or progerin-associated genes 
To examine the expression behavior of lamina-associated genes in response 
to overexpression of lamin A or progerin, we analyzed mRNA from WT MEFs 
transfected with OST-A, OST-P or an empty vector on expression arrays. As 
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previously observed in other systems 31, introduction of progerin changed 
the global transcriptional profile significantly by up-regulating 468 genes 
and downregulating 702 genes (p<0.05; Figure 6A). OST-A expression 
affected 1142 genes (571 up and 517 down) of which 379 targets were also 
affected by expression of OST-P. 
 
When compared to empty vector controls,  lamin A, progerin and common 
targets generally show lower basal expression levels than random sets of 
genes (log2 FC -1.9, p<1x10
-3, Mann-Whitney U-test; Figure 6B). In good 
agreement with their localization at the lamina, common targets were most 
repressed compared to random genes (Δlog2 -2.6, P<1x10-3, Kruskall-Wallis 
test) followed by lamin A unique targets (log2 -2.2 ; P<1x10
-3, Kruskal-Wallis 
test) and progerin unique targets (log2 -1.1; p<1x10
-3, Kruskal-Wallis test). 
mRNA levels of all three individual classes differ significantly from each 
other (p<1x10-3, Kruskal-Wallis test). These basal expression levels of the 
subclasses did not change significantly upon OST-A or OST-P expression in 
WT MEFs (p>0.05, Kruskall-Wallis Test; Figure 6C), suggesting that 
expression of lamin A or progerin is not sufficient to induce a global change 
in gene activity of lamina-associated genes. Overall, these data indicate that, 
independent of the presence of progerin, common lamin A/ progerin targets 
have lower basal expression levels than lamin A or progerin unique targets, 
which appear to partially escape the repressive effect of the NE. 
Progerin-induced changes in gene expression of lamina-associated 
genes 
To further probe the effect of progerin on lamina-associated genes, we 
analyzed individual ChIP targets whose expression were affected by the 
expression of progerin and not lamin A. 53 of 745 genes associated with 
lamin A and/or progerin display a significantly altered expression (Table S5) 
upon introduction of OST-A or OST-P into WT MEFs. 28 of 53 genes respond 
only to progerin and not lamin A (relative expression changes -27% to +63% 
for OST-P; Table S5), 16 change expression upon lamin A but not progerin 
introduction (-11 to +36% for OST-A; Table S5), and 9 genes respond to both 
progerin and lamin A, of which one (Serpin1ad1) shows an opposite 
response to both lamins (-13% for OST-A; +11% for OST-P), 3  are down-
regulated equally by both lamins (Fcer2a, Smarca5, AI747699; range -4% to -
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46% for OST-A or OST-P), 2 show decreased mRNA levels upon the 
expression of lamin A (Hoxc11- 4%, Srp9 -17% for OST-A) and further 
decreased levels upon the introduction of OST-P (-13 and -26%, 
respectively), and the remaining 3 are down-regulated by progerin (Cysltr1 -
1%, Abpg -6% and 5730494M16Rik -9% for OST-P) and more pronounced by  
 
 
 
Figure 6. Expression profiles of common and differential lamin A- and progerin-associated 
genes. (A) A Venn diagram depicting the amount of genes which are deregulated (p<0.05, 
Anova; no minimal fold change cut-off used) upon introduction of respectively OST-A or OST-
P in WT MEFs. The amount of genes up(↑)- and down(↓)-regulated are indicated. (B) 
Expression heatmaps of lamin A/progerin unique and common targets and a random gene 
set. Expression levels are indicated for WT MEFs expressing OST-A, OST-P or an empty 
control vector. Common interactors have lower expression levels compared to lamin A and 
progerin unique interactors (P<0.001; Kruskall-Wallis test). Unique interactors have lower 
basal expression levels compared to random genes (p<0.001; Kruskall-Wallis test). (C) 
Average expression fold changes (FC) (±sd) are given for all 3 subsets of gene targets, 
comparing WT MEFs expressing OST-A or OST-P with empty vector cells and with each other. 
Fold changes are based on absolute linear expression values and all were insignificant 
(p>0.05; Kruskall-Wallis test). 
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lamin A (-5, -8 and -15% respectively). Despite these significant changes, 
expression levels for 44 of 53 targets remain very low (absolute linear 
expression value 1-50, which is 325-fold lower than the housekeeping gene 
GAPDH). Four genes have moderate expression levels (50-100), and increase 
their expression levels either by either progerin (B130050I23Rik +20%  and 
Krtap5-1 +27% for OST-P), or lamin A (Pnpla2 +17% for OST-A) or decrease 
expression by both lamins (Srp9, -17% for OST-A, -26% for OST-P). 5 genes 
were more highly expressed (>100), of which two change expression levels 
upon the expression of OST-P, but not OST-A (Cmtm3 +19%, Rpn2 +3% for 
OST-P), 5730494M16Rik changes expression upon the introduction of OST-A 
(-5%), but not OST-P, and two genes are down-regulated by both lamins, of 
which Smarca5 responds equally to both lamins (-44% for OST-A, -33% for 
OST-P) and 2700069A02Rik is down-regulated more drastically by lamin A 
than progerin (-15% for OST-A, -9% for OST-P). Overall, these data identify 
novel lamina-associated genes whose expression is specifically deregulated 
by progerin, lamin A or both.  
Discussion 
The presence of chromatin defects in several laminopathies 8 points to an 
important role for A-type lamins in chromatin organization. Recent findings 
16 indicate direct lamin A-chromatin interactions are critical for such 
chromatin organization and suggest that aberrant chromatin-lamin 
interactions may contribute to laminopathies. We here map genes which 
interact with lamin A or with the disease causing lamin A isoform progerin in 
a genome-wide, unbiased fashion. We find that lamin A preferentially binds 
to peripherally localized, genomically clustered and silent genes, and that 
chromatin interactions for progerin and lamin A are substantially different. 
Furthermore, we demonstrate that loss or gain of interaction with lamin A 
or progerin changes the nuclear position of many interacting genes, but  per 
se is not sufficient to change gene expression levels of the interacting genes.  
We speculate, however, that altered gene location may predispose genes 
for subsequent aberrant regulation.  
 
Recent studies using the DamID method to map lamin-interacting genome 
regions 12-13 have revealed the importance of lamina-chromatin interactions 
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in chromatin organization and gene expression regulation by identifying 
sharply defined lamin-associated domains (LADs) across the genome 11. 
LADs are preferentially localized in gene-poor, low expressed regions, yet 
they contain cell-type specifically silenced gene clusters 32. In agreement, 
using an independent approach we find that lamin A-associated genes are 
generally silent or very lowly expressed. Lamin A target genes also show 
preferential localization at the nuclear periphery compared to non-targets 
and are genomically clustered. Consistent with this, GO analysis reveals that 
lamin A-associated genes are enriched in gene groups such as sensory 
perception of smell and bacterial response which are not functional in the 
fibroblasts or cardiomyocytes analyzed here, and are hence expected to be 
transcriptionally silent in these cells 33-34. The presence of over 42 tissue and 
cell-type specific transcription factor binding motifs (TFMs) in lamin A-
associated gene promoters further supports this notion. Other enriched 
TFMs, like RP58, may contribute to the transcriptional repressive 
environment of the NE by helping maintain condensed chromatin 35-36. 
 
We identified targets which associate with lamin A or with progerin or with 
both. The former two classes of differential targets are distinguished from 
common targets by a number of characteristics: First, unique targets are less 
involved in cell-type specific biological processes and are not enriched for 
any of the 172 investigated TFM. Second, lamin A/progerin common target 
genes are more frequently co-localized with lamin B at the nuclear lamina 
than lamin A or progerin unique targets. Correspondingly, we find that the 
peripheral position of common targets is significantly less affected by 
overexpression of lamin A or progerin than that of unique targets. Finally, 
genome-wide expression profile analysis shows that regardless of the 
presence of progerin, basal expression levels of common lamin A and 
progerin targets are lower than those of lamin A or progerin-unique targets. 
These data are in good agreement with our FISH analysis and suggest that 
transcriptional silencing of common targets at the nuclear lamina is 
sustained, whereas unique targets partially escape interaction with the 
lamina under normal conditions, and are likely less influenced by repressive 
capacities of the NE. The observation that in the absence of progerin, 
uniquely lamin A -associated genes show significantly lower expression than 
progerin-specific interacting targets, which in this state do not interact with 
the lamina, further corroborates this notion.  
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To determine the importance of lamin-chromatin interactions in subnuclear 
positioning and regulation of gene expression, we applied FISH and 
expression array technology to lamin A loss- and gain-of-function cell 
models. RNAi-mediated knock-down of lamin A/C reveals substantial 
relocalization of lamin A target loci to the nuclear interior. Despite this 
relocalization, lamin A-associated genes remain overall more frequently 
localized at the NE compared to non-targets. The reverse experimental 
approach, in which we overexpressed lamin A in LMNAKO-/- MEFs, lead to the 
movement of several lamin A target genes to the nuclear periphery. 
Introduction of progerin in LMNAKO-/- MEFs increased the peripheral position 
of progerin unique targets and resulted in a repositioning of lamin A targets 
towards the nuclear interior. Combined, these findings support a facilitating 
role for A-type lamins in recruitment of silenced genes to the nuclear 
periphery. Interactions with additional nuclear lamina proteins, like emerin 
and lamin B, which are known chromatin interactors 11, 13, likely contribute 
to this functional nuclear organization.  
 
A key outcome of our analyses is the notion that while localization of (silent) 
genes to the periphery is dependent on lamin A, dissociation from the 
lamina does not necessarily lead to their activation. We speculate that loss 
of lamina-association is only one of multiple steps required for gene 
activation. Consistent with this, the relocation of the CFTR locus due to 
activation and consequent internalization of neighboring genes by itself is 
insufficient for CFTR activation 37-38. Furthermore, for olfactory receptors, 
which were identifiedas the most prominent group of lamin A targets, many 
additional steps necessary for stochastic activation have been described as 
well 34. It is possible that dissociation from the periphery renders the 
transcriptional status of these genes to “poised” and facilitates their 
activation by subsequent signals that may occur e.g. during differentiation. 
Extending these studies to differentiation models in which additional factors 
support gene activation of specific subsets of target genes are active will be 
important. The herein described identification of specific lamin A and/or 
progerin interacting genes provides a basis for further study of the role of 
lamina-chromatin dissociation in transcriptional activation and the etiology 
of laminopathies.  
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Supplemental Figures and Tables 
 
Figure S1. Characteristics of cell lines expressing One-STrEP tagged lamin A and progerin. 
(A) Immunofluorescent signal of lamin A/C indicating a preferred localization of OST-A and 
OST-P at the nuclear rim in LMNAKO-/- MEFs. DNA is stained with DAPI. (B) Western blot for B-
actin and endogenous lamin A/C in NklTAg cells infected with control and LMNA shRNA.   
 
 
Identification of lamin A- and progerin-interacting genome regions | 111 
 
 
 
Figure S2. Experimental workflow of lamin A and progerin One-STrEP pulldown. (A) Overview of the 
experimental procedures applied to determine lamin A interacting genes in NklTAG cells. The chromatin 
of formaldehyde cross-linked control vector and OST-A expressing NklTAg cells was sheared by sonication 
to an average length of 200-1000 base pairs. After determining the DNA concentration, samples were 
further diluted to contain equal concentrations of DNA. Strep-Tactin matrix was added to these input 
samples for overnight precipitation of OST-A. After removing unbound chromatin by high stringency 
washes, the pull-down fraction, as well as aliquots of input samples were de-cross-linked, and chromatin 
was isolated for subsequent amplification and labeling with Cy-3 and Cy-5. Indicated samples were 
hybridized on genome-wide promoter arrays , and an in-between array biostatistic analysis (See material 
& methods) was applied to identify lamin A associated gene promoters. (B) For the identification of lamin 
A and progerin associated gene promoters a similar technical procedure was applied on OST-A, OST-P 
and control vectors infected WT and LMNAKO-/- MEFs. OSTA- and OST-P associated gene promoters 
needed to be recognized as such independently in al arrays in both WT and LMNAKO-/- MEFs, and are 
collectively referred to as MEF OST-A and OST-P ChIP targets in this paper. 
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Figure S3. Genomic localization plots of all identified lamin A- and progerin-interacting genes. For each 
chromosome identified lamin A targets in NklTAg cells (bottom line) and lamin A unique interactors, progerin 
unique interactors and common interactors in MEFs (upper three lines) are plotted according to their 
genomic localization. A correction for absolute chromosome size has been applied, creating plots of equal 
length.  
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Figure S3 (Continued). 
 
 
114 | Chapter 4 
 
Figure S4. Cluster analysis of lamin A- and progerin-interacting genes. (A) Lamin A-associated genes in NklTAg 
cells were analyzed for their occurrence in gene clusters, defined as two or more lamin A targets being 
genomically located adjacent to each other without interruption of a non targets. The percentage of lamin A-
associated targets representated in clusters is indicated, and compared by Fisher’s exact test  to randomly 
expected occurrences of gene clusters (asterisk p<1x10-4).  (B) Sizes of identified gene clusters for lamin A-
associated genes in NklTAg are indicated by relative frequency. Targets can be divided in unclustered (cluster 
size=1 gene) and clustered (cluster size>1 gene). Comparable analysis was performed for  lamin A-targets (C,D) 
and progerin-associated genes (E,F) in MEFs. 
 
 
 
Figure S5. Genomic conservation plots of lamin A and/or progerin interactors. The CEAS database was used to 
create genomic conservation plots of ChIPed DNA fragments elongated at both ends to a total size of 3 kb, for 
lamin A unique, progerin unique and common interactors in MEFs as well as lamin A interactors in NklTAg. All 
conservation levels fluctuated around 0.1 and were comparable to random promoter sequences.  
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Table S2. Transcription Factor Motif (TFM) analysis of lamin A- and progerin-associated genes. 
 MEF OST-A unique MEF OST-A&P 
Common 
MEF OST-P unique NKLTAG OST-A 
TF Family P-value N P-value N P-value N P-value N 
V$BRN5 1.0E+00 99 1.1E-11 317 3.8E-01 97 2.4E-03 207 
V$SRFF 7.8E-01 92 2.8E-11 268 9.7E-01 64 3.0E-03 170 
V$OCT1 9.7E-01 148 9.8E-11 374 3.4E-01 125 5.9E-03 254 
V$BPTF 8.3E-01 32 2.7E-09 126 7.5E-02 36 9.5E-06 86 
V$HOXC 1.0E+00 84 9.4E-09 291 8.9E-01 81 2.1E-02 188 
V$RUSH 9.8E-01 106 3.9E-08 302 4.9E-01 94 8.1E-02 193 
V$GFI1 1.0E+00 46 6.3E-08 200 8.6E-01 49 5.7E-03 128 
V$BRNF 9.7E-01 128 9.9E-08 336 4.2E-01 110 1.3E-03 233 
V$AIRE 7.4E-01 34 3.9E-06 115 6.0E-01 28 7.8E-05 83 
V$TALE 5.9E-01 97 5.8E-06 249 9.7E-01 65 5.9E-05 181 
V$PIT1 1.0E+00 43 1.0E-05 172 8.1E-01 44 1.0E-01 105 
V$CLOX 9.5E-01 110 3.3E-05 290 5.1E-01 94 3.5E-02 197 
V$TEAF 8.5E-01 62 4.1E-05 182 2.3E-01 58 2.4E-02 120 
V$ZFTR 9.4E-01 54 5.1E-05 170 7.9E-01 45 2.9E-04 124 
V$EVI1 9.7E-01 143 6.8E-05 350 7.7E-01 116 2.6E-01 236 
V$GATA 9.7E-01 132 1.4E-04 331 7.2E-01 109 8.8E-02 227 
V$PDX1 9.9E-01 65 2.2E-04 206 5.6E-01 63 1.4E-03 149 
V$DMRT 9.9E-01 109 3.7E-04 290 7.7E-01 92 3.8E-03 208 
V$LHXF 9.9E-01 110 4.8E-04 295 9.5E-01 89 1.6E-02 208 
O$PTBP 1.0E+00 40 4.9E-04 151 8.2E-01 40 9.9E-02 97 
V$HBOX 9.9E-01 116 5.4E-04 306 7.1E-01 100 2.4E-02 215 
V$NEUR 9.0E-01 91 7.0E-04 240 1.0E+00 62 7.4E-01 145 
V$IRXF 8.5E-01 46 7.0E-04 138 7.0E-01 38 2.0E-03 101 
V$HNF6 9.8E-01 71 7.4E-04 208 9.0E-01 58 2.5E-02 144 
V$HMTB 7.6E-01 64 7.6E-04 174 7.7E-02 62 1.2E-02 122 
V$CART 1.0E+00 100 8.3E-04 289 7.9E-01 92 1.7E-01 195 
V$FAST 1.0E+00 66 9.0E-04 207 3.5E-01 68 1.3E-02 146 
V$DLXF 1.0E+00 60 1.3E-03 201 8.4E-01 58 2.6E-01 129 
V$SIXF 9.9E-01 48 1.5E-03 161 1.0E+00 35 1.6E-01 104 
V$AP1F 9.3E-01 55 1.6E-03 163 6.0E-01 49 5.7E-03 118 
V$MEF2 1.0E+00 60 1.9E-03 219 5.0E-01 71 2.1E-01 144 
V$BCL6 1.0E+00 67 2.0E-03 205 6.8E-01 63 3.8E-01 130 
V$PCBE 3.6E-01 43 2.2E-03 109 9.2E-01 25 3.1E-01 65 
V$FKHD 1.0E+00 135 2.3E-03 346 2.0E-01 125 8.0E-03 250 
V$BTBF 6.0E-01 30 2.9E-03 86 9.9E-01 15 6.9E-03 63 
O$YTBP 9.9E-01 19 2.9E-03 86 7.8E-01 21 5.9E-02 57 
V$SF1F 9.2E-01 58 3.1E-03 166 9.8E-01 40 1.3E-01 110 
V$PARF 9.8E-01 118 3.3E-03 298 7.0E-01 99 5.3E-02 210 
V$HOXF 1.0E+00 132 4.0E-03 333 4.4E-01 117 2.9E-03 244 
V$PBXC 5.4E-01 86 4.2E-03 207 9.9E-01 53 1.5E-02 149 
V$LEFF 9.9E-01 77 4.5E-03 223 9.7E-01 62 1.3E-01 152 
V$OVOL 9.9E-01 63 4.8E-03 191 8.7E-01 55 1.3E-01 129 
V$PPAR 9.9E-01 19 5.4E-03 83 8.7E-01 19 2.2E-01 51 
V$NBRE 1.0E+00 25 7.8E-03 111 8.3E-01 29 7.7E-03 83 
O$INRE 8.9E-01 65 9.5E-03 175 9.9E-01 44 1.0E-04 141 
V$RP58 6.0E-01 37 9.6E-03 99 2.7E-01 33 4.7E-03 76 
V$NKXH 1.0E+00 129 1.2E-02 327 5.8E-01 114 1.5E-01 230 
V$NF1F 9.8E-01 62 1.2E-02 181 9.6E-01 49 4.4E-01 116 
V$ABDB 1.0E+00 131 1.3E-02 328 6.2E-01 114 2.3E-01 229 
V$PERO 9.3E-01 87 1.4E-02 224 9.8E-01 63 2.8E-01 151 
O$VTBP 9.9E-01 127 1.7E-02 313 8.6E-01 104 1.4E-02 229 
V$GREF 9.9E-01 105 1.7E-02 272 1.0E+00 76 2.7E-01 187 
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Results of the TFM analysis using MatInspector software and the Genomatix transcription factor motif 
database (www.genomatix.de) show the amount of TFM (N) identified in ChIPed DNA fragments and 
corresponding significance levels for 170 transcription factor families. Significant results are indicated 
in bold (p<0.05; Statistical analysis described previously23). Extra note: This list was shortened for 
publication purposes. 
 
 
Table S3. Absolute and relative subnuclear positioning of common and unique lamin A/progerin-
associated genes 
 
 LMNAKO-/- MEF WT MEF 
 Absolute Values +Ctrl +OST-A +OST-P +Ctrl +OST-A  +OST-P 
Ch
IP
 
Ta
rg
et
s OST-A Unique 19% 26% 17% 17% 19%  15% 
Common OST-A&P 47% 52% 53% 58% 57%  55% 
OST-P unique 11% 13% 20% 16% 18%  23% 
 LMNAKO-/- MEF WT MEF 
 Relative Values +Ctrl +OST-A +OST-P +Ctrl +OST-A  +OST-P 
Ch
IP
 
Ta
rg
et
s OST-A Unique 100% 159% ←*→ 83% 100% 138% ←#→ 87% 
Common OST-A&P 100% 111% 111% 100% 99%  97% 
OST-P unique 100% 118% ←*→ 186% 100% 110% ←#→ 206% 
 
Legend: FISH quantifications (Figure 5B) of OST-Aunique (Eef1a2, Kcnip2, Scn5a, Sdro), common OST-
A&P (Cyp3a25, OLFR804, ABPD, Defcr5) and OST-Punique targets (Daf2, Tcf21, Trim30, Abcb10) were 
averaged per subclass, to obtain absolute frequencies on lamin B signal overlap. Relative values were 
calculated by setting the frequency for each individual locus in empty virus infected cells to 100% and 
adjusting quantification results in the other cell lines accordingly. Asterisks and hashed indicate 
respectively significant (p<0.05, Student’s t-test) and bordeline significant (0.05<p<0.10, Student’s t-
test) differences in lamin B overlap between OST-A and OST-P expressing cells. 
V$NKX6 1.0E+00 73 1.7E-02 230 6.9E-01 75 4.7E-03 173 
V$CHRF 1.0E+00 39 1.9E-02 154 9.5E-01 41 3.3E-02 112 
V$CDXF 1.0E+00 86 2.2E-02 237 8.0E-01 76 3.1E-01 161 
V$THAP 9.0E-01 22 2.2E-02 73 9.3E-01 16 3.9E-01 44 
V$AARF 1.0E+00 6 2.5E-02 52 6.1E-02 21 6.5E-01 27 
V$HAND 1.0E+00 134 4.4E-02 330 1.0E+00 95 7.8E-01 223 
V$NKX1 1.0E+00 30 7.1E-02 112 9.6E-01 28 7.8E-01 66 
…. …. …. …. …. …. …. …. …. 
V$ZF5F 1.0E+00 14 1.0E+00 11 1.0E+00 5 1.0E+00 15 
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Table S4. Overview of lamin A-associated genes in NklTAg myocytes that change expression 
levels. 
Genes that were identified by ChIP technology to interact with OST-A in NklTAg cardiac myocytes 
and significantly (p<0.05, no fold-change criterion used; Student’s T-test) changed their expression 
level upon loss of lamin A/C in cardiac tissue (WT vs. LMNAGT-/-). Entrez gene ID, absolute linear 
expression values, expression fold changes and p-values are indicated.  
 
 
Table S5. Overview of common and differential lamin A/progerin-associated genes in MEFs that 
change expression levels. 
Entrez 
Gene ID 
Gene 
Abbreviation 
Target Type
Expression 
WT+Ctrl 
Expression 
WT+OST-A
Expression 
WT+OST-P 
FC A/Ctrl
FC  
P/Ctrl 
FC  
P/A 
Pvalue 
A/Ctrl 
Pvalue 
P/Ctrl 
Pvalue 
P/A 
56229 Thsd1 OST-A 28.1 26.0 25.5 0.92 0.91 0.98 0.05 0.48 0.89 
245308 Zdhhc19 OST-A 14.4 13.5 13.8 0.94 0.96 1.02 0.11 0.02 0.49 
244653 Hydin OST-A 9.5 9.2 9.1 0.98 0.96 0.98 0.16 0.02 0.26 
14128 Fcer2a OST-A 9.2 8.9 9.0 0.96 0.97 1.01 0.03 0.02 0.14 
14939 Gzmb OST-A 12.8 13.8 12.8 1.08 1.00 0.92 0.01 0.88 0.06 
70073 Zdhhc25 OST-A 7.7 8.0 7.9 1.04 1.03 0.99 0.03 0.06 0.60 
209268 Igsf1 OST-A 10.6 11.6 11.0 1.10 1.04 0.95 0.50 0.05 0.68 
258426 Olfr995 OST-A 5.1 5.5 5.5 1.08 1.07 0.99 0.32 0.04 0.93 
15564 Htr5b OST-A 10.4 11.3 11.3 1.09 1.08 0.99 0.26 0.03 0.91 
13532 Dub2 OST-A 14.3 14.9 15.6 1.04 1.09 1.05 0.27 0.00 0.22 
20703 Serpina1d OST-A 8.5 7.4 9.4 0.87 1.11 1.28 0.03 0.02 0.01 
76071 Jakmip1 OST-A 17.7 16.1 19.7 0.91 1.12 1.22 0.00 0.10 0.03 
22639 Zfa OST-A 5.9 6.4 6.9 1.09 1.18 1.08 0.10 0.01 0.09 
68119 Cmtm3 OST-A 622.9 639.2 738.3 1.03 1.19 1.15 0.82 0.01 0.29 
213027 B130050I23Rik OST-A 76.4 85.3 92.1 1.12 1.20 1.08 0.08 0.03 0.24 
625599 LOC625599 OST-A 9.4 10.4 11.5 1.11 1.23 1.11 0.08 0.00 0.10 
50774 Krtap5-1 OST-A 60.3 60.7 76.6 1.01 1.27 1.26 0.90 0.04 0.05 
627585 LOC627585 Common 160.2 90.1 107.5 0.56 0.67 1.19 0.00 0.02 0.08 
381236 AI747699 Common 16.4 13.2 11.9 0.81 0.72 0.90 0.00 0.04 0.25 
233164 4930549O06 Common 16.6 22.5 12.2 1.36 0.73 0.54 0.24 0.01 0.08 
258016 Olfr453 Common 11.6 10.3 9.8 0.89 0.84 0.94 0.26 0.05 0.46 
252829 Obox5 Common 44.3 42.4 38.1 0.96 0.86 0.90 0.63 0.03 0.32 
258281 Olfr780 Common 5.7 5.3 5.0 0.93 0.87 0.93 0.42 0.04 0.38 
233099 Abpb Common 7.4 7.6 6.5 1.02 0.87 0.85 0.27 0.04 0.04 
259070 Olfr829 Common 7.2 7.0 6.6 0.98 0.92 0.94 0.74 0.00 0.33 
16769 Dsg4 Common 10.1 9.9 9.4 0.98 0.93 0.95 0.37 0.01 0.08 
258339 Olfr1269 Common 6.5 6.3 6.0 0.97 0.93 0.96 0.47 0.02 0.38 
Entrez Gene 
ID 
Gene 
Abbreviatio
n 
Target Type Expression 
WT 
Expression 
LMNAGT-/- 
FC 
LMNAGT-/-  
vs. WT 
P-value 
13195 Ddc NklTAg OST- 603.2 868.3 1.44 0.01 
258627 Olfr1504 NklTAg OST- 13.3 15.5 1.17 0.01 
53318 Pdlim3 NklTAg OST- 23.0 26.3 1.14 0.01 
13602 Sparcl1 NklTAg OST- 3464.8 3939.0 1.14 0.05 
93674 Cml3 NklTAg OST- 6.1 6.3 1.03 0.04 
68172 Rpl39l NklTAg OST- 8.0 8.1 1.02 0.02 
56640 Klk4 NklTAg OST- 5.5 5.6 1.02 0.05 
239368 BC030476 NklTAg OST- 6.9 7.0 1.02 0.04 
56448 Cyp2d22 NklTAg OST- 10.1 8.9 0.89 0.02 
70101 Cyp4f16 NklTAg OST- 15.3 11.1 0.72 0.04 
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72925 39873 Common 10.3 9.6 9.7 0.93 0.94 1.01 0.01 0.02 0.33 
229214 Gpr103 Common 13.4 12.9 12.6 0.97 0.94 0.97 0.00 0.56 0.78 
110187 Abpg Common 5.5 5.1 5.2 0.92 0.94 1.02 0.00 0.01 0.03 
387131 Ssxb9 Common 4.1 3.6 3.9 0.88 0.95 1.09 0.00 0.14 0.05 
258387 Olfr720 Common 7.6 7.9 7.3 1.04 0.96 0.93 0.27 0.04 0.10 
259119 Olfr578 Common 5.9 6.6 5.8 1.12 0.98 0.88 0.02 0.44 0.03 
20684 Sp100 Common 17.6 16.1 17.7 0.91 1.01 1.10 0.04 0.79 0.05 
258464 Olfr1384 Common 6.5 7.4 6.7 1.14 1.03 0.91 0.05 0.34 0.11 
258771 Olfr473 Common 4.7 4.6 4.9 0.99 1.04 1.05 0.70 0.02 0.16 
258405 Olfr1420 Common 10.7 11.4 11.2 1.06 1.04 0.98 0.53 0.04 0.83 
545047 MGC118309 Common 5.7 6.0 5.9 1.06 1.05 0.99 0.24 0.01 0.80 
259058 Olfr646 Common 9.1 10.3 9.6 1.13 1.06 0.94 0.04 0.28 0.29 
244187 Olfr684 Common 6.6 7.5 7.0 1.13 1.06 0.94 0.01 0.06 0.03 
258970 Olfr1242 Common 6.8 7.2 7.4 1.07 1.09 1.03 0.32 0.03 0.66 
258252 Olfr813 Common 4.9 5.5 5.4 1.12 1.11 0.99 0.01 0.05 0.71 
27058 Srp9 OST-P 99.1 81.9 73.4 0.83 0.74 0.90 0.03 0.00 0.05 
110115 Cyp11b1 OST-P 23.7 22.6 18.9 0.96 0.80 0.83 0.55 0.05 0.08 
109663 Hoxc11 OST-P 9.4 9.0 8.2 0.96 0.87 0.91 0.04 0.00 0.01 
75553 2700069A02Rik OST-P 427.7 362.9 387.7 0.85 0.91 1.07 0.01 0.00 0.05 
66648 5730494M16Rik OST-P 219.9 208.0 209.5 0.95 0.95 1.01 0.04 0.25 0.83 
69774 Ms4a6b OST-P 6.6 7.2 6.5 1.08 0.98 0.91 0.04 0.30 0.03 
58861 Cysltr1 OST-P 8.8 8.3 8.7 0.95 0.99 1.05 0.03 0.03 0.03 
20014 Rpn2 OST-P 1107.9 1123.5 1141.0 1.01 1.03 1.02 0.53 0.04 0.48 
67484 2310005P05Rik OST-P 12.9 13.6 13.4 1.05 1.04 0.99 0.05 0.06 0.04 
66853 Pnpla2 OST-P 81.5 95.0 93.4 1.17 1.15 0.98 0.01 0.10 0.75 
75284 4930556P03Rik OST-P 24.4 27.7 29.6 1.13 1.21 1.07 0.02 0.14 0.50 
20128 Trim30 OST-P 19.2 22.2 31.3 1.16 1.63 1.41 0.16 0.02 0.06 
 
Note: Genes that were identified by ChIP technology to interact in MEFs with OST-A only, OST-P only or with both lamins and in 
addition significantly (p<0.05, no fold-change criterion; Anova) changed their expression level either upon introduction of OST-A 
or OST-P in WT MEFs. Entrez gene ID, absolute linear expression values, fold changes and significance values between WT MEFs 
infected with empty virus (Ctrl), OST-A or OST-P are indicated. 
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Abstract 
Physiological and premature aging are characterized by multiple defects in 
chromatin structure and accumulation of persistent DNA damage. Here we 
identify the NURD remodeling complex as a key modulator of these aging-
associated chromatin defects. We demonstrate loss of several NURD 
components during premature and normal aging and we find aging-
associated reduction of HDAC1 activity.  Silencing of individual NURD 
subunits recapitulates some chromatin defects associated with aging and 
we provide evidence that structural chromatin defects precede DNA 
damage accumulation. These results outline a molecular mechanism for 
chromatin defects during aging.  
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A hallmark of normal and premature aging are global changes in chromatin 
including loss of heterochromatin structure, altered patterns of histone 
modifications 1-4, loss of key heterochromatin proteins2-3, and increased 
levels of persistent DNA damage.5-6 To begin to elucidate the molecular 
mechanisms leading to these aging-related chromatin defects, we have 
taken advantage of the premature aging disorder Hutchinson-Gilford 
Progeria Syndrome (HGPS). This early childhood disease is caused by a 
recurrent de-novo point mutation in exon 11 of the lamin A/C gene (LMNA),  
which encodes for the intermediate filament proteins lamin A and lamin C, 
two of the key architectural proteins of the cell nucleus.7 The disease-
causing mutation in LMNA leads to the production of a mutant form of 
lamin A, referred to as progerin, which lacks 50 aa near the C-terminus, and 
acts in a dominant negative fashion causing multiple cellular defects of 
physiological and accelerated-aging.1-2, 8-9 In particular, HGPS cells exhibit 
several chromatin defects which are also characteristic for physiological 
aging including loss of heterochromatin structure, loss of methylation at 
H3K9 and H3K27, down-regulation of the heterochromatin protein HP1, and 
increased transcription of pericentromeric Satellite III repeats (SatIII).2, 4 In 
addition, as normally aged cells, HGPS patient cells exhibit increased steady-
state levels of DNA damage.3, 5 
  
To identify the molecular basis of aging-associated chromatin defects, we 
performed a yeast two hybrid screen using a C-terminal region of lamin A 
(aa 562-664) which overlaps with the region deleted in progerin (Fig. 1A). 
We identified the WD40 domain chromatin protein RBBP4 as a lamin A 
interactor in four independent experiments.  None of the other lamin A 
fragments tested (aa 1-118, aa 416-568, aa 604-657) interacted with RBBP4 
by two-hybrid analysis (data not shown). The interaction between RBBP4 
and the aa 562-664 fragment of lamin A was confirmed by GST-pull down 
(Supplementary Fig. 1A). RBBP4 and RBBP7 are evolutionary conserved 
histone binding proteins.10 They are shared subunits of several multi-protein 
complexes involved in the establishment of heterochromatin including the 
NUcleosome Remodeling and Deacetylase (NURD) complex11 and the 
Polycomb PRC2 complex.12 RBBP4 is also the p48 subunit of the CAF-1 
complex, which assembles chromatin upon DNA replication and DNA 
damage repair.13 In support of a physical interaction between lamin A and 
RBBP4/7, recombinant forms of both proteins bound in vitro to GST-lamin A  
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Fig. 1. Loss of RBBP4 and RBBP7 in progerin expressing cells. (A) Schematic representation of lamin A. The 
fragment used as a bait in the Y2H assay (aa 562-664) is underlined. (B) GST pulldown assays with 
recombinant GST-RBBP4/7 and in vitro transcribed and translated lamin A (aa 1-664) or progerin. (C) 
Crosslinked protein lysates were prepared from U2OS cells expressing One-Strep (OST)-tagged lamin A and 
then incubated with Streptactin beads. Input and pulled down material was probed by Western blot with 
antibodies against the indicated endogenous proteins. (D) Immunofluorescence staining on control and HGPS 
primary dermal fibroblasts with the indicated antibodies. DAPI, 4’, 6’-diamidino-2-phenylindole. Quantitative 
analysis of fluorescence intensity signal in control and HGPS patient cells. The percentages of cells with 
reduced protein level are indicated.  N>200; values represent averages ± S.D from at least three experiments. 
Cells were analyzed around population doubling (PD) 25 in the RBBP4 experiments and around PD 20 in the 
RBBP7 experiments. Control cells were passage-matched to HGPS cells in each experiment. (E) Western blot of 
cell lysates prepared from control and HGPS dermal fibroblasts. (F) Immunofluorescence with indicated 
antibodies in wt fibroblasts that were either induced (on) or not induced (off) to express a GFP-tagged version 
of progerin. Arrowheads indicate cells with reduced levels of heterochromatin proteins. Scale bars: 10 µm. 
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(1-664) and to a lesser extend to a C-terminal fragment (residues 390 – 646) 
(Fig. 1B; Supplementary Fig. 1B).  Importantly, neither protein bound to GST-
progerin which lacks residues 607-657 of mature lamin A (Fig. 1B). The in 
vivo interaction of RBBP4, and more weakly of RBBP7, with lamin A was 
confirmed by immunoprecipitation of endogenous RBBP4/7 by 
overexpressed One-Strep (OST)-tagged lamin A (Fig. 1C). These results 
identify the two histone chaperone proteins RBBP4 and 7 as lamin A 
interactors. 
 
To ask whether RBBP4 and RBBP7 are involved in aging-associated 
chromatin defects, we probed their status in HGPS cells. Strikingly, a 
substantial fraction (48 +/- 2%) of HGPS patient cells showed reduced 
protein levels of RBBP4 when compared to passage- and age-matched 
controls from healthy donors by quantitative immunofluorescence 
microscopy as previously described (Fig. 1D, E).2-3 The protein level of RBBP7 
was similarly reduced in HGPS patient cells (Fig. 1D, E).  As previously 
observed for other nuclear defects in HGPS cells, the extent of reduction 
was variable amongst cells in the population, but its extent was similar to 
that observed in HGPS for several other nuclear proteins including all 
isoforms of the heterochromatin protein HP1. Furthermore, loss of RBBP4/7 
occurred in the same cells that exhibited lower levels of HP1 pointing to 
global chromatin defects in those cells (Fig. 1D).2 Reduction of RBBP4 and 
RBBP7 in HGPS skin fibroblasts relative to control cells was confirmed by 
Western blot analysis on total cell lysates (Fig 1E). Similar observations were 
made in several independent primary HGPS patient cell lines (data not 
shown) and, as observed for HP1γ, the extent of RBBP4/7 reduction 
increased during cell passaging (data not shown; ref. 3-4). RBBP4 and RBBP7 
down-regulation occurred at the protein level since similar levels of mRNAs 
were present in HGPS and control fibroblasts as determined by RT-PCR 
(Supplementary Fig. 2A). Consistent with the reduction of RBBP4/7, the 
levels of the centromeric protein CENP-A was reduced in HGPS cells 
(Supplementary Fig. 2B, 2C), in agreement with earlier observations 
demonstrating loss of CENP-A after concomitant siRNA silencing of RBBP4 
and RBBP7.14  
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The loss of RBBP4 and RBBP7 was dependent on progerin. Upon controlled 
induction of a GFP-tagged version of progerin in immortalized wild-type skin 
fibroblasts using a tetracycline-dependent expression system6, RBBP4 and 
RBBP7 were almost completely lost within 4 days when compared with the 
uninduced control (Fig 1F). The control protein RAD52 was not affected by 
GFP-progerin expression (Fig. 1F). Conversely, elimination of progerin pre-
mRNA from HGPS skin fibroblasts by a previously characterized RNA 
morpholino approach2 rescued the levels of RBBP4 when compared to the 
same cells treated with a scrambled control oligonucleotide (Supplementary 
Fig. 2D). In addition, staining of HGPS primary fibroblasts with specific anti-
progerin antibodies revealed that expression of progerin inversely 
correlated with RBBP4 levels in these cells (Supplementary Fig. 2E). 
Collectively, these results demonstrate loss of the histone chaperones 
RBBP4 and RBBP7 in HGPS cells in a progerin-dependent manner. 
 
Given the role of RBBP4 and RBBP7 in various chromatin remodeling and 
assembly complexes, we hypothesized that their loss contributes to the 
changes in chromatin structure and elevated levels of DNA damage that 
occur during premature and normal aging. To directly test whether the 
absence of RBBP4/7 is sufficient to cause these defects, we analyzed the 
status of pericentromeric heterochromatin after siRNA-mediated 
knockdown of RBBP4 and RBBP7, either alone or in combination (Fig. 2).  
Efficient knockdown was confirmed by Western blotting (Supplementary 
Fig. 3A). As expected, cells treated with  non-targeting control siRNA 
oligonucleotides displayed several bright foci of H3K9me3, corresponding to 
pericentromeric heterochromatin15, as confirmed by partial colocalization of 
these foci with CREST antibody which recognizes centromeric proteins (Fig. 
2A). Upon simultaneous knock-down of RBBP4 and RBBP7 the focal 
accumulation of H3K9me3 was lost (Fig. 2A). Silencing of either RBBP4 or 
RBBP7 alone was not sufficient to cause heterochromatin alterations (Fig. 
2A), most likely reflecting the functional overlap between these two highly 
similar proteins.  In line with previous observations14 concomitant silencing 
of RBBP4 and RBBP7 led to loss of the centromeric protein CENP-A 
(Supplementary Fig. 3B). To further test whether RBBP4 and RBBP7 are 
involved in mediating the chromatin defects observed in HGPS cells, we 
probed the effect of loss of RBBP4 and RBBP7 on DNA SatIII repeat 
transcription by semi-quantitative RT-PCR (Fig. 2B). 
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SatIII repeats are normally maintained in a transcriptionally silent state but 
are activated in HGPS cells, most likely as a result of heterochromatin 
disruption.4, 16 As observed in HGPS cells, simultaneous silencing of RBBP4 
and RBBP7 caused a significant increase in SatIII transcription compared to 
control siRNA treated cells (Fig. 2B).  
 
To test whether loss of RBBP4 and RBBP7 is also sufficient to induce the 
increased levels of DNA damage present in HGPS cells, we probed RBBP4 
and RBBP7 depleted cells for the presence of phosphorylated histone H2AX, 
a marker of DNA damage.17 Similar to cells from HGPS patients and aged 
individuals, the percentage of cells containing multiple prominent phospho-
H2AX foci increased from 5% in control cells to more than 60% in cells 
depleted of RBBP4 and RBBP7 (Fig. 2C, D).3 The increase in endogenous DNA 
damage upon RBBP4/7 silencing was mirrored by an increased proportion of 
cells in S-phase as detected by FACS analysis (Supplementary Fig. 3C, D; P < 
0.01 for Hela cells, P < 0.01 for U2OS cells), in agreement with the 
accumulation in S-phase of late-passage HGPS cells (Supplementary Fig. 3E, 
P < 0.01 ). While the percentage of cells with aberrant chromatin structure 
in RNAi-treated cells was significantly increased 72 h after RNAi knockdown 
when compared to the control (Supplementary Fig. 4A), DNA damage only 
became evident at 120h (Supplementary Fig. 4B), suggesting the occurrence 
of structural chromatin defects prior to DNA damage.  Similar results were 
obtained after reduction of RBBP4/7 levels by induced expression of 
progerin (Supplementary Fig. 5).  
 
RBBP4 and RBBP7 are shared subunits of multiple protein complexes 
involved in chromatin metabolism, including the NURD complex and the 
PRC2 complex.11-12 In addition, RBBP4 is an integral subunit of the CAF-1 
complex.13 To test which of these complexes mediates the aging-associated 
chromatin defects caused by RBBP4 and RBBP7 loss, we tested the status of 
other subunits of the NURD, CAF-1 and PRC2 complexes in HGPS cells (Fig. 
3). Similar to RBBP4 and RBBP7, two additional subunits of the NURD 
complex, MTA3 and HDAC1, were largely lost from HGPS cells as judged by 
quantitative single-cell microscopy and Western blotting (Fig. 3A-C). 
Consistent with a possible regulatory role of lamin A on the NURD complex,  
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Fig. 2.  Heterochromatin defects and increased DNA damage upon RBBP4 and RBBP7 silencing. 
(A)  HeLa cells were transfected with the indicated combinations of siRNA for 144 hrs and 
processed for immunofluorescence staining with the indicated antibodies. (B) Semi-quantitative, 
strand specific RT-PCR analysis of SatIII G-rich transcripts in cells knocked down for the indicated 
gene. (C) Detection of DNA damage in knock-down cells using α-phospho-H2AX antibody. (D) 
Quantitative analysis of the percentage of p-H2AX positive cells (defined as containing more than 8 
foci per cell).Values represent averages ± S.D. from three experiments. N>200. Scale bars: 10 µm. 
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Fig 3. Loss of NURD subunits in HGPS cells. (A) Immunofluorescence staining of control and HGPS 
primary dermal fibroblasts with the indicated antibodies. (B) Quantitative analysis of the 
fluorescence intensity signal in control and HGPS cells.  N>200; Values represent averages ± S.D. 
from three experiments. (C) Western blot with the indicated antibodies on total cell lysates 
prepared from dermal fibroblast from two unaffected individuals and two HGPS patients. (D) 
HDAC activity measured in total lysates or in HDAC1 immunoprecipitates prepared from primary 
fibroblasts. Values represent averages ± S.D. from three experiments. Scale bar: 10 µm. 
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HDAC1 physically interacted with lamin A in vivo as demonstrated by its 
immunoprecipitation with OST-lamin A (Supplementary Fig. 6A). In contrast, 
protein levels of p150 and EZH2, the catalytic subunit of the CAF-1 and the 
PRC2 complexes, respectively, were unaffected in HGPS cells (Fig. 3C). The 
p60 subunit of the CAF-1 complex was up-regulated in HGPS primary 
fibroblasts (Fig. 3C), likely as a consequence of persistent DNA damage.18 
We conclude the NURD complex is lost from HGPS patient cells.  
 
The loss of HDAC1 protein in HGPS cells pointed to the possibility that the 
observed chromatin defects are caused by loss of cellular HDAC1 
deacetylase activity.  To test this hypothesis we measured HDAC1 activity in 
HGPS patient cells. HDAC1 activity in total cell extracts and in HDAC1 
immunoprecipitates prepared from HGPS patient cells was reduced by ~ 
40% compared to matched control cells (Fig. 3D). To directly probe whether 
the NURD complex is responsible for the aging-associated chromatin 
defects, we individually knocked down the NURD subunits HDAC1, MTA3, 
CHD3 or CHD4 in Hela cells (Supplementary Fig. 6B). In a manner similar to 
RBBP4/7 knock down, silencing of any subunit increased the percentage of 
cells lacking H3K9me3 and HP1γ heterochromatin foci (Fig. 4A, B). 
Furthermore, shRNA mediated silencing of HDAC1, MTA3, CHD3 or CHD4 in 
primary human fibroblasts (Supplementary Fig. 6C , D) increased the 
percentage of cells containing phospho-H2AX positive foci to similar levels 
as observed in HGPS cells (Fig. 4C, D). These results demonstrate that 
HDAC1 activity is reduced in HGPS cells and that loss of NURD complex 
components is sufficient to recapitulate some aging-associated chromatin 
defects. 
 
Since chromatin defects associated with HGPS also occur during 
physiological aging3, we finally probed the status of the NURD subunits in 
cells from normally aged individuals. Quantitative immunofluorescence 
microscopy analysis on cells obtained from two young donors (7 and 9 
years, respectively) and passage-matched primary fibroblasts from two old 
donors (92 and 88 years, respectively), revealed significant differences in 
RBBP4, RBBP7, and HDAC1 protein levels (Fig 5A-C). Cell populations from 
old individuals consistently showed a 4-5 fold increase in the percentage of 
cells with reduced protein levels of RBBP4, RBBP7 and HDAC1 (Fig. 5D). At 
the single cell level, the extent of reduction of NURD components strictly  
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Fig. 4.  Heterochromatin defects and increased DNA damage upon silencing of NURD subunits. (A) HeLa 
cells were transfected with the indicated siRNA for 96 hrs and processed for immunofluorescence staining 
with the indicated antibodies. Scale bar: 10 µm. (B) Quantitation of the percentage of siRNA treated Hela 
cells in which H3K9me3 or HP1γ foci are absent. Values represent averages ± S.D. from two experiments. 
N>200. (C) Quantitation of the percentage of phospho-H2AX positive cells (defined as containing more 
than 8 foci per cell).Values represent averages ± S.D. from three experiments. N>200. Scale bar: 10 µm. 
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correlated with each other and with HP1γ levels, albeit less pronounced 
than that observed for HGPS cells as previously described 3. In contrast to 
HGPS cells, no loss of CENP-A was detected in normally aged cells. We 
conclude that loss of the RBBP4, RBBP7, and HDAC1 subunits of NURD is not 
limited to premature aging but is also a feature of physiologically aged cells.  
Here we have identified the NURD chromatin remodeling complex as a 
mediator of aging-associated chromatin defects.  We demonstrate  
reduction of several NURD subunits in cells from a progeroid syndrome and 
from normally aged individuals. Loss of any one of these components and 
reduction of HDAC1 activity is sufficient to recapitulate multiple aging-
associated chromatin defects. The in vivo physical interaction of lamin A 
with RBBP4, RBBP7 and HDAC1 observed here, and previously suggested by 
biochemical fractionation19, points towards a regulatory role for the nuclear 
lamina in the function of the NURD complex in normal cells.  
 
We find that loss of RBBP4/7 is dependent on the presence of progerin and 
is an early event in the appearance of aging-associated chromatin defects. 
Upon induction of progerin or upon knock-down of RBBP4 and RBBP7, 
changes to heterochromatin structure occur and are followed by 
accumulation of DNA damage. We suggest that loss of critical chromatin 
components RBBP4/7 is an upstream event in the formation of aging-
associated chromatin defects. Loss of RBBP4/7 compromises the 
establishment and maintenance of histone modifications and higher order 
chromatin structure, possibly making chromatin more susceptible to DNA 
damage. The increase in DNA damage might be a consequence of higher 
susceptibility of the affected chromatin to damage or alternatively due to 
impaired DNA replication.20 Interestingly, similar to the effects we observe 
upon silencing of RBBP4 and RBBP7, impairment of the H4K20 histone 
methyltransferase PR-Set7, which is necessary for proper H4K20 tri-
methylation associated with heterochromatin, interferes with DNA 
replication, arrests cells in S-phase and causes increased levels of DNA 
damage.21-22  
 
Our finding that multiple NURD components are lost in HGPS and normally 
aged cells suggests that the integrity of the NURD complex is compromised 
and its components are down-regulated during premature and physiological 
aging.  Whether loss of these proteins occurs by activation of a specific  
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Fig 5. Loss of NURD subunits in physiological aging. (A), (B) and (C) Immunofluorescence microscopy of 
passage-matched primary dermal fibroblasts from healthy young (7 yrs and 9 yrs) or old (92 yrs and 88 
yrs) donors were fixed and stained with the indicated antibodies. (D) Quantitative analysis of the 
fluorescence intensity signal measured in dermal fibroblasts from young and old individuals. N>200; 
Values represent averages ± S.D. from three experiments. Arrowheads indicate cells with reduced levels 
of heterochromatin proteins. Scale bars: 10 µm. 
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protein degradation program or by interference with the normal 
homeostasis of the NURD protein complex remains to be determined.  The 
involvement of a specific pathway is suggested by the fact that progerin 
affects the protein levels of several subunits of the NURD complex, but not 
of other RBBP4- or RBBP7-containing complexes, such as CAF-1 or PRC2. 
While we cannot rule out that the degradation mechanism of NURD 
components are distinct in HGPS cells and in normally aged cells, the fact 
that progerin is also expressed at low levels in cells from normally aged 
individuals is consistent with a conserved degradation mechanism.3  Overall, 
these results implicate declining NURD remodeling complex function in 
aging-associated chromatin defects and accumulation of DNA damage 
during aging. 
Materials and Methods 
Cell culture 
Primary dermal fibroblast cell lines were obtained from the NIA and NIGMS 
collections of the Coriell Cell Repository (CCR), from the American Type 
Culture Collection (ATCC) or the Progeria Research Foundation (PRF). The 
cells from HGPS patients were AG01972 (Patient age 14 years, CCR, 
population doublings (PD) 20 at purchase), AG06297 (8 years, CCR, PD17), 
HGDAFN003 (2 years, PRF, PD7). Control cell lines were CRL-1474 (7 years, 
ATCC, PD19) GM00038 (9 years, CCR, PD17), AG05247 (88 years, CCR, PD15) 
and AG09602 (92 years, CCR, PD 12). Cells were used at PD’s 19-27. WI-38 
primary human fetal fibroblasts (3 month gestation fetus, ATCC, PD8)were 
used at PD’s 10-18. All primary fibroblasts were grown in Minimum Essential 
Medium (MEM, Gibco) , 15% FCS, 2mM L-glutamine, 100 U/ml penicillin and 
100 µg/ml streptomycin at 37 0C in 5% CO2. Growth and induction of  
immortalized, Tet-off human fibroblasts expressing GFP-Progerin was as 
previously described 6. U2OS cells stably expressing One-Strep-Lamin A were 
maintained in McCoy’s 5A medium (Gibco), 10% FCS, 2mM L-glutamine, 10 
µg/ml blasticidin at 37 0C in 5% CO2. 
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 Plasmids 
Plasmids expressing GST -RBBP4/7 were a kind gift of B. Stillman (Cold 
Spring Harbor, NY)10.  Vectors for in vitro transcription and translation of 
lamin A and progerin were constructed as follows: an EcoRI/BamHI 
fragment containing the entire CDS of lamin A (1-664) or progerin was 
excised from either pEGFP-Lamin A or pEGFP-Lamin ∆50 2 , respectively, and 
cloned into the pCDNA3.1 (-) vector (Invitrogen) cut with the same enzymes. 
pGBKT7-lamin A (390-646) was a kind gift of T. Dittmer (NCI/NIH, Maryland). 
N-terminal One-Strep tag (IBA BioTagnology, Göttingen, Germany) 
oligonucleotides (Sigma, Zwijndrecht, Netherlands) were cloned into BamHI 
and EcoRI sites of pBabe puro (Plasmid 1764, Addgene). The retroviral  
pBabe puro One-Strep-Lamin A plasmid was generated by inserting lamin A 
from the pBabe puro HA-Lamin A vector23 into the SalI and EcoRI sites. In 
order to generate a lentiviral expression system a BamHI and EcoRI 
containing multiple cloning site was introduced in the pCDH1-MCS1-EF1-
Puro vector (System BioSciences, Mountainview, California, USA), the 
puromycin cassette was replaced by a blasticidin cassette from the 
pLenti6/V5-GW/LacZ vector (Invitrogen, Carlsbad, California, USA) and the 
One-STrEP-tagged lamin A from the pBabe puro One-Strep-Lamin A vector 
was ligated into the BamHI and EcoRI restriction sites, thereby generating 
the lentiviral pCDHblast MCSNard OST-Lamin A vector. The Yeast Two 
Hybrid screen was performed as described24-25 
siRNA and shRNA constructs 
siGenome SMART pool siRNA oligos against human RBBP4 and RBBP7 were 
purchased from Dharmacon-Thermo Scientific and transfected at 0 and 72h 
into Hela cells at 50 nM using Oligofectamine (Invitrogen) or Dharmafect1 
(Dharmacon-Thermo), following the manufacturer instructions.  
RBBP4:  
Target 1:   5’-GAUACUCGUUCAAACAAUA 
Target2:   5’-GAACUGCCUUUCUUUCAAU 
Target3:   5’-GGAUACUCGUUCAAACAAU 
Target4:   5’-AACAAUACUUCCAAACCAA 
RBBP7:  
Target1:   5’-GGAUAAGACCGUAGCUUUA 
Target2:   5’-CCACUGGUCUCCACAUAAU 
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Target3:   5’-GGACACACUGCUAAGAUUU 
Target4:   5’-AAGUAAACCGUGCUCGUUA 
HDAC1: 
Target1:   5’-CUAAUGAGCUUCCAUACAA 
Target2:   5’-GAAAGUCUGUUACUACUAC 
Target3:   5’-GGACAUCGCUGUGAAUUGG 
Target4:   5’-CCGGUCAUGUCCAAAGUAA 
MTA3: 
Target1:   5’-GCAGAAACAUCAGUUGAAA 
Target2:   5’-UGACUAGCAUCAUUGAAUA 
Target3:   5’-CUUCAAUGACAUACGGCAA 
Target4:   5’-GUGCAACAGAAACGUCUAA 
CHD3: 
Target1:   5’-CGUAUGAGCUGAUCACCAU 
Target2:   5’-GAGGAGAAGUACUAUCGUU 
Target3:   5’-GAGGCACCCUGCACAUGUA 
Target4:   5’-CAAGAUAGAUCAUAAGUUG 
CHD4: 
Target1:   5’-CCAAGGACCUGAAUGAUGA 
Target2:   5’-CAAAGGUGCUGCUGAUGUA 
Target3:   5’-GAAAGAGGCAUCUGUGAAA 
Target4:   5’-GAUGAUAUCCUCAAAUUUG 
 
GIPZ lentiviral vectors expressing shRNAmir sequences targeted against 
human HDAC1, MTA3, CHD3 and CHD4 were purchased from Open 
Biosystems-Thermo Scientific (Waltham, MA) and virus produced in 293FT 
packaging cells (Invitrogen) usingFUGENEHD (Roche), following the 
manufacturer’s instructions. Target WI38 fibroblasts (~ 50% confluent) were 
incubated for 8 hrs with a 1:1 mix of filtered viral supernatant and 
MEM+15%FBS and in the presence of 6 µg/ml Polybrene (Sigma-Aldrich). A 
second round of infection with fresh lentiviral vector-containing supernatant 
was performed after 24 hrs. 48-72 hrs after the first round of infection, 
puromycin (2 µg/ml) was added to the medium to select shRNAmir 
expressing cells. Experiments were performed 6 days after the first round of 
infection. 
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GIPZ non-targeting sequence:  5’-TCTCGCTTGGGCGAGAGTAAG 
HDAC1-A: 5’-CCCGAATCCGCATGACTCATAA 
HDAC1-B: 5’-AACCCATTCTTCCCGTTCTTAA 
MTA3-A: 5’-CCCTAATATGCAGTGTAGATTA 
MTA3-B: 5’-CCGGCCGTTTGTTGCTATTAAT 
CHD3: 5’-AGGAATTACCACTATCTAGTAA 
CHD4-A: 5’-CGCTGCTGACATCCTATGAATT 
CHD4-B: 5’-CGCCCTCCAAGACAGAACTAAT 
Antibodies 
The following antibodies were used in immunofluorescence, Western 
blotting and immunoprecipitation: α-HP1γ  mouse monoclonal  (MAB3450, 
Chemicon), α- H3K9me3 rabbit polyclonal (4861, kindly provided by T. 
Jenuwein), α-RBBP4 mouse monoclonal  (11G10, Abcam), α-RBBP4 rabbit 
polyclonal  (ab1765, Abcam), α-RBBP7 rabbit polyclonal  (ab3535, Abcam), 
α-RAD52 rabbit polyclonal  (3425, Cell Signaling), α-p-H2AX mouse 
monoclonal (JBW301, Millipore), α-p-H2AX mouse monoclonal  (2F3, 
Abcam), α-HDAC1 rabbit polyclonal  (PA1-860, ABR), MTA3 rabbit polyclonal  
(A300-160A, Bethyl Laboratories), α-p150 CAF-1  mouse monoclonal SS1 
and α-p60 CAF-1 mouse monoclonal SS53  (kind gifts of B. Stillman), α-EZH2 
rabbit polyclonal  (39103, Active Motif), α-CHD3 rabbit polyclonal (A301-
219A, Bethyl Laboratories),  α-CHD4  rabbit polyclonal (H-242, St. Cruz), α-
CHD4  mouse monoclonal (91984, Genetex), α-Lamin A goat polyclonal (N-
18, St. Cruz), α-progerin mouse monoclonal  13A4, (Alexis Biochemicals), α- 
centromeric proteins CREST human autoimmune serum (Antibodies Inc.), α-
CENP-A  mouse monoclonal (3-19, Abcam). 
Immunofluorescence microscopy and image quantitation 
Indirect immunofluorescence microscopy was performed as previously 
described 2. Quantitative microscopy measurements were performed as 
previously described 2-3. For single cell analysis, at least 200 cells per sample 
were counted in triplicate and the error bars in the histograms represent 
the standard deviation. 
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Western blotting 
Cells were rinsed in PBS and lysed in either 1X Laemmli SDS-PAGE loading 
buffer or, alternatively, in a buffer containing 150 mM NaCl, 20 mM Hepes 
pH 7.4, 0.5% NP40, 1mM EDTA, 10 mM β-Glycero-phosphate, 1 mM NaF, 1 
mM  Na3VO4, Protease Inhibitors Cocktail SetIII (Calbiochem). Western 
blotting and immunodetection were performed as previously described 2. 
Recombinant proteins expression and in vitro binding assays 
GST-fusion proteins were expressed in E. coli BL21(DE3)pLysS (Promega) and 
affinity purified on glutathione Sepharose beads (GE Healthcare). For in vitro 
binding assays, GST fusion proteins (1-5 µg) immobilized on glutathione 
Sepharose beads were pre-washed twice in NETN150 (20 mM Tris-HCl pH 
7.5, 150 mM NaCl, 1mM EDTA, 0.5% NP40, 1 mM DTT), incubated 30 min at 
4°C with Benzonase, washed once in NETN1000, blocked for 30 min in 
NETN150, 1 mg/ml BSA and then washed twice in NETN150. [35S]- labelled 
proteins were generated by in vitro transcription/translation using a 
T7TNTQuick-rabbit reticulocyte lysate system  (Promega). Equal amounts of 
in vitro translated, [35S]-labelled proteins were incubated in a total volume 
of 50 µL of NETN150 with either GST or the appropriate GST fusion protein 
for 1 hr at 4°C in binding buffer. The beads were washed 6x with NETN150, 
boiled for 5 min in 1x SDS-PAGE  Laemmli loading buffer, and resolved on a 
SDS-PAGE gel. The gel was dried and [35S]- labelled proteins were visualized 
using a Storm 860 (Molecular Dynamics).  
RNA extraction and RT-PCR 
RNA was extracted from cells using the RNeasy Mini Kit (QIAGEN) following 
the manufacturer instructions. Residual contaminating genomic DNA was 
eliminated by treating the RNA with Turbo DNA-free DNAse (Ambion).  
RBBP4 and RBBP7 mRNA levels in control and HGPS cells were measured by 
retrotranscribing 1 µg of RNA using random primers and the Mo-MulV RT 
enzyme included in the High Capacity Archive cDNA kit (Applied Biosystems) 
for 2 hr at 42 0C, after a denaturation step of 5 min at 65 0C. Equal volumes 
of cDNA were employed as template in a real-time Q-PCR reactions using iQ 
SYBR Green Supermix (Biorad) in a Biorad iCycler. Reaction conditions were: 
3 min at 95 0C, 1 cycle; 20 sec at 95 0C, 30 sec at 56 0C, 41 cycles. Melting 
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curves of the amplified product were generated to verify that a single 
amplicon was generated. Primers : 
RBBP4-6-Fw (5’-TCTGTTTGGGTCAGTTGCTG-3’)  
RBBP4-6-Rw (5’-AACTGAGTGGCTTGGTTTGG -3’) 
 RBBP7-6-Fw (5’-CTGGCCACTCAGCTGTTGTA -3’)  
RBBP7-6-Rw (5’-AGGTGGTATTGGACCTGGTG -3’).  
 
All the values were normalized to the internal control Cyclophilin A gene: 
Cycl-Fw (5’-GTCAACCCCACCGTGTTCTT-3’) and Cycl-Rw (5’-
CTGCTGTCTTTGGGACCTTGT -3’). The G-rich strand of SatIII transcripts was 
retrotranscribed and  PCR amplified as previously described 26.  
HDAC1 immunoprecipitation and HDAC assays 
CRL- 1474 and AG01972 primary fibroblasts were grown in 10 cm dishes to 
70-90% confluency. Cells were rinsed in PBS and resuspended in Lysis buffer 
(300 mM NaCl, 50 mM Hepes pH 7.4, 0.5% NP40, 1 mM EDTA, 20% glycerol, 
10 mM β-Glycero-phosphate, 1 mM NaF, 1 mM Na3VO4, Protease Inhibitors 
Cocktail SetIII (Calbiochem)). The cell lysate was incubated for 30 min at 4 0C 
on a rotating wheel and then centrifuged for 12 min at 12000 g. Total 
protein concentration of lysates was measured using the Bradford Assay 
reagent (Biorad). Equal quantities of protein lysate from different samples 
(1.5-2.0 mg) were diluted to 1 ml with Lysis buffer. Lysates were pre-cleared 
by incubation for 1hr at 4 0C with rabbit-preimmune serum and Protein 
A/G+ agarose (St. Cruz) and then incubated  o/n  at 4 0C with  a α-HDAC1 
rabbit polyclonal  antibody. Immunocomplexes where captured by adding 
Protein A/G+ agarose. Beads were washed 5X in Lysis buffer and rinsed 
twice in HDAC assay buffer (see below).  HDAC activity in total lysates and in 
HDAC1 immunoprecipitates was measured with the Fleur de Lys Fluorescent 
HDAC assay kit (Biomol) following the manufacturer instructions.  
OneSTrEP-lamin A pulldown  
U2OS cells stably expressing OneSTrEP-lamin A were grown in 150 mm 
dishes, fixed in formhaldeyde and lysed in SDS lysis buffer (1% SDS, 10 mM 
EDTA, 50 mM Tris pH 8.1). After extensive sonication, the SDS concentration 
in the lysate was lowered 10-fold by addition of SDS dilution buffer (0.01% 
SDS, 1.1 % Triton X-100, 1.2 mM EDTA, 17 mM Tris pH 8.1, 170 mM NaCl). 
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Both SDS lysis buffer and SDS dilution buffer were supplemented with 2 mM 
ortohovanadate and protease inhibitors (Boehringer Mannheim, 
Indianapolis, USA). Undissolved fractions were discarded after a 10 minute 
centrifugation step at 4 degrees at 10, 000xg. Streptactin Matrix (IBA 
BioTagnology, Göttingen, Germany) prewashed in SDS dilution buffer was 
added and samples were incubated on a rotating wheel o/n at 4 0C.  
Precipitated protein complexes were washed extensively, and eluted from 
the beads by incubation at 95 0C in 1X Laemmli SDS-PAGE loading buffer. 
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Supplemental Figures 
 
 
Figure S1.  Validation of the RBBP4 interaction with lamin A (aa 562-664) by GST pull-down 
assay. (A) GST pulldown assays with recombinant GST-lamin A (aa 562-664) and 35S-labelled, 
in vitro transcribed and translated RBBP4. (B) GST pulldown assays with recombinant GST-
RBBP4 or RBBP7 and 35S-labelled, in vitro transcribed and translated lamin A (aa 390-646). 
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Figure S2.  Characterization of RBBP4 and 7 reduction. (A) Quantitative RT-PCR analysis of RBBP4 and 
RBBP7 mRNA extracted from two independent HGPS cell lines (#1 and #2) and a passage age-matched 
control cell line. The absolute values of RBBP4 and RBBP7 mRNA expression were normalized to the 
housekeeping gene Cyclophilin A. Values represent averages ± S.D. from three experiments. (B) 
Immunofluorescence staining of control and HGPS primary dermal fibroblasts with the indicated 
antibodies. (C) Western blot of cell lysates prepared from control and HGPS dermal fibroblasts. (D) Rescue 
of RBBP4 protein levels upon correction of aberrant lamin A splicing in HGPS cells. Immunofluorescence 
staining with the indicated antibodies on HGPS primary dermal fibroblasts treated with either a sequence-
specific morpholino oligonucleotide against the HGPS pathogenic mutation (EXO11) or a scrambled 
sequence control as previously described 3. (E) Reduction of RBBP4 protein levels in HGPS patient cells 
expressing progerin. Immunofluorescence staining with the indicated antibodies on HGPS primary dermal 
fibroblasts. Scale bars: 10 µm. Arrowheads indicate cells with reduced levels of heterochromatin proteins. 
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Figure S3.  siRNA-mediated silencing of RBBP4 and RBBP7 induces accumulation of cells in S-phase. 
(A) Western blot of cell lysates prepared from Hela cells treated for 72hrs with the indicated 
combinations of siRNA oligos against RBBP4 and RBBP7. (B) Immunofluorescence staining with the 
indicated antibodies on Hela cells fixed 144hrs after oligo siRNA transfection. (C, D) Relative 
percentages of siRNA-treated Hela (C) or U2OS  (D) cells in a specific phase of the cell-cycle 144 hrs 
after oligo siRNA transfection.  (D) Relative percentages of primary dermal fibroblasts in the different 
phases of the cell-cycle.  Cells from two unaffected controls (#1 and #2) and a HGPS patient were 
passage-matched.  Scale bar: 10 µm. 
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Figure S4. Kinetics of heterochromatin defects and DNA damage upon silencing of RBBP4 
and RBBP7.  Quantitation of the percentage of Hela cells that either exhibit loss of 
pericentromeric H3K9me3 foci (A) or that were scored positive for phospho-H2AX staining 
(more than 8 foci per cell) (B) at different time points after the transfection of the indicated 
combinations of siRNA oligonucleotides. N>200.  
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Figure S5. Kinetics of heterochromatin defects and DNA damage upon GFP-progerin 
expression. Quantitative single-cell analysis of fluorescence intensity signals at different time 
points (2-8 days) after the induction of GFP-progerin expression in normal immortalized 
human fibroblasts.  Quantitation of the percentage of cells that either exhibit loss of RBBP4 
(A) or HP1γ (B). (C) Quantitation of the percentage of cells that were scored positive for 
phospho-H2AX staining (more than 8 foci per cell) N>200; values represent averages ± S.D 
from three experiments 
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Figure S6. In vivo interaction of lamin A with HDAC1 and silencing of single NURD subunits in Hela 
cells and human primary fibroblasts.  
(A) Crosslinked protein lysates were prepared from U2OS cells expressing One-Strep (OST)-tagged 
lamin A and then incubated with Streptactin beads. Input and pulled down material was probed by 
Western blot with antibodies against endogenous HDAC1. (B) Western blots of Hela cells 72 hrs 
post-transfection with siRNA targeting different subunits of the NURD complex. (C) and (D) 
Western blot of cell lysates obtained from WI-38 human primary fibroblasts infected with lentiviral 
vectors expressing short hairpin RNA sequences against the indicated genes. The asterisk indicates 
a cross-reacting band in these lysates. 
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Post-natal myogenic and adipogenic 
development defects and metabolic 
impairment upon loss of A-type lamins 
 
Kubben N*, Voncken W*, Konings G, van Weeghel M, Gijbels M,  
van Erk A, Schoonderwoerd K, van den Bosch B,  
Dahlmans V, Calis C, Houten S, Misteli T, Pinto Y. 
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Abstract 
 
A-type lamins are a major component of the nuclear lamina. Their expression is 
developmentally regulated and is absent during embryonic development until 
the onset of tissue differentiation and maturation. Mutations in the LMNA 
gene, which encodes the A-type lamins A and C, cause a set of phenotypically 
diverse diseases collectively called laminopathies. While adult LMNA null mice 
show various symptoms typically associated with laminopathies, the effect of 
loss of lamin A/C on early post-natal development is poorly understood. Here 
we developed a novel LMNA null mouse (LMNAGT-/-) based on genetrap 
technology and analyzed its early post-natal development. We detect LMNA 
promoter activity in heart, liver, intestine and somites during early embryonic 
development. Loss of A-type lamins results in severe growth retardation and 
developmental defects of the heart, including impaired myocyte hypertrophy 
without functional cardiac defects, skeletal muscle hypotrophy, decreased 
amounts of subcutaneous adipose tissue and impaired ex vivo adipogenic 
differentiation. These defects cause death at 2 to 3 weeks post partum 
associated with muscle weakness and metabolic complications, but without the 
occurrence of dilated cardiomyopathy or an obvious progeroid phenotype. Our 
results indicate that defective early post-natal development critically 
contributes to the disease phenotypes in adult laminopathies. 
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Introduction 
Nuclear lamins are intermediate filament proteins mainly localized in the 
nuclear lamina, a protein meshwork lining the nucleoplasmic face of the 
inner nuclear membrane. Lamins are classified as A-type or B-type. The 
A-type lamins consist of the three LMNA splicing isoforms lamin A, AΔ10 
and C. B-type lamins are encoded by the LMNB1 and B2 genes. Whereas 
B-type lamins are expressed in all mammalian cells throughout 
development, A-type lamin expression is developmentally regulated. 
Lamin A/C expression commences in the zygote but is lost at the morula 
stage 1-3. It is only at the beginning of tissue differentiation, in mouse at 
day E12.0, that lamin A/C expression restarts in myoblasts. In many 
other tissues, lamin A/C was reported to be absent until well after birth 
4-5. The notion of lamin A/C being expressed upon tissue differentiation 
is further strengthened by its absence in embryonic stem cells and its re-
expression after loss of pluripotency markers upon neuronal or cardiac 
myocyte differentiation 6. Similarly, embryonic carcinoma cells are 
devoid of lamin A/C in contrast to differentiated derivatives 3, 7. Loss of 
lamin A/C results in increased proliferation due to hyperphosphorylation 
of the retinoblastoma protein 8 and correlates with poor histological 
differentiation and prognosis in primary gastric carcinomas 9.  
 
Mutations in A-type lamins cause a group of phenotypically diverse 
diseases, collectively called laminopathies. They include several types of 
muscular dystrophies, lipodystropies, cardiomyopahties, neurological 
disorders and premature aging syndromes 10. Several of the LMNA 
mutations affect cell differentiation. Mutations that lead to Dunnigan 
familial partial lipodystrphy (FPLD) interfere with the binding of lamin A 
to the adipocyte differentiation factor sterol element binding protein 1 
(SREBP1) and impair adipocyte differentiation 11. In the premature aging 
disease Hutchinson-Gilford Progeria Syndrome (HGPS), the disease-
causing lamin A mutant isoform progerin inhibits adipogenic 
differentiation and favors osteogenic differentiation of human 
mesenchymal stem cells via increased Notch signalling 12. To study the 
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role of lamin A/C in skeletal, cardiac and adipose tissue and to probe 
how LMNA mutations affect the functioning of these tissues in 
laminopathies, several lamin A/C mouse models have been created 13. 
Tissue defects in these models mostly become manifest in young adult 
mice and are therefore mainly studied in weaned mice. As a 
consequence, little is known about the effect of loss of lamin A/C on 
early post-natal development or the contribution of defective 
development to laminopathies.  
 
In this study we set out to probe the effects of loss of lamin A/C on early 
post-natal development as this is the period in which most tissue 
differentiation and maturation occurs. To this end, we created a novel 
LMNAGT-/- mouse model which combines loss of LMNA function with 
LMNA-controlled reporter gene expression. We demonstrate early 
activity of the LMNA promoter at day E11 during embryonic 
development in heart, liver, intestine and somites. Loss of lamin A/C 
results in growth retardation at 2 weeks post partum, with impaired 
post-natal hypertrophy of cardiac myocytes, skeletal muscle hypotrophy, 
decreased subcutaneous adipose tissue deposits, decreased adipogenic 
differentiation of MEFs and metabolic derangements. Ultimately these 
tissue differentiation and maturation defects are lethal before mice are 
weaned. These results demonstrate that lamin A/C is crucial in the early 
post-natal period and they provide novel insights into the physiological 
function of A-type lamins in the context of the developing animal. 
Materials & Methods 
Targeting of the LMNA gene   
LMNAGt(FHCRC-GT-S7-1F1)Sor AK7.1 ES cells (strain of origin 129S4/SvJaeSor) 
containing a ROSAFARY Genetrap (GT) vector in the LMNA gene were 
obtained from the International Genetrap Consortium 
(www.genetrap.org). Chimaeric mice were created by ES cell injection 
into C57Bl/6 recipient blastocysts at the Transgenesis and gene 
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Targeting Unit Maastricht (Maastricht, The Netherlands). Resulting 
chimaeric males were bred to wildtype (WT) C57Bl/6 mice. Resulting 
heterozygous LMNAGT (LMNAGT+/-) mice were interbred to achieve 
homozygocity (LMNAGT-/-). For genotyping, PCR-primer pairs Fw 
(forward) 5’GACGGGTTGTTACTCGCTCAC3’ and Rev (reverse) 
5’CAGGTCAAATTCAGACGGCAAA3’  were used to selectively amplify GT; 
Fw 5’ACCATCTCCCCAGCCCTTAG3’ and Rev 
5’CAACATTCCTGATTCTTTCTGC3’ to detect the endogenous LMNA gene. 
All studies involving animal experiments were approved by the Animal 
Care and Usage Committee of Maastricht University (Maastricht, The 
Netherlands) and the National Institutes of Health (NIH, Bethesda, USA) 
and were performed in accordance with regulations formulated in Dutch 
and US law on care and use of experimental animals. 
Histology, Immunohistochemisty and Transmission Electron Microscopy 
(TEM) 
LMNAGT mice were sacrificed by decapitation or cervical dislocation. 
Blood was removed from the vascular system by perfusing of 5 ml 
physiological buffered saline via the left ventricle (LV) of the heart; 
muscle relaxation was induced by a consecutive injection with 100μl of a 
0.1N cadmium chloride solution. Tissues for histological analysis and 
immunohistochemistry were fixed for 4-6 hours in 4% 
paraformaldehyde, washed three times 5 minutes in PBS, stored 
overnight in 70% ethanol, embedded in paraffin and sectioned at 4 
microns. Tissues sections were stained with haematoxylin eosin (H&E) 
and Picro Sirius Red (SR) as described before 14. H&E staining was used 
for quantification of cardiac- and skeletal-myocyte cross sectional areas. 
Impaired post-natal hypertrophy was quantified by cardiac myocyte 
cross-sectional area (CSA) counts in LV myocytes opposite or adjacent to 
the septum. Tissues for RNA isolation were snap frozen in liquid 
nitrogen. Tissues for TEM analysis were fixed in 2.5% glutaraldehyde and 
further analysis was performed as previously described 15. Whole-mount 
embryos were β-galactosidase stained as described 16. 
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RNA isolation and microarray analysis 
RNA was isolated from mouse embryonic fibroblasts (MEF) and LV of 
LMNAGT mice using the RNAeasy minikit (Qiagen, Hilden, Germany). For 
whole transcriptome analyses, RNA from LV’s of 5 and 13 days old WT 
and LMNAGT-/- mice (N=2 for each genotype and age) was isolated and 
hybridized to Nugo Mouse Affymetrix expression arrays. Intensity values 
after hybridization were normalized to the median signal intensity of the 
array. Enrichment of deregulated genes in specified biological pathways 
was tested using GENMAPP 2.1 software. For expression analysis by PCR 
cDNA was synthesized with the iScriptTM cDNA synthesis kit (BioRad, 
Hercules, USA). SYBR Green real-time quantitative PCR analysis was 
performed with primers for ANF (Fw  5’ATTGACAGGATTGGAGCCCAGAGT3’, Rev 
5’TGACACACCACAAGGGCTTAGGAT3’), BNP (Fw 5’GTTTGGGCTGTAACGCACTGA3’, Rev 
5’GAAAGAGACCCAGGCAGAGTCA3’), Ki67 (Fw 5’TCAACAGCTGGTATGCCTAACAG3’, 
Rev 5’TTCCAGTGGTCAAAGAGTCATTAGC3’), PCNA (Fw 
5’AGGGTTGGTAGTTGTCGCTGTAG3’, Rev 5’GGTCCCCCGATTCACGAT3’), GAPDH (Fw 5’ 
GGTGGACCTCATGGCCTACA3’, Rev 5’CTCTCTTGCTCAGTGTCCTTGCT3’) and HPRT (Fw 
5’GCGTCGTGATTAGCGATGATGAAC3’, Rev 5’CCTCCCATCTCCTTCATGACATCT3’). 
Echocardiography and electrocardiogram (ECG) analysis 
WT, LMNAGT+/-  and LMNAGT-/-  cardiac functioning was monitored by 
serial echocardiography and ECG analysis at days 10, 13 and 17 post 
partum  (PP10, PP13 and PP17). ECG analysis was performed under 2% 
isoflurane sedation; P wave, QRS and QT time were assessed using 
IDEEQ v1.7 software (Instrument Development Engineering & 
Evaluation, Maastricht University, The Netherlands). Echocardiography 
was performed uder similar sedative conditions, with a 30MHz 
transducer on a Vevo770TM high-resolution in vivo micro-imaging system 
(VisualSonics B.V., Amsterdam, The Netherlands). LV parameters were 
obtained from M-mode recordings in the short axis-view. Fractional 
shortening (FS) was calculated using the the formula: FS = 100x((Left 
Ventricle Inner Diameter in diastole – Left Ventricle Inner Diameter in 
systole)/Left Ventricle Inner diameter in diastole). To study the effects of 
α- and β-adrenergic receptors antagonists on LMNAGT-/- cardiac 
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performance, labetalol was administered twice daily by subcutaneous 
interscapular injections at a dose of 10 mg/kg from day PP10 onward;  
ECG analysis was performed as indicated above at day PP13. To study 
the effects of LMNA heterozygosity on cardiac hypertrophy, 
echocardiography was performed as indicated above on 60-70 weeks old 
LMNAGT+/- mice and WT controls. Furthermore 16-18 weeks old WT and 
LMNAGT+/- mice were infused subcutaneously with 1.5 μg/g/day 
angiotensin II for 4 weeks by an osmotic minipump (Alzet osmotic 
minipumps, Cupertino, CA). Echocardiograms were made at 2 and 4 
weeks after the start of the angiotensin II treatment. 
Funtional assessment of skeletal muscles. 
Total quadriceps muscle weight were normalized to tibia length for all 
genotypes. Skeletal muscle strength was assessed by quantifying the 
capacity to hang upside down on a grid with use of both fore- and hind 
limbs. Time in seconds indicates the time from placing the raster upside 
down until the mouse dropped from the grid. Measurements on each 
genotype were performed in triplicate (n=4, PP15). 
 
Adipocyte differentiation assay 
MEFs were isolated from E12.0 LMNAGT-/-, LMNAGT+/- and WT embryos by 
digesting skin isolates for 20 min in 3 ml 0.05% trypsin at 37⁰C during 
which the solution was resuspended every 10 minutes. This was 
followed by addition of an equal volume of fresh trypsin solution and a 
20 minute incubation step; this was repeated once and incubated for 5 
additional minutes, after which a cell pellet was obtained by 
centrifugation and plated in Dulbecco’s modified eagle medium (11360-
070, Invitrogen, San Diego, USA) with 2mM L-glutamine, 10mM non-
essential amino acids (NEAA), 110 mg/l pyruvate, 10% fetal bovine 
serum (FBS) and antibiotics. Passage 2 (P2) cells were seeded at 50% 
confluency in 6-wells plates for adipogenic differentiation and grown to 
confluency for 3 days. The medium was replaced and cells were left for 3 
days on induction medium: hMSC basal medium (PT-3238, Lonza, Basel, 
Switzerland) with 2mM L-glutamine, 10mM NEAA, 110 mg/l pyruvate, 
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10% FBS, antibiotics, 10μg/ml insulin, 0.5 mM 3-isobutyl-l-methylxantine 
(IBMX) and 1μM dexamethasone. After 3 days the medium was replaced 
by maintenance medium (similar to induction medium with omission of 
IBMX and dexamethasone) and left for 2 days. This 5 day cycle of 
induction and maintenance was repeated three times. Oil Red O staining 
and quantification after each cycle (6, 10 and 16 days post induction) 
were performed in triplicate as previously described 12. 
Metabolic characterization 
To asses core body temperature, mice received an inter-intestinal 
temperature probe through a small abdominal incision directly after 
applying isoflurane anesthesia. Core body temperature was measured as 
soon as it reached a plateau phase (i.e. before ambient temperature 
decreased body temperatures). Subcutaneous adipose tissue deposits 
were determined by incising the skin along the saggital axis, collecting 
and weighing subcutaneous adipose tissue in between the left fore- and 
hind leg. Subcutaneous adipose tissue weights were standardized by 
tibia length. For blood chemistry measurements, WT, LMNAGT+/- and 
LMNAGT-/- mice were intraperitoneally injected with 50 μl of a 500 
Units/ml heparin solution as an anticoagulant before decapitation and 
collection of blood. For glucose, lactate and betahydroxybutyrate 
analysis the collected blood was mixed with equal amounts of 1M 
perchloric acid and centrifuged to obtain a supernatant fraction for 
further analysis 17. The acylcarnitine spectrum was determined by mass 
spectrometry on regular blood plasma as described 18. Urea, creatinine 
and creatinine kinase were determined on EDTA anticoagulated blood. 
For mitochondrial functioning LV samples were snap frozen in liquid 
nitrogen and used to determine catalytic activity of citrate synthase and 
individual oxidative phosphorylation complexes as described 19. 
Mitochondrial DNA copy numbers were assessed in LV cardiac muscle 
and quadriceps skeletal muscle 19.  
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Statistical analysis 
Data are represented as average ± SD. The data for each study group 
were compared using 2-way ANOVA or student’s t-test where 
appropriate. Analyses were performed using the statistical package SPSS 
11.0. P<0.05 was considered to be statistically significant. 
Results 
Generation of a LaminGT-/- mouse  
We created LMNA null mice by interruption of the endogenous lamin 
A/C locus by a promoter-trap construct, which introduces an in-frame 
LMNA-βgeo fusion allele. The construct was inserted in second LMNA 
intron (Figure 1A). Lamin A/C transcripts (Figure 1B) and protein were 
undetectable in LMNAGT-/- animals 15 days post partum. As expected, 
LMNAGT+/- mice expressed approximately half the amount of lamin A and 
C mRNA (Figure 1B) and protein compared to WT controls. RT-PCR 
analysis confirmed the absence of randomly integrated GT vector 
sequences elsewhere in the genome, as well as the absence of 
alternative LMNA splicing products (data not shown).  
 
The LMNA-β-geo fusion protein is encoded by the first LMNA exon 
followed by β-galactosidase-neomycin cDNA (Figure 1A), which allows 
for direct visualization of LMNA promoter activity in LMNAGT+/- and 
LMNAGT-/- whole mounts and tissue sections. At E8.0 and E9.0, only 
LMNAGT+/- placental tissue showed LMNA promoter activity (Figure 1C). 
At E11.0 the LMNA promoter was active in heart, liver, intestines and 
embryonic somites. Late in embryonic development (E18.0) LMNA 
promoter activity was observed macroscopically in all organs. Specificity 
of β-galactosidase signal was confirmed by staining adult LMNAGT+/- 
mice, which showed absence of LMNA promoter activity in various cell 
types, as reported previously 4 (data not shown).  
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At birth, genotypes were present in normal Mendelian ratios and no 
obvious macroscopic differences were detected between WT, LMNAGT+/- 
and LMNAGT-/- mice. At PP7,  onset of initial growth retardation was 
observed in LMNAGT-/- mice, which was confirmed  by decreased body 
weight (BW) (Figure 1D and E).  LMNAGT-/- body weight peaked at PP13 
and decreased slightly thereafter, leveling off at approximately half the 
BW of that of WT and LMNAGT+/- at PP16 (Figure 1E). Complete loss of 
lamin A/C due to insertion of the GT sequence was invariably lethal 
between PP16 and PP18 (Figure 1F). BW and survival curves of LMNAGT+/- 
mice were comparable to those of WT siblings. Grooming behavior and 
foraging appeared normal for all genotypes, and were only diminished 
for LMNAGT-/- mice at days PP16-PP18. LMNAGT-/- autopsy at PP17 
revealed an increased amount of intra-intestinal gas, but did not reveal 
obvious differences in food content or GI tract histology. Pathological 
examination at PP15 revealed heart, skeletal muscle myocytes and 
adipose tissue abnormalities. LMNAGT-/- mice did not show overt 
abnormalities in stomach, intestines, liver, kidneys, spleen, thymus, 
thyroid, lung, bladder, pancreas and brain. No obvious indications of 
abnormal bone or dentation were observed (data not shown), in 
contrast to reports on  other LMNA mouse models 13. Hence, we 
conclude that loss of lamin A/C leads to defects in early post-natal 
development and ultimately death. 
Transcriptome analysis 
To assess how loss of lamin A/C affects tissue differentiation and 
maturation, microarray expression analysis was performed on left 
ventricle (LV) cardiac tissue at PP5 and PP13. At PP5 expression of 671 
genes changed more than 1.2 fold (199 up, 472 down) in LMNAGT-/- mice 
compared to WT siblings (Figure 2A and B). 28 of those genes were still 
misregulated at PP13, 3 of which in similar and 25 in opposite direction. 
In addition, 359 genes were more than 1.2 fold deregulated at PP13 (194 
up, 165 down) while normally expressed at PP5 (Figure 2A and B). 
Genmapp analysis indicates that the deregulated genes are significantly 
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Figure 1. General phenotypical characterization of the LMNAGT-/- murine model. (A) Overview of the 
ROSAFARY genetrap (GT) sequence insertion in the LMNA gene. The GT consists of a splice acceptor (SA) 
containing βgeo-reporter with a polyA signal (bpA) and a PGK promoter driven hygromycin antibiotics 
resistance cassette surrounded by FRT sites and harbouring a splice donor (SD) site. 5’ and 3’ ends of the GT 
sequence are demarcated by long terminal repeats (LTR). (B) Relative mRNA expression levels for full length 
lamin A, C and the LMNA-βgeo splicing product. Expession levels are normalized to HPRT mRNA levels. (C) 
LMNA promoter activity is visualized by β-galactosidase staining in LMNAGT+/- embryo’s (E8.0, E9.0, E11.0 and 
E18.0). LMNAGT+/- maternal placental tissue is indicated by an asterisk. (D) Macroscopical view  of WT, 
LMNAGT+/- and LMNAGT-/- siblings 12 days post partum (PP12). (E) Body weight over time graph (PP2-PP18). 
Asterisks indicate a significant difference for LMNAGT-/- opposed to LMNAGT+/- and WT littermates (N=10, 
P<0.05). (F) Survival curves for all three genotypes during the first 3 weeks post partum. 
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 (P<0.05) over-represented in fatty acid beta oxidation (PP5), striated 
muscle contraction (PP5),  electron transport chain (PP13), adipogenesis 
(PP13) and hypertrophy (PP13). The most highly deregulated genes 
included Mybcp2, My6, Tnni1 (striated muscle contraction); Hdac9, 
Gata4, Atf3 (hypertrophy); Dci, Slc25a20 (fatty acid beta oxidation); 
Cebpd, Nrip, Dlk (adipogenesis) and ATP5g2, Cox8a, Cox8b (electron 
transport chain) (Figure 2C). These results indicate that loss of lamin A/C 
resulted in myogenic, adipogenic and metabolic defects during early 
post-natal stages of development. 
Cardiac morphology phenotype 
In keeping with transcriptome analysis, histological examination 
revealed that cardiac myocytes were smaller in the LV of LMNAGT-/- mice 
compared to WT controls (PP13; Figure 3A). We examined cardiac 
hypertrophy by weighing LV as a function of time post partum. LV weight 
(LVW; normalized to tibia length) was decreased by 14% at PP11 and up 
to 47% at PP15 in LMNAGT-/- mice compared to WT age-matched controls 
(PP11 2.2±0.2 mg/mm LMNAGT-/- vs. 2.6±0. 2 mg/mm WT p<0.05; PP15 
1.9±0. 3 mg/mm LMNAGT-/- vs. 3.6±0.3 mg/mm WT p<0.01) (Figure 3B). 
Post-natal hypertrophy was significantly impaired at PP11 in 
homozygous GT animals: cross-sectional aera (CSA) counts were nearly 
2-fold reduced  (116 ± 17μm2 LMNAGT-/- vs. 220 ± 34 μm2 WT; Figure 3C 
p<0.01), and reached a substantially lower maximum of 153±17 μm2 in 
LMNAGT-/- mice vs 380±8 μm2 in WT siblings (p<0.001). Real-time 
quantitative PCR analysis showed comparable expression levels of the 
proliferative markers Ki67 and PCNA in the LV of all genotypes in early 
post-natal development and a general decrease in levels after birth 
(p>0.05; Figure 3C). The cardiac hypertrophy markers BNP and ANF 
showed 10- to 100-fold upregulation in LMNAGT-/- mice, at PP11 and 
PP13 and onwards, respectively (p<0.05; Figure 3D). No cardiac myocyte 
degenerative areas, fibrosis or obvious abnormalities in interstitial 
spaces and Z-disc organization were observed (data not shown). These 
data show that A-type lamins are essential for normal post-natal cardiac 
hypertrophy. 
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Figure 2. Transcriptome analysis of the LMNAGT-/- mouse. (A) mRNA expression levels of left ventricle cardiac 
tissue were analyzed by microarrays at PP5 and PP13. Scatter plots indicate logarithmic expression levels of 
mRNA of LMNAGT-/- mice vs. WT littermates at both time points. Twofold up- and down regulation borders are 
indicated by straight lines within the scatter plots. (B) A Venn diagram of over 1.2 fold up- or down-regulated 
genes in the LMNAGT-/- mice compared to WT siblings at PP5 and PP13. The number of genes and direction of 
change are indicated for all deregulated genes at PP5, PP13 and genes which are deregulated at both time 
points. (C) Heatmaps with mRNA expression levels of the most deregulated genes at PP5 and PP13 within the 
biological pathways striated muscle contraction, hypertrophy, fatty acid beta oxidation, adipogenesis and 
electron transport chain. WT expression levels for each gene were set at 1.0 (black color code). Relative 
differences in expression levels for LMNAGT-/- mice are indicated as fold change values and color coded.  
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Figure 3. Post-natal cardiac hypertropy in the LMNAGT-/- mouse.  (A) Haematoxylin and eosin 
(H&E) staining on left ventricle sections of WT and LMNAGT-/- mice (PP13). (B) Bar graph 
indicating left ventricle weight (LVW) standardized by tibia length over time (PP5-PP18) for all 
three genotypes. (C) Bar graph with cardiac myocytes cross sectional area over time (PP2-PP18) 
for LMNAGT-/- and WT sibblings. (D) mRNA levels of proliferative markers Ki67 and PCNA and 
hypertrophic markers ANF and BNP, standardized for GAPDH. Asterisks in figure 3 indicate 
significant differences for LMNAGT-/- vs. both LMNAGT+/- and WT values (N=5, P<0.05). 
  
Cardiac function phenotype 
To determine whether decreased cardiac hypertrophy results in 
compromised cardiac function, LMNAGT mice were subjected to 
echocardiography and electrocardiography (ECG). Impaired post-natal 
hypertrophy was confirmed by lower relative LVW in LMNAGT-/- mice 
(PP17: 2.1±0.3 mg/cm LMNAGT-/- vs. 3.7±0.1 mg/cm WT p<0.01; Table 1). 
Nevertheless, fractional shortening (FS), which measures the fraction of 
LV diastolic dimension lost in systole, as an indicator for LV contractility,   
Developmental defects and metabolic impairment upon loss of A-type lamins | 161 
 
Ta
bl
e 
1.
 C
ar
di
ac
 fu
nc
ti
on
in
g 
up
on
 p
ar
ti
al
 a
nd
 c
om
pl
et
e 
lo
ss
 o
f l
am
in
 A
/C
. 
* 
p<
0.
05
 L
M
N
A
G
T-
/-
 v
s.
 b
ot
h 
ag
e-
m
at
ch
ed
 L
M
N
A
G
T+
/-
 a
nd
 W
T 
va
lu
es
;  
# 
p<
0.
05
 w
ith
in
 t
he
 s
am
e 
ge
no
ty
pe
 c
om
pa
re
d 
to
 th
e 
st
ar
t  
of
 a
ng
io
te
ns
in
 
II 
tr
ea
tm
en
t.
 A
bb
re
vi
at
io
ns
: I
VS
s=
In
tr
av
en
tr
ic
ul
ar
 S
ep
ta
l W
al
l T
hi
ck
ne
ss
 in
 s
ys
to
le
, L
VI
D
s=
Le
ft
 V
en
tr
ic
ul
ar
   
In
te
rn
al
 D
im
en
si
on
 in
 s
ys
to
le
, 
LV
PW
s=
Le
ft
 V
en
tr
ic
le
 P
os
te
rio
r W
al
l T
hi
ck
ne
ss
 in
 s
ys
to
le
, I
VS
d=
In
tr
av
en
tr
ic
ul
ar
 S
ep
ta
l W
al
l T
hi
ck
ne
ss
 in
 d
ia
st
ol
e,
 L
VI
D
d=
Le
ft
 V
en
tr
ic
ul
ar
 
In
te
rn
al
 D
im
en
si
on
 in
 d
ia
st
ol
e,
 L
VP
W
d=
Le
ft
 V
en
tr
ic
le
 P
os
te
ri
or
 W
al
l T
hi
ck
ne
ss
 in
 d
ia
st
ol
e,
 F
S=
Fr
ac
tio
na
l S
ho
rt
en
in
g.
 
162 | Chapter 6 
was comparable in all 3 genotypes at days PP10, PP13 and PP17 (PP17: 
31±7% LMNAGT-/-, 32±9% LMNAGT+/-, 32±8% WT). No signs of LV 
dilatation nor thinning of the LV wall were observed as all 
echocardiographic parameters appeared comparable for all genotypes 
(Table 1). ECG analysis, which captures electrical activity of the heart 
over time, did not reveal any differences in P wave duration (reflects 
atrial depolarization),  QRS time (reflects ventricular depolarization), or 
QT time (prolonged QT time is a risk factor for ventricular tachy-
arrythmias and sudden death). ECG analysis did reveal a significantly 
lower heart rate in LMNAGT-/- mice from day PP15 onwards (PP17: 
279±34 bpm. LMNAGT-/- vs. 420±57 bpm. WT p<0.05). Decreasing cardiac 
workload by lowering blood pressure and decreasing heart rate was 
reported to be beneficial in dilated cardiomyopathy, which is  observed 
in various LMNA mouse models 13, 20. We therefore assessed whether 
treatment with the α- and β-adrenergic antagonist labetalol had 
beneficial effects in LMNAGT-/- mice (Figure S1A). Labetalol increased QRS 
time in all genotypes (p<0.05). In contrast to WT and LMNAGT+/- mice, 
labetalol treatment significantly increased P time (from 23.7±2.6 ms to 
29.8±3.2 ms; P<0.05) and lowered heart rate (396±51 bpm to 232±20 
bpm; p<0.05) in LMNAGT-/- mice (Figure S1B). However, treatment with 
labetalol lead to earlier post-natal death in LMNAGT-/- mice compared to 
LMNAGT+/- and WT siblings (Figure S1C). 
 
To assess whether age-related physiological cardiac hypertrophy is 
subject to gene dosage effects 60-70 weeks old WT and LMNAGT+/- mice 
were subjected to echocardiography. Although the average FS was 
slightly decreased in LMNAGT+/- mice, this difference was not significant 
(23±7% LMNAGT+/- vs. 30±8% WT p>0.05; Table 1). Other cardiac 
parameters did not differ significantly. Similarly, angiotensin II treatment 
induced comparable levels of hypertrophy under acute pathological 
conditions in 16-18 weeks old LMNAGT+/- and WT mice, based on relative 
LVWs (LMNAGT+/- from 5.8±0.4 to 7.3±0.6 mg/cm p<0.05; WT from 
6.1±0.5 to 7.9±0.6 mg/cm p<0.05). No signs of cardiac failure were 
observed as FS, other echocardiographic parameters and relative lung 
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weight were all comparable (p>0.05; Table 1). Therefore, we conclude 
that partial loss of lamin A/C only slightly decreased LV weight without 
impairing the ability to respond structurally or functionally to increased 
load. Complete loss of lamin A/C impairs post-natal cardiac hypertrophy, 
lowers the heart rate moderately but does not  cause any other direct 
functional abnormalities. 
Skeletal muscle phenotype  
Initial gross anatomical examination showed hunched posture and 
abnormal gait, characterized by splayed hind legs from day PP13 
onwards in LMNAGT-/- mice. Histological examination revealed smaller 
quadriceps skeletal myocytes at day PP15 (Figure 4A). Based on 
transcriptome analysis and these initial findings we further assessed 
post-natal skeletal muscle development. Pathological findings were 
confirmed by quantification of the CSA of skeletal myocytes and the total 
quadriceps muscle weight (normalized to tibia length). Quadriceps 
muscle in LMNAGT-/- mice showed hypotrophy at PP15 (relative 
quadriceps weight 5.0±0.5 mg/mm LMNAGT-/- vs. 7.1±0.6 mg/mm WT 
p<0.05) whereas they did not at PP9 (3.8±0.95 mg/mm LMNAGT-/- vs. 
4.7±0.35 mg/mm WT p>0.05; Figure 4B). Accordingly, myocyte CSA did 
not differ at PP9 (195±100 μm2 LMNAGT-/- vs. 259±59 μm2 WT p>0.05), 
but was significantly lower at PP15 (270±55 μm2 LMNAGT-/- vs. 500±50 
μm2 WT p<0.01; Figure 4C). Consistent with these findings, LMNAGT-/- 
mice displayed reduced muscular strength (lag time dropping from grid: 
0.9±0.5 sec LMNAGT-/- vs. 6.7±1.4 sec WT PP15; p<0.05; Figure 4D). 
Histological analysis did not show any overt signs of fibrosis, as assessed 
by Sirius Red staining and Z-disc deorganization assessed by TEM (data 
not shown). These observations suggest that lamin A/C is important for 
maintaining sketelal muscle mass and strength.  
Adipogenic Phenotype  
As pathological findings included reduced subcutaneous adipose tissue 
at PP15 in LMNAGT-/- mice, we further investigated the role of lamin A/C 
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during early post-natal differentiation and maturation of adipose tissue. 
Subcutaneous adipose deposits at PP5 were comparable in weight for 
WT and LMNAGT-/- mice (weight corrected for tibia length: 0.38±0.35 
mg/mm LMNAGT-/- vs. 0.40±0.17 mg/mm WT p>0.05; Figure 5A). During 
early post-natal development both WT and LMNAGT+/- mice increase their 
subcutaneous fat storage (PP14 1.13±0.17 mg/mm WT p<0.05 compared 
to PP5), while this storage was severely impaired in LMNAGT-/- mice (PP14 
0.62±0.16 mg/mm, p<0.05 compared to age-matched WT). Gonadal fat 
patches and subscapular brown adipose tissue were present in all 
genotypes and macroscopically showed no obvious mass reduction.  
 
 
 
 
 
Figure 4. Post-natal skeletal muscle morphology and functioning in the LMNAGT-/- model. (A) 
Typical example of a haematoxylin and eosin (H&E) staining on quadriceps skeletal muscle 
sections of LMNAGT-/- and WT sibling (PP15). (B) Total quadriceps muscle weight normalized to 
tibia length assessed at PP9 and PP15 in LMNAGT-/-, LMNAGT+/- and WT mice. (C) Quantification of 
the cross sectional area of quadriceps skeletal muscle myocytes for all 3 genotypes (PP9, PP15). 
(D) Assessment of skeletal muscle strength: time (in seconds) indicates the lag time until a mouse, 
hanging upside down, releases the grid; Asterisks in Figure 4 indicate significant differences for 
LMNAGT-/- vs. both LMNAGT+/- and WT values (P<0.05; n=4). 
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To directly investigate whether lack of subcutaneous adipose tissue 
could be caused by differentiation defects, E12.0 mouse embryonic 
fibroblasts (MEFs) were harvested from all 3 genotypes and adipogenic 
differentiation was induced ex vivo. Oil Red O lipid staining was 
substantially reduced upon complete loss of lamin A/C (0.284±0.033 
LMNAGT-/- vs. 0.615±0.159 WT at 16 days post induction, p<0.05; Figure 
5B, C). These findings suggest that that loss of lamin A/C results in 
impaired adipogenic differentiation and decreased post-natal 
subcutaneous fat deposition. 
 
 
 
 
 
Figure 5. Adipogenic capacity of the LMNAGT-/- murine model. (A) Quantification of 5 and 14 day 
old subcutaneous adipose tissue deposits normalized to tibia length (See Material & Methods). 
(B) Representative examples of Oil Red O staining at 16 days of differentiation for all genotypes. 
(C) Quantification of Oil Red O staining at 6, 10, and 16 days post induction. Asterisks in Figure 5 
indicate significant differences for LMNAGT-/- vs. both LMNAGT+/- and WT values (P<0.05; n=3). 
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Metabolic Parameters  
As loss of subcutaneous adipose tissue is expected to influence general 
metabolism, a metabolic fingerprint was taken at PP12 and PP16 by 
determining the status of carbohydrate, fat and protein metabolism. 
Glucose metabolism was determined by measuring blood levels of 
glucose (the major carbohydrate energy source for the glycolytic 
pathway), liver glycogen levels (energy storage) and serum lactate (a by-
product of anaerobic metabolism). Only  lactate levels were reduced at 
PP12 (1.41±0.37 mM LMNAGT-/- vs. 2.01±0.54 mM WT p<0.05). Metabolic 
complications were observed at PP16 (Table 2) as LMNAGT-/- mice 
became hypoglycemic (1.88±0.97 mM LMNAGT-/- vs. 5.40±1.54 WT 
p<0.05) while serum lactate levels remained normal. In further 
agreement with lowered blood glucose levels, glycogen deposits in the 
liver were undetectable in LMNAGT-/- mice at PP18 in contrast to WT and 
LMNAGT+/- mice (Figure S2). 
 
Fat/Triglycerides metabolism was monitored by determining the 
acylcarnitine profiles (carnitine-coupled free fatty acid (FFA)) substrates 
for ß-oxidation) (18), and by measuring serum levels of the ketone body 
betahydroxybutyrate (by-product of fatty acid catabolism; alternative 
energy source during hypoglycemia). At PP12 most of these parameters 
were normal, with the exception of lowered C12 carnitine levels 
(0.08±0.01 pmol/mg LMNAGT-/- vs. 0.013±0.02 pmol/mg WT p<0.05).  
Metabolic complications became apparent in LMNAGT-/- mice at PP16 
(Table 2), as elevated levels of the ketone body betahydroxybutyrate 
(1.94±0.18 mM LMNAGT-/- vs. triglycerides into fatty acids and ketone 
bodies. An elevated ratio of 1.26±0.21 mM WT p<0.05) indicate 
increased conversion of free carnitine to bound carnitine (0.72±0.17 
LMNAGT-/- vs. 0.038±0.05 WT p<0.01), C2 acetyl-carnitine (18.86±1.90 
pmol/mg LMNAGT-/- vs. 14.67±1.73 pmol/mg WT p<0.05) and C16 
palmitoyl-carnitine (0.86±0.13 pmol/mg LMNAGT-/- vs. 0.57±0.15 
pmol/mg WT p<0.05) indicate increased FFA transport across the 
mitochondrial membrane. 
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A metabolic profile was determined on blood samples by assessing glucose, lactose, 
betahydroxybutyrate and various acylcarnitines levels at day PP12 and PP16. Body core temperature, 
creatinin, urea and creatin kinase levels were assessed at day PP9 and PP15. Asterisks indicate 
significant differences for LMNAGT-/- vs. both LMNAGT+/- and WT values (P<0.05). 
 
 
Table 2. Post-natal metabolic fingerprint of the LMNAGT-/- mouse.  
Age Parameter Measured N= wt +/-  -/-  
PP9 
       
Body Core Temperature (⁰C) 5 31.5 ± 2.0 32.1 ± 1.5  29.5 ± 0.9*  
Creatin Kinase  (units/liter) 4 646 ± 169   551 ± 231  
Creatinine (μM) 4 8.0 ± 1.7   7.1 ± 1.2  
Ureum (mM)
 
4
 
8.7 ± 2.1
 
 
 9.2 ± 1.2 
 
 
PP12 
       
Glucose (mM) 6 3.20 ± 0.83 3.23 ± 0.80  3.08 ± 1.24  
Lactate (mM) 6 2.01 ± 0.54 2.52 ± 1.14  1.41 ± 0.37*  
Betahydroxybutyrate (mM) 6 0.97 ± 0.22 1.02 ± 0.20  0.90 ± 0.25  
C0, Free Carnitine (pmol/mg) 6 31.88 ± 8.96 32.03 ± 2.85  29.07 ± 1.70  
C2, Non-Free Carnitine (pmol/mg) 6 10.39 ± 3.60 11.52 ± 2.69  9.97 ± 1.33  
C0/C2, Free Carnitine/Non-free Carnitine 6 0.32 ± 0.06 0.31 ± 0.12  0.34 ± 0.05  
C2, Acetyl-carnitine(pmol/mg) 6 10.39 ± 3.60 11.52 ± 2.69  9.97 ± 1.33  
C5 carnitine (pmol/mg) 6 0.38 ± 0.22 0.36 ± 0.21  0.38 ± 0.06  
C12 Carnitine (pmol/mg) 6 0.13 ± 0.02 0.12 ± 0.02  0.08 ± 0.01*  
C16, palmitoyl-carnitine (pmol/mg) 6 0.75 ± 0.42 0.59 ± 0.22  0.40 ± 0.09  
C18:1, Oleoyl-carnitine (pmol/mg)
 
6
 
0.26 ± 0.19
 
0.20 ± 0.11
 
 0.12 ± 0.05 
 
 
PP15 
       
Body Core Temperature (⁰C) 5 32.5 ± 1.0  32.5 ± 1.8  27.5 ± 0.8*  
Creatin Kinase  (units/liter) 4 667 ± 310   1561 ± 287*  
Creatinine (μM) 4 9.6 ± 2.3   8.75 ± 0.9  
Ureum (mM)
 
4
 
8.9 ± 3.3
 
 
 10.2 ± 3.9 
 
 
PP16 
       
Glucose (mM) 4 5.40 ± 1.54 4.94 ± 1.11  1.88 ± 0.97*  
Lactate (mM) 4 3.28 ± 0.65 2.50 ± 0.62  2.81 ± 0.44  
Betahydroxybutyrate (mM) 4 1.26 ± 0.21 1.26 ± 0.17  1.94 ± 0.18*  
C0, Free Carnitine (pmol/mg) 4 39.28 ± 9.06 33.01 ± 4.01  26.73 ± 2.6*  
C2, Non-Free Carnitine (pmol/mg) 4 14.76 ± 1.73 12.40 ± 2.06  18.86 ± 1.90*  
C0/C2, Free Carnitine/Non-free Carnitine 4 0.38 ± 0.05 0.38 ± 0.04  0.72 ± 0.17*  
C2, Acetyl-carnitine(pmol/mg) 4 14.67 ± 1.73 12.40 ± 2.06  18.86 ± 1.90*  
C5 carnitine (pmol/mg) 4 0.41 ± 0.28 0.25 ± 0.13  0.40 ± 0.20  
C12 Carnitine (pmol/mg) 4 0.15 ± 0.03 0.14 ± 0.05  0.23 ± 0.12  
C16, palmitoyl-carnitine (pmol/mg) 4 0.57 ± 0.15 0.57 ± 0.08  0.86 ± 0.13*  
C18:1, Oleoyl-carnitine (pmol/mg) 4 0.14 ± 0.06 0.17 ± 0.06  0.25 ± 0.17  
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As general markers for protein catabolism, creatin kinase, creatinin and 
ureum were determined. Blood creatin kinase levels (marker for muscle 
damage or wasting), were elevated at PP15 (1561±287 U/L LMNAGT-/- vs. 
667±310 U/L WT p<0.05), but not at PP9. However, urea and creatinin 
levels (indicators of protein breakdown and kidney functioning), did not 
differ significantly (urea: 11.1±1.5 mmol/L LMNAGT-/- vs. 9.1±1.7 mmol/L 
WT; creatinin: 8.2±1.3  μmol/L LMNAGT-/- vs. 9.7±1.2 μmol/L WT; PP15; 
p>0.05). In addition to these metabolic parameters, core body 
temperature was lower both at PP9 (29.5±0.9 ⁰C LMNAGT-/- vs. 31.5±2.0 
⁰C WT p<0.05) and PP15 (27.5±0.8 ⁰C LMNAGT-/- vs. 32.5±1.0 ⁰C WT 
p<0.01). 
 
As the metabolic fingerprint and the expression array analysis (Figure 2B) 
supported an abnormal metabolic phenotype, morphology and function 
of mitochondria was assessed. Transmission electron microscopy 
revealed no differences in mitochondrial morphology (Figure S3A). 
Mitochondrial DNA copy numbers were comparable in both heart and 
quadriceps skeletal muscle at PP15 (p>0.05; Figure S3B). Electron 
transport chain subcomplex activities were determined in LV tissue at 
PP15 and were shown to be almost fully comparable between WT and 
LMNAGT-/- mice (Figure S3B). A slight elevation in the amount of 
mitochondria was observed, however (CS 1712±307 LMNAGT-/- vs. 
1508±118 WT p<0.05), and complex II activity was slightly, but 
significantly lowered (0.114±0.00024 LMNAGT-/- vs. 0.122±0.007 WT 
p<0.01). These observations show the LMNAGT-/- mice become severely 
catabolic in the 3rd week post partum, without apparent abnormal 
mitochondrial function.  
Discussion 
Lamin A/C expression is developmentally regulated and has been 
specifically linked to early mesenchymal commitment 4-6. Little is known, 
however, about the effect of A-type lamins in embryonic and early post-
natal development. We have generated a novel LMNAGT-/- mouse model 
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and demonstrate that loss of A-type lamins results in defective post-
natal differentiation and defective maturation of adipose-, cardiac- and 
skeletal muscle tissue.  
 
For many essential organs in mice, differentiation and maturation start 
during embryonic development and continues throughout early post-
natal development 21-23. Immunohistochemical studies revealed a diffuse 
lamin A/C protein staining in connective tissue and myoblasts at E11.0 4-
5. 5. Lamin A/C protein levels increase until day E14.0 and lamin A/C 
protein was only detected in a few more tissues during embryonic 
development from this age onwards. Lamin A/C was reported to be 
absent in epithelia of lung, liver, kidney, intestine, heart and brain until 
well after birth. Using a β-galactosidase reporter gene  in our LMNAGT-/- 
mouse model we here report LMNA promoter activation, coinciding with 
the onset of tissue differentiation (E11.0) in somites, heart, liver and 
intestines and widespread LMNA expression by the end of in utero 
development (E18.0). In good agreement, promoter activity of the lamin 
A processing enzyme Zmpste24 in a GT mouse model partially mirrors 
the LMNA promoter activity described here 16. It is conceivable that 
previous immunohistochemical studies may have been limited in their 
sensitivity and specificity toward e.g. potential embryonic LMNA splicing 
variants. The detection of LMNA promoter activity from the earliest 
stages of tissue differentiation onward supports the importance of lamin 
A/C in tissue differentiation and maturation. Although we cannot 
formally exclude discordant mRNA and protein synthesis , e.g. as a result 
of pre-/posttranslational regulation, our findings suggest that lamin A/C 
is expressed earlier than previously reported.   
 
Despite apparently morphologically normal overall fetal development, 
the consequences of loss of lamin A/C becomes aparent during early 
post-natal development. By and large, post partum development in the 
absence of LMNA reveals no gross phenotypical abnormalities from PP1 
until PP6. The growth of LMNAGT-/- mice is retarded from PP7 to PP12 
compared to WT and LMNAGT+/- siblings. We observe a prominent 
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abnormal post-natal cardiac development in LMNAGT-/- mice: whereas 
normal LV myocytes undergo post-natal hypertrophy upon cell cycle exit 
in the first week after birth 21, 24, cardiac hypertrophy is severely 
impaired in LMNAGT-/- mice. The comparable post partum decrease in 
cardiac proliferative activity (PCNA, Ki67) between WT and LMNAGT-/- 
siblings suggests altered hypertrophy is not caused by an inability of 
myocytes to exit the cell cycle. Instead, elevated expression of the 
hypertrophic markers ANF and BNP, suggests that pro-hypertrophic 
signaling is increased in the absence of productive physiological cardiac 
hypertrophy. Finally, overall body growth ceases between PP13 and 
PP18 and BW decreases in LMNAGT-/- mice. During this stage, skeletal 
muscle display hypotrophy and a prominent catabolic phenotype is 
manisfested, with reduced blood glucose (PP16), absent hepatic 
glycogen storage (PP18) and increased utilization of alternative energy 
sources (ketone bodies, FFA and muscle tissue; PP15-16). Although the 
direct cause of death is currently not clear, it most likely relates to a 
combination of muscle weakness and metabolic complications. Cardiac 
function appears not sufficiently impaired to explain premature death at 
this stage, but  we cannot exclude the possibility that the short life-span 
of these mice prevents further development of cardiac malfunction. 
Decreased heart rate and core body temperature are typical side effects 
of a catabolic state. Both parameters decline in human anorexia nervosa 
patients as does blood pressure 25. Progressive lowering of blood 
pressure and heart rate further deteriorates the condition during 
starvation 26. This notion also provides an explanation for the 
detrimental effects of labetalol in LMNAGT-/- mice, which furthermore 
demonstrates that in the end-stage increased sympathetic activity 
prolongs survival to some extent, possible by its effects on overall 
metabolism. Although it is unclear at this stage whether muscular 
wasting contributes to the abnormal metabolic state of LMNAGT-/- mice, 
the impaired adipogenic capacity upon loss of lamin A/C provides a 
direct etiological connection to the defective energy metabolism.  
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The LMNAGT-/- mouse complements previously established LMNA murine 
models. Using a conventional gene targeting strategy, Stewart and 
colleagues created a functional LMNA knock-out mouse (LMNAKO-/-) 
which displays growth retardation starting 2-3 weeks post partum, 
followed by skeletal abnormalities, decreased subcutaneous adipose 
deposits, cardiac dilatation and, ultimately at 6-8 weeks post partum, 
life-threatening impaired cardiac function 27-29. Considering the onset 
and progression of these symptoms over time, the overall phenotype of 
the LMNAKO-/- animals is comparatively milder than that of LMNAGT-/- 
mice. A possible explanation for the hypomorphic phenotype in LMNAKO-
/- mice is the difference in targeting strategy between the models. In the 
contrast to the LMNAGT-/- mouse, where a GT sequence is introduced at 
the LMNA’s second intron, in the LMNAKO-/- mouse the LMNA gene is 
disrupted in exon 8.  Northern blot analysis revealed expression of faster 
migrating LMNA mRNAs, possibly indicative of truncated but potentially 
functional N-terminal LMNA gene products in LMNAKO-/- mice 29. In the 
LMNAGT-/- mouse no partial LMNA splicing products were detected at the 
mRNA level besides the LMNA-β-geo fusion protein. This synthetic gene-
product does not induce obvious phenotypic defects as LMNAGT+/- mice 
were  phenotypically indistinguishable from WT mice in all tested assays. 
Interestingly, the use of genetrap approaches was associated with more 
dramatic phenotypes compared to conventional gene targeting 
strategies including the lamin A processing enzyme Zmpste24 loss-of 
function mouse models 16, 30. Besides the targeting strategy, phenotypes 
may be affected by genetic background, as identical mutated LMNA gene 
products give rise to different laminopathies in humans 31. In comparison 
to other LMNA mutant mice, lethality in the LMNAGT-/- model occurs 
much earlier, and, notably, in the absence of cardiac functional defects 
and HGPS related bone abnormalities and hair loss 13. Cardiac 
hypertropic defects may not have had sufficient time to progress to 
heart failure in our model, as other tissue defects dominate during post-
natal development.  
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The combined observations presented here show that the LMNAGT-/- 
mouse model is the most severe lamin A/C mouse model to date and, 
relevantly, our results show that loss of lamin A/C induces severe and 
widespread defects in post-natal tissue maturation. This leads to an early 
post-natal and fully penetrant lethal phenotype, which is conceivably 
due to combined muscle weakness and metabolic complications, and 
occurs in the absence of a dilated cardiomyopathy or obvious progeroid 
phenotype. This novel LMNA mouse provides new opportunities to 
dissect the molecular and cellular mechanisms underlying the role of 
lamin A/C in early post-natal development. 
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Supplemental Figures 
 
Figure S1. Cardiac effects of α- and β-adrenergic receptor antagonist treatment in LMNAGT mice. (A) 
Labetalol inhibits sympatic? activity by antagonizing α- and β-adrenergic receptors, thereby suppressing 
sympatic? stimulation of heart rate and vasoconstriction. Arrows and T-shaped ends indicate respectively 
stimulatory and inhibitory actions. (B) ECG analysis indicating heart rate ,P time, QRS duration and QT time 3 
days after the start of subcutaneous labetalol or control injections in all genotypes (See Materials & 
Methods). Asterisks in this figure indicate significant (P<0.05; n=5) differences between labetalol and control 
injections within the same genotype. (C) Survival curve for LMNAGT-/- mice treated from PP10 onward with 
labetalol or control injections (dashed lines) versus survival curves for labetalol treated LMNAGT+/- and WT 
siblings (straight lines).  
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Figure S2. Post-natal hepatic glycogen storage in LMNAGT-/- mice. Formalin fixed liver 
sections were Periodic Acid Shiff (PAS) stained to visualize glycogen deposits in a light 
purple/pink color. LMNAGT-/- mice show absence of glycogen deposits at all ages 
investigated, whereasin WT and LMNAGT+/-  livers glycogen is detectable at day PP18.  
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Figure S3. Mitochondrial morphology and functioning in LMNAGT-/- mice. (A) Transmission Electron 
Microscopy pictures of left ventricle cardiac tissue at day PP15 WT and LMNAGT-/- mice, showing cardiac 
muscle fiber and Z-disc orientation, and (in close-up) a typical example of a mitochondrion. (B) Mitochondrial 
DNA copy numbers in both quadriceps skeletal and cardiac muscle as determined at PP15 by RT-PCR. 
Asterisks indicate significant differences for WT and LMNAGT-/-values (P <0.05). 
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A-type lamins define the nuclear lamina and are key architectural proteins 
of the cell nucleus involved in various nuclear processes including 
transcription, DNA replication, DNA repair and cell signaling.1 Mutations in 
the LMNA gene, encoding for A-type lamins A and C, are associated with 11 
different diseases including muscular dystrophies, lipodystrophies, 
neuropathies and premature aging syndromes.2 The phenotypic diversity 
amongst these diseases, referred to as laminopathies, is hypothesized to be 
caused by mutation specific changes in lamin A protein- and chromatin 
interactions. Technological limitations hamper obtaining experimental 
evidence for a direct interaction of lamin A with chromatin in vivo, as well as 
mapping lamin A protein interactors in a proteome wide fashion. In this 
thesis novel techniques have been implemented to map lamin A-protein and 
-chromatin interactions in an unbiased approach, to identify differences in 
these interactomes for a progeria associated lamin A mutant and to study 
the biological relevance of LMNA mutations in the context of chromatin 
organization and early postnatal differentiation.  
Lamin A protein- and chromatin-interactions 
Experimental approaches to identify lamin interactors are severely 
hampered by the biochemical properties of the nuclear lamina, classically 
defined as a non-ionic detergent, salt and nuclease insoluble peripheral 
nuclear structure3 (See Chapter 2). This insoluble character impedes 
immunoprecipitation (IP) studies, as solubilization by high concentrations of 
detergents disrupts protein- and chromatin interactions and hampers 
antigen-epitope binding. Alternative assays that do not depend on 
solubilization of intact complexes have been used instead, but suffer from 
specific drawbacks including low recovery, high false positives and non-
physiological conditions (Chapter 2). We therefore developed and applied a 
novel approach to identify lamin A-interacting proteins and chromatin. To 
map the full spectrum of both types of interactors we tagged lamin A with 
the biotin resembling OneSTrEP (OST) tag and expressed  OST-tagged lamin 
A (OST-A) at endogenous levels in murine cells (Chapter 3 and 4). OST-A 
recapitulated endogenous lamin A in terms of prelamin A processing, 
subnuclear localization, attachment of Emerin to the nuclear envelope (NE) 
and cell proliferative effects (Chapter 3 and 4). A mild cross-linking prior to 
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OST precipitation enabled full solubilization and isolation of intact lamin A 
bound protein- and chromatin complexes. Although cross-linking is already 
commonly applied in chromatin immunoprecipitations (ChIP), it’s 
combination with mass spectrometry (MS) is more recent4 and limited due 
to the enormous complexity of cross-linking reaction mixtures.5 To 
circumvent cross-linking induced artifacts we reverted cross-linking by 
extensive heating prior to analysis by mass spectrometry (MS; for protein 
interactions) or microarray technology (for DNA interactions). By OST 
pulldown we identified a total of 225 lamin A interacting proteins (Chapter 
2) and 782 lamin A associated genes (Chapter 3). 
 
We probed for the reliability of MS identified protein interactors by verifying 
several lamin A interactions with OST pulldown and western blot, including 
Ku70 and Trim28, two previously unknown interactors that were just above 
the cut-off of our stringent inclusion criteria. Both proteins interacted 
weakly but significantly with lamin A (Chapter 3). In addition, a comparative 
analysis with published data6-7 confirmed that our method reproducibly and 
reliably co-purified lamin A protein interactors. Half of the identified lamin A 
interactors were previously identified as NE components6-7 and their gene 
ontology (GO) signature highly resembles those of the NE proteome, 
including functions in NE structural organization, chromatin assembly and 
nuclear cytoplasmic transport via the nuclear pore complex (NPC) (Chapter 
3). Observed GO differences with studies that biochemically purify and 
extract the NE, includes detection of interactions that are predicted to be 
short-lived (Zmpste24, proteasomes), as well as interactors involved in 
protein folding, processing and vesicle trafficking (Chapter 3). These 
differences are expected to occur due to preservation of temporal 
interactions by cross-linking and precipitation of the total lamin A pool by 
OST pulldown, including endoplasmic reticulum (ER) localized partially 
unfolded or unprocessed lamin A. In addition, ER localized proteins can as 
well diffuse to the continuous INM and anchor to the lamina.8 OST pulldown 
technology was furthermore used to confirm yeast two-hybrid (Y2H) 
(Chapter 2) discovered novel interactions of the lamin A carboxy-terminus 
(amino acids 562-664) with Rbbp4, Rbbp7 and HDAC1, all members of the 
nucleosome remodeling and deacetylase (NURD) complex (Chapter 5). 
Rbbp4 is also a subunit of the CAF-1 complex, which assembles chromatin 
during DNA replication and DNA damage repair9, and together with Rbbp7 
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part of the Polycomb PRC2 complex.10 The NURD, CAF-1 and PRC2 complex 
are all involved in establishment of heterochromatin.9-12 Trim28 is 
associated with the Polycomb PRC1 complex (unpublished data) and 
involved in similar processes.13-14 Together with the observations that the 
nuclear periphery mostly contains heterochromatin and various LMNA 
mutations are associated with heterochromatin defects and DNA damage15-
16, these findings suggest that A-type lamins are crucial in maintaining 
higher-order chromatin organization. 
 
In line with this, we identified in total 782 gene promoters that directly 
interact with lamin A by OST pulldown (Chapter 4). All examined lamin A 
targets preferentially localize at the nuclear periphery compared to non-
targets, are genomically clustered and transcriptionally silenced (Chapter 4). 
Consistent with this, GO analysis revealed that lamin A-associated genes are 
typically involved in highly specified biological pathways, including the 
perception of smell and defensive responses to bacteria. Most likely 
proteins of both pathways, typically expressed by neurons and neutrophils 
respectively17-18, are not functional in fibroblast and cardiac myocytes used 
in our screen and hence expected to be transcriptionally silent. The 
presence of over 42 tissue and cell type specific transcription factor binding 
motifs (TFMs) in lamin A associated gene promoters further supports this 
notion (Chapter 4). Our findings are in keeping with DamID (Chapter 2) 
detected lamin B/gene interactions, which revealed sharply defined lamin-
associated domains (LADs) across the genome19, typically gene poor and low 
expressed regions, yet containing cell-type specific silenced gene clusters as 
well.20 To determine how crucial A-type lamin chromatin interaction is in 
peripheral positioning and regulation of gene expression, we monitored 
spatial positioning and gene expression upon RNAi-mediated knock-down of 
lamin A/C (Chapter 4). Upon lamin depletion target loci relocalize 
substantially to the nuclear interior, yet remain more frequently localized at 
the NE compared to non-targets. These findings were confirmed in a 
reversed approach,  lamin A overexpression in LMNA knock-out (KO) MEFs, 
which showed increased peripheral localization for several lamin targets 
(Chapter 4). This supports a facilitating role for A-type lamins in recruitment 
of silenced genes to the nuclear periphery. Interactions with additional 
chromatin interacting nuclear lamina proteins, like emerin and Lamin B, 
contribute to this functional nuclear organization.19, 21 Unchanged global 
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expression levels for lamin A targets in a LMNA loss-of-function model, the 
lamin A gene trap (LMNAGT-/-) mouse (Chapter 6), argues that an escape 
from the repressive NE environment per se is not sufficient for gene 
activation. Most likely, loss of lamina-association is one of the multiple steps 
towards gene activation. Consistent with this, the CFTR locus’ relocation due 
to activation and consequent internalization of neighboring genes by itself is 
insufficient for CFTR activation.22-23 For the olfactory receptor lamin A 
targets many additional steps necessary for stochastic activation have been 
described as well.18       
Progeria related changes in protein- and chromatin-interactions 
Hutchinson-Gilford Progeria Syndrome (HGPS) is a premature ageing disease 
hallmarked by global changes in chromatin, including loss of 
heterochromatin structure, altered patterns of histone modification, loss of 
key heterochromatic proteins and increased levels of persistent DNA 
damage.15-16, 24-25 To elucidate the molecular mechanisms leading to 
Hutchinson-Gilford Progeria Syndrome (HGPS) we compared protein- and 
chromatin-interactions for lamin A and progerin, an HGPS causing lamin A 
mutant lacking 50 amino acids near the carboxy-terminus. OST tagged 
progerin recapitulated HGPS characteristic distortions of the nuclear lamina 
and global loss of LAP2 and HP1γ nuclear levels16 (Chapter 3 and 4). 
 
Of the identified 150 lamin A and 170 progerin interactors in MEFs, 35 
proteins either had an increased affinity for lamin A (8 targets) or progerin 
(26 targets). These preferential interactors included proteins with GTPase 
activity and were involved in RNA metabolism or nucleocytoplasmic 
transport, including several NPC members (Nup98, Nup153, Tpr). Nup153 
anchors NPCs to the nuclear lamina26-27 and directly interacts with Tpr, 
which is involved in formation of NPC associated heterochromatin exclusion 
zones.28 A diminished interaction between progerin and Nup153 could 
explain a loss of NPC anchoring to the nuclear lamina 26, subsequent NPC 
clustering and defective NPC mediated nuclear import, all associated with 
HGPS.27, 29-30 We also detected an increased interaction of progerin with 
paired related homeobox1 (Prx1), a transcriptional co-activator involved in 
skeletogenesis and vasculogenesis.31-32 Prx1 induces vascular smooth muscle 
cell proliferation and extracellular matrix (ECM) modeling by direct 
184 | Chapter 7 
 
upregulation of tenascin C expression.31-32 Loss of Prx1 manifests itself in 
vertebrae and craniofacial skeletal defects, including absence of the 
mandible’s zygomatic arches.32 These phenotypes highly resemble defects 
observed in progeria related mouse models, which suffer from osteogenesis 
imperfecta related fractures in vertebrae and mandible’s zygomatic arch33 
as well as tenascin C mediated progressive loss of vascular smooth muscle 
cells and ECM composition changes.34-35 Due to the mapping of protein 
interactions (Chapter 3) many more candidates potentially involved in HGPS 
aetiology are on the shelve and await confirmation and further 
investigation. An interesting candidate would be proliferating cellular 
nuclear antigen (Pcna). Pcna regulates initiation of genomic DNA replication, 
which is hypothesized to be disturbed in HGPS by trapping of Pcna in 
intranuclear lamin aggregates, thereby contributing to premature ageing 
associated DNA damage.24, 36 This hypothesis is in line with the increased 
interaction of Pcna with progerin observed by OST pulldown (Chapter 3). 
 
In a second approach to identify a molecular basis for premature aging-
associated chromatin defects, we probed for progerin interaction of the Y2H 
identified and OST pulldown confirmed novel lamin A interactors Rbbp4 and 
Rbbp7 (Chapter 5). For the Y2H assay a carboxy terminal lamin A fragment 
(amino acids 562-664) was used that includes the 50 amino acids deleted in 
progerin (amino acids 607-657). Both NURD complex subunits interacted 
with lamin A but not with progerin, and showed reduced protein levels 
during normal and premature ageing (Chapter 5). This loss occurred in the 
same cells that showed HGPS characteristic global chromatin defects, 
including HP1 loss, loss of H3K9 tri-methylation15-16, increased transcription 
of pericentromeric satellite III repeats37 and increased levels of 
phosphorylated H2AX25, indicative of DNA double strand breaks (Chapter 5). 
A global loss of NURD components preceded the occurrence of persistent 
DNA damage. RNAi-mediated knock-down of both Rbbp4 and Rbbp7 was 
sufficient to recapitulate these HGPS chromatin defects. Other subunits of 
the NURD complex were also downregulated in old individuals and HGPS 
patients and a knock-down of several of these subunits caused HGPS-
associated chromatin defects as well. These findings demonstrate how loss 
of several NURD components occurs during premature and normal ageing 
and contributes to structural chromatin defects ultimately leading up to the 
accumulation of DNA damage. The observed DNA damage might be a 
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consequence of increased susceptibility of the affected chromatin to 
damage or, alternatively, might be caused by impaired DNA replication.38  
 
To probe for other mechanisms through which progerin can affect 
chromatin organization we compared direct chromatin interactions for 
lamin A and progerin (Chapter 4). By OST-pulldown we identified 3 
subclasses of chromatin interactors: those that interact with both lamin A 
and progerin (common targets) and those interacting with only lamin A or 
progerin (differential targets). We identified several characteristics that 
distinguish these groups. Differentially interacting genes were least involved 
in cell-type specific biological processes and not enriched for any 
transcription factor binding motif, in contrast to common targets (Chapter 
4). Furthermore, lamin A/progerin commonly bound genes colocalized more 
frequently at the nuclear lamina, and this positioning was significantly less 
affected by addition of lamin A or progerin in comparison to differential 
interactors. Finally, genome-wide expression profiles show that, regardless 
of the presence of progerin, expression levels of common targets are lower 
than for genes that bind either lamin A or progerin. Unique interactors are 
still lower expressed compared to random genes though (Chapter 4). Overall 
this suggests that common targets are kept silent at the nuclear lamina, 
whereas differential interactors partially escape laminar interactions and are 
less likely to be influenced by repressive capacities. The observation that, in 
the absence of progerin, lamin A uniquely associated genes show 
significantly less expression then progerin uniquely interacting targets, 
which in this state do not interact with the lamina, further corroborates this 
notion. Introduction of progerin in LMNAKO-/- MEFs increased the peripheral 
position of several progerin unique targets. Upon the introduction of 
progerin induced changes in chromatin organization and spatial positioning 
were insufficient to change expression levels of common or unique targets 
in wild-type MEFs. Most likely the absence of such effects is due to the 
presence of endogenous A-type lamins which partially counteract 
internalization of unique lamin A interactors and repositioning towards the 
nuclear rim for progerin unique targets. In line with this, spatial 
repositioning effects in wild-type MEFs were much less pronounced 
compared to LMNAKO-/- MEFs (Chapter 4). A second factor contributing, as 
mentioned before, is the lack of additional factors needed for gene 
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activation, which have been demonstrated to change gene interactions for 
B-type lamins21 and induce expression of cell-type specific gene clusters.20  
Biological relevance of A-type lamins in postnatal tissue 
differentiation  
The revealed interaction of the nuclear lamina with highly specialized and 
cell-type specific silenced genes (Chapter 4)  and with cell-fate regulating 
chromatin remodeling proteins (NURD39, Trim2840; Chapter 3 and 5) 
suggests a role for A-type lamins in cell differentiation. This notion is further 
corroborated by the finding that lamin A/C expression is absent during 
embryonic development until the onset of tissue differentiation and 
maturation41-42 and in stem cells lamin A is only expressed after 
differentiation induced loss of pluripotency43. Furthermore, several LMNA 
mutations interfere with adipogenic and osteogenic differentiation.44-45 In 
order to determine the biological relevance for A-type lamins in 
differentiation we developed and used a novel LMNA gene trap (LMNAGT-/-) 
mouse model for LMNA loss-of-function (Chapter 6) in studying tissue 
differentiation defects during early postnatal development.  
 
The gene trap enabled us to detect LMNA promoter activity during 
embryonic development by β-galactosidase staining. LMNA was strongly 
stained for near the beginning of embryonic tissue differentiation (E11.0) in 
somites, heart, liver and intestines (Chapter 6). At the end of intra-uterine 
development (E18.0) LMNA promoter activity was macroscopically visible in 
all tissues. The detection of LMNA promoter activity from the very early 
beginning of tissue differentiation onward supports the importance of lamin 
A/C in tissue differentiation and maturation. Our findings are in contrast to 
previous studies, which are unable to detect lamin A/C protein in many 
tissues until well after birth by immunohistochemistry (IHC).41-42 Although 
we can’t strictly exclude a discrepancy between mRNA production and 
protein expression (e.g. pre-/posttranslational regulation), the data 
presented here suggest that reported IHC studies may have been hampered 
by relative insensitivity of antisera used, or inability to detect potential 
embryonic LMNA splicing variants. In support of our observations, promoter  
activity of the lamin A processing enzyme Zmpste24 in a GT mouse model 
resembles the LMNA promoter described in Chapter 6.46  
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Table 1. LMNA mouse models 
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LMNAGT-/- Day 16-18 Day 7 N Y N N N Y ? N N N Y N Y N Y 
LMNA L530P KI* 2½-6 weeks Day 5-10 N Y Y ? N Y ? Y Y ? N Y ? Y Y 
Progerin KI ** 3-4 weeks ? ? ? ? ? ? N ? Y Y ? N Y ? Y Y 
LMNAKO-/- 6-8 weeks 2-3 weeks Y Y Y Y Y Y ? N N ? N Y Y N Y 
LMNA N195K KI 2½-4 months 4 weeks Y N Y Y Y Y ? ? ? ? N N ? ? ? 
Zmpste24GT-/- 2-7 months 4-5 weeks Y N Y ? ? Y ? Y Y Y N Y ? Y Y 
Zmpste24KO-/- 6-7 months 3 weeks N N N ? ? Y ? Y Y N Y N N Y Y 
LMNA H222P KI 4-13 months ? Y N Y Y Y Y ? ? ? ? N N Y ? ? 
Progerin TG Unaffected Unaffected N N N ? ? N Y N N ? N N ? N N 
Legend: Y= Defect is present, N=Defect is absent, ?=It is not reported whether defect is 
present, KO=knock-out, KI=knock-in, TG=Transgene, GT=Gene trap; * LMNA transcripts lack 
either exon 9 or 9-12 due to a splicing anomaly. Lamin C absent, lamin A reduced levels;**  
Transgenic allele only produces progerin, no lamin A or C 
 
Though no morphological defects were observed during embryonic 
development, the more pronounced the effect of loss of lamin A/C became 
manifest during early postnatal development. LMNAGT-/- mice uniformly died 
within 3 weeks after birth with clear adipose, cardiac and skeletal muscle 
tissue defects (Chapter 6). Cardiac myocyte hypertrophy was impaired 
despite increased expression of hypertrophic markers. No cardiac functional 
defects were observed(Chapter 6). The increased expression of hypertrophy 
markers, which do not induce but mainly signify cardiac hypertrophy47, 
suggests that pro-hypertrophic signaling pathways may be increased in an 
attempt to induce the desired physiological hypertrophy. Skeletal muscles 
were hypotrophic and in addition LMNAGT-/- mice displayed an impaired 
body growth, decreased subcutaneous adipose tissue and a catabolic blood 
profile several days before the occurrence of death. Metabolic defects can 
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in part be explained due to a reduced adipogenic capacity, as adipogenic 
differentiation was found to be impaired in vitro (Chapter 6). This is in line 
with LMNA mutations affecting adipogenic differentiation.44-45 It remains 
unclear whether observed muscle wasting contributes to the abnormal 
metabolic state of LMNAGT-/- mice. Although an exact cause of death could 
not be pinpointed, death is likely due to a combination of muscle weakness 
and metabolic complications. 
 
Observed tissue differentiation and maturation defects of the LMNAGT-/- 
mouse complement previously established LMNA  murine models (Table 1). 
Stewart and colleagues created a functional LMNA knock-out (LMNAKO-/-) 
mouse5-7 which displays growth retardation starting 2-3 weeks post partum, 
followed in time by skeletal abnormalities, decreased subcutaneous adipose 
deposits, cardiac dilatation and ultimately at 6-8 weeks post partum life-
threatening impaired cardiac functioning5-7 (See Table 1). This phenotype is 
comparatively milder then for the LMNAGT-/- mice considering onset and 
progression of symptoms over time (Chapter 6). A potential explanation for 
this discrepancy could be the place at which the LMNA gene was genetically 
modified. In LMNAGT-/- mouse a GT sequence is introduced after lamin A’s 
first exon, while the LMNA gene is targeted at the 3’ end in the LMNAKO-/- 
mouse. The latter is more likely to permit expression of shorter but 
potentially functional partial LMNA products from the 5’ end of the gene. 
Northern blot assays indeed showed faster migrating 10-fold lower 
expressed LMNA mRNA products in LMNAKO-/- mice7. No shortened LMNA 
products were detected however at protein level7, possibly due to the 
absence of an AB recognizable epitope. Interestingly, the use of GT 
sequences has been reported to cause more drastic phenotypes compared 
to conventional gene targeting strategies in Zmpste24 loss-of function 
mouse models as well3, 9 (Table 1). Besides the chosen gene targeting 
strategy, phenotypes might be prone to differences in genetic background, 
as identical LMNA amino acid changes have been reported to give rise to 
different laminopathies in humans.14 The phenotype of the LMNAGT-/- mouse 
differs from existing dominant negative LMNA models,  by a much earlier 
time at which lethality occurs and by the absence of cardiac functional 
defects and progeria related bone abnormalities and hair loss (Table 1). The 
absence of ageing related derangements can be explained by the fact that 
these are especially caused by dominant gain-of-function lamin A mutants, 
General discussion | 189 
 
like progerin15 and the L530P mutation induced aberrant splicing products2, 
while the LMNAGT-/- is a loss-of-function model system.  
Future research directions 
Many questions regarding the molecular mechanisms behind HGPS and 
other laminopathies still remain unanswered. For example, it is unknown 
which mechanisms are involved in the loss of proteins from the NURD 
complex and how altered chromatin modifications result in persistent DNA 
damage. The involvement of a specific pathway in loss of NURD complex 
members is suggested by the fact that progerin affects protein levels of 
several subunits of the NURD complex, but not of the other complexes, such 
as the CAF-1 or PRC2, that also contain Rbbp4 and Rbbp7. Increased DNA 
damage might simply be a consequence of increased susceptibility due to 
globally affected chromatin structure, or be caused by specific nuclear 
processes like DNA replication as elsewhere postulated.16 An experimental 
approach to identify common pathways involved in HGPS related loss of 
NURD components and DNA damage, is to identify and compare protein 
interactomes for several HGPS related mutations and define common 
derangements compared to wild-type lamin A. Such an approach assumes 
that defective lamin-protein interactions are the basis for HGPS aetiology.  
An even more unbiased way to define primary molecular defects in HGPS 
aetiology is to detect targets whose knock-down can rescue an HGPS 
phenotype. Developing a fluorescent HGPS-phenotype read-out enables 
pursuing this goal by high-throughput genome-wide RNAi screening 
combined with automized fluorescent microscopy .   
 
In the context of protein- and chromatin-interactions an interesting 
question to address, is whether the presence of progerin also does affect 
the interactomes of wild-type lamin A or simply exerts dominant negative 
effects by interacting itself with different proteins and chromatin regions. In 
addition, it remains elusive to which regions outside of gene promoters A-
type lamins interact. Upgrading OST pulldown studies by novel ChIP 
sequencing technology and comparing OST-lamin A interactomes in the 
absence and presence of untagged progerin can provide answers herein. 
The relevance of changes in chromatin interactions in the context of gene 
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expression can further be studied in differentiation models that possess 
relevant sequential factors necessary for gene activation. A long term 
exciting  project would be to compare protein- and chromatin-interactions 
between various tissues and disease stages by creating a OST-A knock-in 
mouse, especially relevant as laminopathies are highly tissue-specific and NE 
proteomes vary drastically amongst tissues.17  
 Conclusions 
The research in this thesis has started to unravel the role of A-type lamins 
and the effect of LMNA mutations in the context of disruption of protein- or 
chromatin interactions, chromatin organization and early postnatal tissue 
differentiation. Combined, our findings demonstrate that A-type lamins are 
important for chromatin organization by directly interacting with chromatin, 
thereby facilitating a peripheral localization of highly cell-type specific 
silenced genes (Chapter 4). We expect these interactions to be part of a 
transcriptional memory system for differentiation specific gene programs, as 
has been described for B-type lamins18-19. Adipogenic, skeletal- an cardiac 
muscle tissue early postnatal differentiation and maturation defects upon 
loss of A-type lamins are in line with this (Chapter 6). An HGPS causing 
LMNA mutation specifically modifies chromatin- and protein-interactions 
(Chapter 3 and 5) and thereby contributes to aging-related disruption of 
NPC organization (Chapter 3), heterochromatin defects and DNA damage 
(Chapter 5). Our findings herein provide a relevant basis for ongoing 
research determining defective pathways that precede and are caused by 
observed chromatin defects. Furthermore, the molecular toolbox developed 
within this thesis can be used to systematically map chromatin- and protein 
interactions for various LMNA mutations in order to identify novel disease 
mechanisms and, in time, develop possible cures for various laminopathies.  
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The nuclear periphery is marked by  the nuclear envelope (NE), which is 
composed of an outer and inner nuclear membrane (ONM, INM, 
respectively) interrupted by nuclear pore complexes (NPC). The nuclear 
lamina lines the NE and consists amongst others of the intermediate 
filament  A-type (Lamin A, C) and B-type lamins (Lamin B1, B2), INM proteins 
anchoring the lamina to the NE and proteins interacting with chromatin and 
modifying its structure. Mutations in A type lamins, encoded by the LMNA 
gene, cause several human diseases collectively referred to as 
laminopathies , which include several types of muscular dystrophies, 
lipodystrophies, cardiomyopathies, neurological disorders and premature 
aging syndromes. At the basis for this thesis lies the major enigma how 
mutations in one gene can cause so much phenotypic diversity (Chapter 1). 
The working hypothesis of this thesis is that LMNA mutations affect specific 
lamina protein- and chromatin-interactions, thereby giving rise to 
laminopathy specific defects.  
 
Chapter 2 describes the most commonly used tools to study lamina protein- 
and chromatin interactions and discusses the advantages and disadvantages 
inherent to each method. At the beginning of this thesis’ research, in vivo 
interactions of A-type lamins with chromatin were hypothesized yet 
remained to be experimentally proven, and methodologies to identify 
protein interactions were severely hampered  by the salt- and detergent-
insoluble properties of the nuclear lamina. These biochemical properties 
forced researchers to make a trade-off between the degree of solubilization 
of lamina proteins and the amount of interactions potentially disrupted by 
used lysis conditions. Alternative assays circumventing this technical 
problem each have their specific drawbacks. In order to overcome 
limitations of available methods we developed a novel approach, the 
OneSTrEP (OST) pulldown, to study protein- and chromatin-interactions in a 
unbiased proteome- and genome-wide fashion. This technique consists of 
expressing lamin A tagged by a biotin resembling OST epitope, high affinity 
precipitation of fully solubilized but intact OST-lamin A complexes, and 
subsequent analysis of the isolated complexes for protein by mass 
spectrometry (MS) and for DNA by array technology. 
 
We used this approach to identify proteins that interact with lamin A and its 
mutant isoform progerin, which causes the premature aging disorder 
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Hutchinson-Gilford Progeria Syndrome (HGPS) (Chapter 3). We identified 
150 lamin A and 170 progerin-interacting proteins, including novel lamina 
interactors. Lamin A interactors are preferentially involved in NE structural 
organization, chromatin assembly and nuclear cytoplasmic transport via the 
NPC. Of the lamin A and progerin interactors 35 proteins preferentially 
bound to either lamin A or progerin. These differential interactors included 
several transcription factors, proteins with GTPase activity, and proteins 
involved  RNA metabolism or nucleocytoplasmic transport, including several 
NPC members. The global identification of novel lamin A and progerin 
interactors  has generated several leads for studies of specific interaction 
partners of lamin A and its mutants with the goal of uncovering the 
molecular mechanisms of tissue-specific laminopathies. 
 
Next, we mapped genome-wide chromatin interactions of  A-type lamins 
and identified 595 lamin A- and 552 progerin-associated gene promoters 
(Chapter 4). We find that lamin A preferentially binds peripherally localized, 
silent genes. This association facilitates, but does not determine, peripheral 
localization and loss of the interaction is not sufficient for gene activation. 
Further analysis identified multiple classes of common or uniquely lamin A- 
or progerin-associated genes. Basal expression of the unique categories 
correlates to their relative subnuclear location. Changes in subnuclear 
position upon introduction of progerin are insufficient to change  basal 
expression levels. These observations demonstrate that lamin A and 
progerin differently directly affect chromatin-lamina organization and that 
loss of peripheral localization and lamin association of endogenous gene loci 
is insufficient for their activation.  
 
In order to identify a molecular basis for premature ageing characteristic 
defects in chromatin structure and accumulation of persistent DNA damage, 
we performed a yeast two-hybrid screen to identify differential lamin 
A/progerin interactors (Chapter 5). The nucleosome remodeling and 
deacetylase (NURD) complex subunits Rbbp4 and Rbbp7 were found to 
interact with lamin A, but not with progerin, and showed reduced protein 
levels during normal and premature ageing. Furthermore, the activity of 
histone deacetylase 1 (HDAC1), another component of the NURD complex, 
was reduced with aging. Silencing of individual NURD subunits recapitulated 
aging associated chromatin defects, which preceded the occurrence of 
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persistent DNA damage. These findings demonstrate that loss of several 
NURD components occurs during premature and normal ageing and 
contributes to structural chromatin defects ultimately leading up to the 
accumulation of DNA damage. 
 
Next, we probed for the biological relevance of A-type lamins in early post-
natal tissue differentiation and maturation, relevant as LMNA expression is 
reversely correlated to the degree of differentiation and several LMNA 
mutations induce differentiation defects. To this end, we created a novel 
LMNA gene trap (LMNAGT-/-) mouse model which combines loss of LMNA 
function with LMNA-controlled reporter gene expression (Chapter 6). We 
demonstrate early activity of the LMNA promoter during the beginning of 
embryonic tissue differentiation in heart, liver and somites. The loss of lamin 
A/C results in growth retardation at 2 weeks post partum, with impaired 
postnatal hypertrophy of cardiac myocytes, skeletal muscle hypotrophy, 
decreased subcutaneous adipose tissue deposits, decreased adipogenic 
differentiation of mouse embryonic fibroblasts and metabolic 
derangements. Ultimately these tissue differentiation and maturation 
defects are lethal before mice are weaned. These results demonstrate that 
lamin A/C is crucial in the early post-natal period and provides novel insights 
into the physiological function of A-type lamins in the context of the 
developing animal. 
 
The significance of the results and their interrelationship are discussed in 
Chapter 7. The research in this thesis has started to unravel the role of lamin 
A and the effect of LMNA mutations in the context of disruption of protein- 
and chromatin interactions, chromatin organization and early postnatal 
tissue differentiation. These findings provide a solid foundation for ongoing 
research to determine disease mechanisms and ultimately potential cures 
for laminopathies.  
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De nucleaire periferie wordt begrensd door de nucleaire envelop, die 
bestaat uit een buitenste en binnenste nucleair membraan, onderbroken 
door nucleaire porie complexen (NPC). De nucleaire lamina liggen aan de 
binnenkant van de nucleaire envelop en bestaan onder andere uit de 
intermediare filamenten A- (lamine A, C) en B-type lamines (lamine B1, B2), 
eiwitten van het binnenste nucleaire membraan die de lamina verankeren in 
de nucleaire envelop, en eiwitten die binden aan chromatine en de 
chromatine structuur modificeren. Mutaties in A-type lamines, geëncodeerd 
door het LMNA gen, veroorzaken verschillende humane ziektes, tezamen 
laminopathieën genoemd, waaronder enkele vormen van spierdystrofie, 
lipodystrofie, cardiomyopathie, neurologische afwijkingen en versnelde 
verouderings syndromen. Ten grondslag aan deze thesis ligt het centrale 
vraagstuk hoe mutaties in één gen zo’n grote phenotypische variëteit 
kunnen veroorzaken (Hoofdstuk 1). De werkhypothese van deze thesis is dat 
LMNA mutaties specifieke eiwit- en chromatine-interacties met de lamina 
beinvloeden, en daardoor laminopathie specifieke defecten worden 
veroorzaakt.  
 
Hoofdstuk 2 beschrijft de meest voorkomende technieken die gebruikt 
worden om eiwit- en chromatine-interacties met de lamina te bestuderen, 
en bediscussiëerd de voor- en nadelen inherent aan elke methode. Aan het 
begin van het onderzoek uit deze thesis werden in vivo interacties van A-
type lamines met chromatine gehypothetiseerd, maar moesten nog 
experimenteel bewezen worden. Methodologieën om eiwit interacties te 
identificeren waren sterk belemmerd door de zout- en detergentia-
onoplosbare eigenschappen van de nucleaire lamina. Deze biochemische 
karakteristieken dwongen onderzoekers om een balans te vinden tussen de 
mate waarin eiwitten van de lamina in oplossing worden gebracht en de 
hoeveelheid interacties die mogelijk onderbroken worden door de gebruikte 
lysis condities. Alternatieve methodes om deze technische problemen te 
omzeilen hebben elk secifieke nadelen. Om de gebreken van bestaande 
methodes te boven te komen, hebben we een nieuwe techniek ontwikkeld, 
de OneSTrEP (OST) pull-down, om eiwit- en chromatine-interacties op een 
onbevooroordeelde manier proteoom en genoom-wijd te kunnen 
bestuderen. Deze techniek bestaat uit het expresseren van lamine A 
gelabeled met een op biotine lijkende OST epitoop, hoge affiniteits 
purificatie van volledig opgeloste maar intacte OST-lamine A complexen, en 
Samenvatting | 201 
 
daarop volgende analyse van geïsoleerde complexen voor eiwitten met 
massa spectrometry en voor DNA met array technologie. 
 
We hebben deze techniek gebruikt om eiwiten die binden aan lamine A en 
progerine, een lamine A mutant die de versnelde verouderings ziekte 
Hutchinson-Gilford Progeria Syndroom (HGPS) veroorzaakt, te identificeren 
(Hoofdstuk 3). We detecteerden 150 lamine A en 170 progerine-bindende 
eiwitten, waaronder nieuw interactors van de nucleaire lamina. Lamine A 
interactors zijn bij voorkeur betrokken in structurele organisatie van de 
nucleaire envelop, chromatine assemblage en nucleair cytoplasmatisch 
transport via de NPC. Van de geïdentificeerde lamine A- en progerine-
bindende eiwitten, binden 35 bij voorkeur danwel lamine A of progerine. 
Deze differentiëel bindende eiwitten bestaan o.a. uit transcriptie factoren, 
eiwitten met GTPase activiteit en eiwitten betrokken bij RNA metabolisme 
of nucleocytoplasmair transport. De identificatie van nieuwe lamine A- en 
progerine-interactors levert verschillende aanknopingspunten op voor 
studies naar specifieke interactie partners van wild-type en mutant lamine 
A, met als doel het ontrafelen van moleculaire mechanismes van weefsel-
specifieke laminopathieën. 
 
Vervolgens hebben we genoom-wijd chromatine interacties van A-type 
lamines gemapt en identificeerden 595 lamine A- en 552 progerine-
geassocieerde gen promoters (Hoofdstuk 4). We hebben vastgesteld dat 
lamine A bij voorkeur perifeer gelocaliseerde, inactieve genen bindt. Deze 
associatie faciliteert, maar is niet bepalend voor perifere localisatie en 
verlies van de binding is onvoldoende voor transcriptionele activatie van 
genen. Verdere analyse leidde tot een onderscheid in gemeenschappelijke 
en unieke lamine A- of progerine-bindende genen. Basale expressie van de 
unieke categorieën correleert met hun relatieve subnucleaire localisatie. 
Deze observaties demonstreren dat lamine A en progerine op directe en 
verschillende wijze chromatine-lamina organisatie beïnvloeden en dat 
verlies van perifere localisatie en lamine-associatie van endogene gen loci 
onvoldoende is voor transcriptionele activatie. 
 
Om de moleculaire basis voor premature verourderingsziekte 
karakteristieke defecten in chromatine structuur en accumulatie van 
persistente DNA schade te identificeren, hebben we een yeast two-hybrid 
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screening uitgevoerd om differentiële lamine A/progerine interactors te 
identificeren (Hoofdstuk 5). Rbbp4 en Rbbp7, onderdelen van het 
chromatine nucleosome remodelerings en deacetylase (NURD) complex, 
binden lamine A, maar niet progerine, en vertonen verlaagde eiwit niveaus 
tijdens normale en premature veroudering. Bovendien is de activiteit van 
histon deacetylase 1 (HDAC1), een andere component van het NURD 
complex, verminderd met veroudering. Inactivatie van verschillende NURD 
complex eiwitten recapituleerde verouderings geassocieerde chromatine 
defecten, die voorafgingen aan het ontstaan van persistente DNA schade. 
Deze bevindingen laten zien dat verlies van diverse NURD complex 
componenten plaatsvindt tijdens premature en normale veroudering  en 
bijdraagt aan structurele chromatine defecten, uiteindelijk leidend tot de 
accumulatie van DNA schade.  
 
Tot slot hebben we de biologische relevantie van A-type lamines in vroege 
postnatale weefsel differentiatie en maturatie onderzocht, relevant omdat 
LMNA expressie omgekeer evenredig is met de mate van differentiatie en 
verschillende LMNA mutaties differentiatie defecten induceren. Met dat 
doel voor ogen hebben we een nieuw ‘LMNA gene trap’ (LMNAGT-/-) 
muismodel gecreëerd, dat het het verlies van LMNA functie combineert met 
een LMNA-gestuurde reporter gen expressie (Hoofdstuk 6). We tonen 
vroege activiteit van de LMNA promoter tijdens het begin van embryonale 
differentiatie in hart, lever en somieten. Het verlies van lamine A/C resuleert 
in groei retardatie 2 weken postnataal, met verzwakte postnatale 
hypertrophy van cardiale mycoyten, skeletspier hypotrofie, verminderde 
subcutane voorraden van adipoos weefsel, verminderde adipogene 
differentiatie van muis embryonale fibroblasten en metabole afwijkingen. 
Het eindresultaat van deze weefsel differentiatie en maturatie defecten is 
letaliteit, nog voordat muizen gespeend zijn. Deze resultaten bewijzen dat 
lamine A/C cruciaal is in de vroege postnatale ontwikkeling en leveren 
nieuwe inzichten in de fysiologische functie van A-type lamines in de context 
van het ontwikkelende dier.   
 
De significantie van de resultaten en hun onderlinge relatie worden 
bediscussiëerd in Hoofdstuk 7. Het onderzoek in deze thesis is begonnen 
met het ontrafelen van de rol van lamine A en de effecten van LMNA 
mutaties in de context van het verbreken van eiwit- en chromatine-
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interacties, chromatine organisatie en vroege postnatale weefsel 
differentiatie. Deze bevindingen leveren een solide fundament voor 
voortgaand onderzoek ter bepaling van ziekte mechanismes en, als ultiem 
doel, mogelijke genezing van laminopathieën. 
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AHCTF1 AT hook containing transcription factor 1
ANF Atrial natriuretic factor  
BAC Bacterial artificial chromosome 
BNP Brain natriuretic peptide 
BPTF Bromodomain and plant homeo domain transcription Factor  
BRN5 Brain-5 
BW Body weight 
CBB Coomassie brilliant blue 
CEAS Cis-regulatory element annotation system 
ChEC Chromatin endogenous cleavage
ChIC Chromatin immunocleavage
ChIP Chromatin immunoprecipitation
CMD1A Dilated cardiomyopathy 1A 
CS Citrate synthase 
DAVID Database for annotation visualization and integrated discovery  
DCM Dilated cardiomyopathy 
Dcr Decorin 
DN Dominant negative 
ECG Electrocardiogram 
ECM Extracellular matrix
EDMD Emery-Dreifuss muscular dystrophy 
ER Endoplasmic reticulum
FC Fold change 
FFA Free fatty acids 
FPLD Dunnigan familial partial lipodystrophy
FS Fractional shortening 
GAPDH Glyceraldehyde 3-phosphate dehydrogenase 
GO Gene ontology
GPC3 Glypican 
GT Gene trap
H&E Hematoxylin and eosin 
HDAC1 Histone deacetylase 1
HE Heterozygous 
HGPS Hutchinson-Gilford Progeria syndrome
HPRT Hypoxanthine-guanine phosphoribosyl transferase 
IBMX 3-isobutyl-l-methylxantine 
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IFNγ Interferon gamma  
IHC Immunohistochemistry
INM Inner nuclear membrane
IP Immunoprecipitation
IVSd Intraventricular septal wall thickness in diastole 
IVSs Intraventricular septal wall thickness in systole 
KI Knock-in 
KO Knock-out
LAD Lamin-associated domain
LMNA-/- Homozygous LMNA knock-out 
LMNA+/+ LMNA wild-type 
LMNAGT-/- Homozygous LMNA genetrap 
LMNAGT+/- Heterozygous LMNA genetrap 
LMNAKO-/- Homozygous LMNA knock-out 
LSB Laemmli sample buffer 
LV Left ventricle 
LVIDd Left ventricular internal dimension in diastole 
LVIDs Left ventricular Internal dimension in systole 
LVPWd Left ventricle posterior wall thickness in diastole 
LVPWs Left ventricle posterior wall thickness in systole 
LVW Left ventricle weight 
MAD Mandibuloacral dysplasia 
MEF Mouse embryonic fibroblast
MS Mass spectrometry
NE Nuclear envelope
NPC Nuclear pore complex
NURD Nucleosome remodeling and deacetylase
NUSAP1 Nucleolar and spindle associated protein 1 
OCT-1 Octamer transcription factor 1 
OLFR Olfactory receptor 
ONM Outer nuclear membrane
OST OneSTrEP
OST-A OneSTrEP tagged lamin A 
OST-C OneSTrEP tagged lamin C 
OST-P OneSTrEP tagged progerin 
PAS Periodic acid shiff 
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Pcna Proliferating cellular nuclear antigen 
PCP Protein correlation profiling
PHD Plant homeo domain 
PP Post partum 
Prx1 Paired related (mesoderm) homeobox 1
RP58 Repressor protein with a predicted molecular mass of 58 kDa  
SDS Sodium dodecyl sulfate  
SR Picro Sirius Red 
Srebp1 Adipocyte differentiation factor sterol element binding protein 1 
SRF Serum responsive factor 
TALE Three-amino acid-loop extension 
TEM Transmission electron microscopy 
TF Transcription factor 
TFM Transcription factor binding motif
Tpr Translocated promoter region 
VMNR Vomeronasal receptor 
VSMC Vascular smooth muscle cell 
WT Wild-type 
Y2H Yeast two-hybrid
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Let us try to teach generosity and altruism, because we are born selfish.  
- Richard Dawkins - 
  
 
 
 
 
  
 
 
 
 
 
 
 
 
  
 
 
 
 
 
